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ABSTRACT 
 Gene edited pigs serve as excellent models for biomedicine and 
agriculture. Currently, the most efficient way to make a reliably-edited transgenic 
animal is through somatic cell nuclear transfer (SCNT) also known as cloning. 
This process involves using cells from a donor (which may have been gene 
edited) that are typically grown in culture and using their nuclear content to 
reconstruct a new zygote. To do this, the cell may be placed in the perivitelline 
space of an enucleated oocyte and activated artificially by a calcium-containing 
media and electrical pulse waves. While it is remarkable that this process works, 
it is highly inefficient. In pigs the success of transferred embryos becoming live 
born piglets is only 1-3%. The creation of more cloned pigs enables further study 
for the benefit of both A) biomedicine in the development of prognosis and 
treatments and B) agriculture, whether it be for disease resistance, feed 
efficiency, gas emissions, etc. Two decades of research has not drastically 
improved the cloning efficiency of most mammals. One of the main impediments 
to successful cloning is thought to be due to inefficient nuclear reprogramming 
and remodeling of the donor cell nucleus. In the following chapters we detail our 
efforts to improve nuclear reprogramming of porcine fetal fibroblasts by altering 
the metabolism to be more blastomere-like in nature. We used two methods to 
alter metabolism 1) pharmaceutical agents and 2) hypoxia. After treating donor 
cells both methods were used in nuclear transfer. Pharmaceutical agents did not 
improve in vitro development of gestational survival of clones. Hypoxia did 
improve in vitro development and we are currently awaiting results of gestation. 
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
1.1 A historical perspective and uses of nuclear transfer 
 Cloning was first described by Hans Spemann as a "fantastical 
experiment" in 1938 (Speman, 1938). Spemann is regarded as the "father of 
cloning" as well as the "founder of micro-surgery". In 1903, Spemann reported 
spliting salamander embryos by using strands of hair. He demonstrated that if 
embryos were split at the two-cell stage, both halves were capable of forming 
whole embryos [reported in (De Robertis, 2006)]. At that point it was proven that 
at the right point of differentiation, cells within an embryo could give rise to two 
separate organisms. It was not determined until years later, that cells could be 
removed and successfully used to make another embryo. Briggs and King were 
first to report transplantation of nuclei into an artificially activated oocyte using the 
North American leopard frog, Rana pipiens in 1952 (Briggs and King, 1952). 
Briggs' motive in conducting these experiments was "to determine whether the 
genome of older somatic nuclei remains equivalent to the zygote nucleus 
throughout development." To this day, we are still investigating this intriguing 
question and the mechanism by which reprogramming of the nucleus occurs. 
Nuclear reprogramming is a term referring to "the switch in gene expression of 
one kind of cell to that of another unrelated cell type" such as an embryo (Gurdon 
and Melton, 2008). The process of nuclear reprogramming is multifaceted and 
encompasses 1) chromatin remodeling, 2) global DNA de-methylation observed 
during fertilization, 3) establishment of proper DNA re-methylation, 4) 
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maintenance of imprinted genes, 5) X chromosome inactivation, and 6) 
regeneration of telomere length (Bourc'His et al., 2001a; Han et al., 2003; Santos 
et al., 2003; Westphal, 2005; Hornen et al., 2007). Experiments have 
demonstrated that reprogramming of a nucleus can occur by: fusion with another 
pluripotent cell, treatment with cellular extract of a pluripotent cell, via 
overexpression of a transcription factor cocktail, or nuclear transfer to eggs or 
oocytes [reviewed in (Gurdon and Melton, 2008)]. The focus of this literature 
review is to highlight investigations to augment cells to be used in nuclear 
transfer to an oocyte in an effort to facilitate nuclear reprogramming and improve 
the success of cloning in mammals. 
 The first successful mammal to be cloned from an adult somatic cell was 
named 'Dolly'; a white-faced ewe cloned from mammary epithelium and born 
from a black-faced surrogate ewe in Scotland (Campbell et al., 1996). Several 
other domestic animals have been successfully cloned including the cow (Prather 
et al., 1987), pig (Polejaeva et al., 2000a), goat (Baguisi et al., 1999), horse (Galli 
et al., 2003), mule (Woods et al., 2003), rabbit (Chesné et al., 2002), rat (Zhou et 
al., 2003a), mouse (Wakayama et al., 1998b), ferret (Li et al., 2006b), cat (Shin 
et al., 2002), and dog (Lee et al., 2005) among others. While we have made 
significant progress and overcame many obstacles to create animals by nuclear 
transfer, the key to what facilitates nuclear reprogramming of a donor cell still 
remains elusive and the efficiency of somatic cell nuclear transfer, cloning, has 
remained stagnant with 1-5% success in mammalian species for two decades 
(Heyman et al., 2002; Whitworth and Prather, 2010).   
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 Immense efforts from scientists have been put forth to determine what 
elements are contributing to the process of improving the efficiency of nuclear 
transfer. Currently if "somatic cell nuclear transfer" is searched on the website 
Pubmed over 2600 publications are returned and a search for "somatic cell 
reprogramming" returns more than 2900 publications, 327 of which were 
published in the last year (2016). As further evidence to our knowledge deficit in 
this area, of the clones successfully created, many are born with "cloning 
syndrome" (Wells et al., 2004). This includes developmental abnormalities such 
as enlarged tongues and other organs in many species, which are evidenced in 
some degree to be due to epigenetic regulation and placental defects (Shin et al., 
2002; Palmieri et al., 2008; Hong et al., 2011; Schmidt et al., 2015). For example 
in a large data set analysis of cloned pigs from Kurome et al. (2013), of the 243 
piglets born alive, only 97 were deemed "clinically healthy and showed normal 
development". In spite of these setbacks the process of cloning is crucial to the 
creation of useful animal models for biomedicine and agriculture, and increasing 
the number of genetically valuable domestic animals.  
 Moreover cloning is becoming a last resort tool when other efforts have 
failed in endangered species conservation. Cloning has been used in efforts to 
rescue the gaur [Bos gaurus] (Lanza et al., 2000); banteng [Bos javanicus] 
(Sansinena et al., 2005); eland  [Taurotragus oryx] (Damiani et al., 2003); 
mouflon [Ovis orientalis musimon] (Loi et al., 2001; Trivedi, 2001); african wildcat 
[Felis silvestris lybica] (Gómez et al., 2004); and grey wolf [Canis lupus] (Oh et 
al., 2008). This technique was also utilized to resurrect the bucardo [Capra 
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pyrenaica pyrenaica], a wild sheep species that formerly lived in Spain (Folch et 
al., 2009). Nearly all of these animals were a result of interspecies transfer using 
domestic animal oocytes and some of these animals have survived, however 
some have also died shortly after birth. 
 The scientific achievements accomplished by means of SCNT are 
undeniable. In biomedicine, pigs are a great model for humans in terms of 
anatomy and physiology but with genetic modification enhanced models have 
been created which better emulate disease phenotypes for several pathological 
conditions. These include cardiovascular diseases, cystic fibrosis, various 
cancers, degenerative eye diseases, epidermal conditions, metabolic diseases, 
muscular atrophies, osteoporosis, neurodegenerative disease, and organ failure, 
reviewed in (Petters and Sommer, 2000; Luo et al., 2012a; Fan and Lai, 2013; 
Prather et al., 2013b). Hitherto the majority of pig models were created by cloning 
and they are being used to study progression and prevention of disease, to test 
effectiveness of treatments, and improve our biological understanding of various 
diseases and cancers. Therefore, further investigation of SCNT technique 
strategies and nuclear reprogramming of donor cells are warranted and 
necessary. 
1.2 Challenges and strategies to improve nuclear transfer 
 The process of nuclear transfer is similar across species involving 1) the 
removal of nuclear material from metaphase II oocytes, 2) the insertion of diploid 
donor nuclei, 3) artificial activation of reconstructed embryos or the oocytes (prior 
to nuclear transplantation), and 4) transfer into the reproductive tract of a 
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surrogate for gestation (Polejaeva et al., 2000a; Lai and Prather, 2003). This 
process has a number of hurdles, however; it has many stages and must align 
with other critical factors including the maturity of oocytes from donor animals 
and the cycle stage of the surrogate recipient. Factors such as the enucleation 
process, artificial oocyte activation, fusion of the newly reconstructed embryo, 
and a multitude of factors regarding the nuclear donor cells and reprogramming 
have been previously investigated and given us insights, but currently the 
success rate remains low.  
 Characteristics of the species used can also present challenges, for 
example, the reproductive tracts and reproductive cycles impact how oocytes can 
be collected, the number of high quality oocytes available, and how and when 
embryos can be transferred. Moreover, there are species differences which make 
the nuclear transfer process more complicated, for example in the horse, the 
zona pellucida must be drilled through for enucleation and nuclear transfer to be 
possible. Additionally for some species like the mouse and cow, embryo 
maturation and culture media have been chemically defined; no longer having 
the inconsistencies of bovine serum or oviductal fluid additives, while for other 
species commercial media may not be as optimal or are still not available.  
 To further complicate matters there are extrinsic factors such as varying 
laboratory environments, different laboratory equipment and technicians, sources 
and availability of  quality oocytes, animal management and embryo transfer 
techniques, differences between 'in house' laboratory embryo culture media and 
protocols, and other aspects. There are a myriad of factors which contribute to 
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the prosperity of nuclear transfer for any given laboratory hence researching all 
aspects of nuclear transfer is quite imperative. A review from Long et al. (2014) 
notes that cloning losses can occur from incompetent oocytes, in-vitro-culture 
insufficiencies, manipulation trauma, and failure of donor nuclei to be 
reprogrammed. Even method of denuding oocytes can impact the subsequent 
development of nuclear transfer embryos (Lin et al., 2015). Evidence supports 
that reprogramming of the donor nucleus may be the main impediment to 
successful creation of SCNT offspring (Hiiragi and Solter, 2005; Whitworth and 
Prather, 2010). This chapter will review literature of previous investigations and 
exploratory attempts to improve donor cell reprogramming for somatic cell 
nuclear transfer.  
1.3 Investigations to improve donor cells for nuclear transfer 
 Early exploration into manipulation and reprogramming of SCNT donor 
cells have focused efforts on reprogramming by the oocyte and synchronization 
of the cell and cytoplast. Investigations of cell type, age, and degree of 
pluripotency have been explored. Other studies have probed to resolve whether 
erasure or correction of epigenetic imprinting can improve cloning efficiency and 
we will discuss the potential of recently discovered epigenetic modifiers. The 
following literature will detail donor cell factors which have been previously 
explored in an effort to improve cloning efficiency and end with our concluding 
thesis to improve nuclear reprogramming via altering donor cell metabolism. 
1.4 Oocyte reprogramming 
 7 
 
 The first findings that the oocyte was capable of reprogramming a 
differentiated cell to totipotency instigated exploration. The cytoplasm of one 
species was found to be capable of reprogramming the nuclei of other species to 
some degree. For example, bovine cytoplasm can support sheep, pig, monkey, 
and rat nuclei to the blastocyst stage (Dominko et al., 1999). These studies were 
important for optimization of nuclear transfer techniques by learning how to 
effectively remove the maternal chromatin/spindle, and imaging during fusion 
enabled us to discover how intermixing of cytoplasmic components between a 
recipient and a donor cell occurred. Even now studies such as these are still 
proving to be useful to researchers. In recent times interspecies nuclear transfer 
was used to determine the best protocol for synchronizing postmortem leopard, 
tiger, and lion fibroblasts via transfer into recipient rabbit oocytes (Yelisetti et al., 
2016).  
 Findings that the aging recipient oocytes are not as successful for nuclear 
transfer (Liu et al., 2007) and that naturally ovulated oocytes are better cytoplast 
recipients than superovulated oocytes (Hiiragi and Solter, 2005) indicate the 
reprogramming capacity of oocytes differs by donor age and by method of 
collection. Duration of in vitro maturation impacted enucleation, fusion, and 
subsequent in vitro development of embryos (Takano et al., 1993). Research 
evidenced different cytoplast requirements for donor cells; embryonic cells such 
as those from blastomeres, could be transferred into S phase oocytes (Barnes et 
al., 1993; Campbell et al., 1994), however somatic cells required MII phase 
oocytes for successful in vitro development (Du et al., 2002). Interestingly, two-
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cell stage enucleated mouse oocytes, support developmental reprogramming of 
nuclei from donor blastomeres, somatic cells, and embryonic stem cells, and 
have even resulted in live cloned pups (Robl et al., 1986; Tsunoda et al., 1987; 
Egli et al., 2007; Riaz et al., 2011).  
 Upon transfer of a nucleus into the oocyte, it undergoes nuclear envelope 
breakdown (NEBD) followed by condensation of chromosome structure by 
maturation promoting factor, MPF, also known as M-phase promoting factor. The 
amount of chromosome condensation in donor nuclei is related to the success of 
cloning (Wakayama et al., 1998b; Shin et al., 2002). Low MPF activity is 
correlated with abnormal pronuclear formation and poor development when 
oocytes are fertilized with sperm (Kikuchi et al., 1995). Selection for oocytes with 
high MPF activity by using a stain such as brilliant cresyl blue enchaces nuclear 
reprogramming and in vitro development in cattle (Su et al., 2012). Increasing the 
activity of MPF by using caffeine improves the rate of blastocyst development in 
pigs (Kawahara et al., 2005).  
 In light of these data, MPF is believed to be the most important 
reprogramming factor in the oocyte cytoplasm. However, other oocyte-secreted 
factors, such as growth differentiation factor-9 are also demonstrated to enhance 
nuclear reprogramming and subsequent development of bovine SCNT embryos 
(Su et al., 2014). Culture of permeablized donor porcine cells with Xenopus  
oocytes reduced donor cell DNA methylation and improved blastocyst cell 
number and development  (Yang et al., 2012). When permeabilized donor 
porcine cells were treated with porcine oocyte extract, the fibroblasts formed 
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stem cell-like colonies and increased expression of pluripotent and chromatin-
modifying genes (Glanzner et al., 2016). Similarly, in bovine fibroblasts cultured 
with Xenopus oocyte extract also began to express the pluripotent marker genes 
such as OCT4 and SOX2 and to form colonies (Miyamoto et al., 2007). Other 
studies have attempted to aggregate embryos in an effort to increase the amount 
of cytoplasm and cytoplasmic factors in cloned embryos, which in part stemmed 
from observations that cloned embryos have fewer total cells than those from in 
vitro fertilization (IVF) or in vivo (IVV) counterparts (Peura et al., 1998; Boiani et 
al., 2003; Misica-Turner et al., 2007). 
 Studies like those previously listed evidencing that oocytes can support 
development of nuclei from various other species demonstrate that the oocyte 
really does have an impressive reprogramming ability and machinery. Perhaps 
the best evidence for this may be findings that serial cloning can restore 
phenotypic normality of incredibly defective pig clones (Cho et al., 2007). 
Hörmanseder et al. (2017) has recently compared NT and IVF Xenopus embryos 
and found 13,083 genes were effectively reprogrammed and 4,504 genes were 
resistant to reprogramming as they were differentially expressed between NT 
and IVF embryos. It is important to note that while the biggest impediment to 
cloning is believed to be ineffective nuclear reprogramming by the oocyte; the 
oocyte evolved to reprogram a haploid sperm nucleus, not the nuclei of somatic 
cells. Recently, a group has sought to take advantage of this in using human 
protamine 1 to protaminize sheep fibroblast nuclei remodeling them into 
spermatid-like structures (Iuso et al., 2015). The results were impressive; 
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protaminized nuclei injected into enucleated oocytes efficiently underwent 
protamine to maternal histone exchange and developed into normal blastocyst 
stage embryos in vitro at a higher rate than controls. However, the ultimate test in 
proving that these donors can serve to produce live lambs has not yet been 
reported. 
1.5 Cell cycle state 
 It is thought that one of the key elements to the achievement of Dolly was 
that Campbell had determined the cell cycle state of the donor cell used for 
nuclear transfer was important and that by serum starvation in culture, the cells 
became quiescent. Experiments from Campbell et al. demonstrated that cells 
from earlier passages had better clone development than cells of later passages 
such as 6-13; however, when the late passage lines were induced to be 
quiescent these were also able to make clones. The researchers postulated that 
quiescence might modify donor chromatin structure aiding in nuclear 
reprogramming (Campbell et al., 1996).  
 The speculated reason cell cycle state is important for nuclear 
reprogramming is because G0/ G1 cells have the correct amount of 
chromosomes; which remain stable for hours allowing nuclear reprogramming 
factors present within the matured oocyte to act upon them. This is in part due to 
studies evidencing that all nuclei transferred into oocytes containing high levels 
of maturation promoting factor activity have nuclear envelope breakdown and 
begin DNA synthesis (Campbell et al., 1993). It is reasoned that cultured cells 
should be in the G0/ G1 phase because these are the two stages at which the 
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cell is not synthesizing DNA, growing, or undergoing mitotic division. In the G0 
phase, cells have exited the G1 phase and are considered to be resting because 
they are not in preparation for division and are performing their cell-type specific 
functions. The G1 phase initiates after the completion of mitosis, thereby starting 
as a newly formed daughter cell. During the G1 phase, the chromosomes have 
stabilized and the cell may be synthesizing organelles and other building blocks it 
may later need. In order to continue to the S phase where DNA is synthesized, 
conditions such as adequate size, energy reserves, and growth factors present 
must be met at the G1 checkpoint.  
 For these reasons, in cultured cells intended for cloning, cell growth and 
availability of growth factors can be limited by culture using media absent of fetal 
bovine serum, known as serum starvation. This is used to induce a G0 state 
wherein cells are no longer dividing. This technique has been employed in an 
effort to synchronize the state of donor cells in many species before nuclear 
transfer and was evidenced to improve the efficiency of nuclear transfer, 
including in vitro development and pregnancy (Campbell et al., 1996; Kato et al., 
1998; Zakhartchenko et al., 1999; Li et al., 2006b). However, there are also 
results and confirmations to the contrary. Cibelli et al. (1998) noted that 
nonquiescent cells in the G1 state may be more suitable for cloning than G0, as 
the absence or loss of proliferation may be indicative of less cellular 
differentiation; the group demonstrated this with the birth of three identical clone 
calves from cycling cells. In this study however, 56% of cycling cells in that study 
were in the G1 stage; therefore the possibility exists that all cloned animals 
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produced in this study were from donor cells at the G1 stage. In experiments 
which synchronized bovine fetal fibroblasts in G0, G1, and different phases within 
G1, serum starvation into G0 resulted in a higher percentage of viable calves at 
term than synchronization in early G1 or late G1 (Wells et al., 2003). Perplexingly 
however, in the same experiments, transgenic fibroblasts selected in G1 had 
higher development to calves at term and higher post-natal survival to weaning 
than cells in G0 (Wells et al., 2003). The authors proposed that to optimize 
cloning, it may be necessary to coordinate specific donor cells to certain cell 
cycle stages.   
 Serum deprivation, even for a few days, can induce DNA fragmentation 
and reduce viability and proliferation of cells (Kues et al., 2000; Kues et al., 2002; 
Park et al., 2010). Tian et al. (2003) demonstrated that serum starvation did not 
further improve bovine blastocyst development compared to normal culture 
growth when adult bull fibroblasts were used as donors. Another study using 
donor cells from a 17 year old Japanese bull found no difference in the rate of 
blastocyst formation between clones from serum starved and normally cultured 
donor cells (Kubota et al., 2000). Therefore results have been mixed and the 
verdict is still unsettled on the matter of whether serum starvation does aid in the 
success of nuclear transfer. Another method of inducing cell synchrony in a G0/ 
G1 state is through cell- to cell contact- inhibition; i.e. culturing cells to high 
confluence. Polejaeva et al. (2000b) compared donor cell serum starvation or 
culturing to confluence on the successful outcome of pig cloning; culturing to 
confluence yielded five piglets vs. zero with serum starvation. In contrast, in 
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rabbit the inverse was true where rate of clone blastocyst production was 
doubled (45 vs. 21%) with serum starved fibroblasts (Li et al., 2006a). Moreover, 
a study from Kasinathan et al. (2001) found no difference in blastocyst production 
of cells cultured to 25 or 100% confluence. Therefore, further research in this 
area is warranted. 
 Aside from serum starvation, a G0/ G1 state can also be achieved 
chemically via cell cycle inhibitors such as roscovitine (Meijer et al., 1997), 
aphidicolin (Ikegami et al., 1978), and butyrolactone I (Kitagawa et al., 1993; 
Kues et al., 2000). While roscovitine and butyrolactone are inhibitors of cyclin-
dependent kinases (cdks; 5 and 2, respectively) which are involved in regulation 
of the cell cycle, aphidicolin inhibits the DNA polymerases α and δ. Roscovitine 
was successfully used in the production of many cloned species (Gibbons et al., 
2002; Hinrichs et al., 2007; Oh et al., 2009; Park et al., 2010; Selokar et al., 
2012). A comparison study of serum starvation, contact inhibition, and roscovitine 
treatment in pig nuclear transfer donor cells found that roscovitine treatment 
yielded the best blastocyst development and also produced healthy cloned 
piglets (Park et al., 2010). In the African wild cat however, there was no 
improvement of subsequent fusion or cleavage with roscovitine or contact 
inhibition of donor cells although no kittens were produced in this study (Gomez 
et al., 2003). Treatment of donor swamp buffalo fibroblasts and granulosa cells 
with aphidicolin prior to nuclear transfer increased blastocyst production of 
clones, and resulted in the birth of 3 calves (Shi et al., 2007). Butyrolactone I has 
been used in different species in an effort to induce and maintain activation of 
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oocytes after fusion (Hill et al., 2000; Zhou et al., 2003a) (Ponderato et al., 2001; 
Yin et al., 2002); however, only one study has used this compound in the culture 
of donor cells and demonstrated cell cycle synchrony, and in that study those 
cells were not subsequently used in SCNT (Kues et al., 2000). 
 Though it was held that quiescent cells are essential to cloning success 
due to the belief this was key to the creation of "Dolly" there is considerable 
indication that non- replicating donor cells may not be necessary. In a nuclear 
transfer study in the rabbit, it was reported that donor nuclei in late S phase 
yielded incomplete or absent meiotic spindle formation and incomplete chromatin 
condensation; however, when G1 and early S phase donors were used 
chromosome constitution in embryos appeared normal (Collas et al., 1992). A 
study from (Lai et al., 2002b) demonstrated that donor fibroblasts treated with the 
microtubule-disrupting agent colchicine, which synchronized ~ 70% of cells in the 
G2/ M stage, were able to make blastocysts and produce a cloned piglet. Nuclear 
transfer of M stage ferret fibroblasts synchronized with brief treatment with 
demecolcine (a microtubule inhibitor) developed into blastocysts and were able 
to establish pregnancies at a normal rate; however, no pregnancies developed to 
term (Li et al., 2005). The amalgamation of these studies demonstrate the 
importance of cell cycle, or lack thereof, is still not fully elucidated. Therefore, 
cycle state of cells perhaps is not a crucial factor in cloning.    
 Part of the donor cell cloning conundrum was thought to be due to species 
differences and type of donor cells used as many of the earlier studies (circa 
1990's) used blastomeres and later studies have used other types of cells. To 
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make matters more complicated results appeared to be impacted by age of cells 
of the same genetic makeup or even amongst similar aged cells collected from 
different individuals. A study from Hill et al. (2000) found that cells from a 21 year 
old bull and those of a gestational day 40 cloned fetus from that bull responded 
differently to serum starvation where the blastocyst rates of fetal cloned cells was 
improved with serum starvation and in adult cells this benefit was not observed. 
Additionally, a study from Powell et al. (2004) demonstrated that the impact of 
serum starvation differed notably between different jersey calf fetal cell lines.  
1.6 Cell type and degree of pluripotency 
 What constitutes the 'ideal' donor cell is an area that was formerly heavily 
investigated. The type of cell as well as the degree to which the cell was aged or 
differentiated may be reflective of the receptiveness of nuclei to reprogramming 
after nuclear transfer. Several cell types have been used for cloning and there is 
not a clear consensus as to which has been the most sucessful. Fetal fibroblasts 
were recognized early as an attractive donor option due to their long G1 phase 
and proliferation in culture (Gadbois et al., 1992); therefore, they are ideal for 
genetic modification. In light of this, there are readily available protocols for 
optimized transfection efficiency (Nakayama et al., 2007; Maurisse et al., 2010).  
 A large scale pig cloning study from Kurome et al. (2013) indicated that 
fetal fibroblasts or kidney cells used as the source for donor cells increased the 
number of piglets born (3.4 piglets) compared to mesenchymal stem cells and 
postnatal fibroblasts (1.6 and 2.0 piglets). Furthermore they found donor kidney 
cells or fetal fibroblasts yielded more healthy piglets (1.4 and 1.9 pigs) than 
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mesenchymal stem cells and postnatal fibroblasts (0.3 and 0.5 pigs). Similarly, in 
Banna miniature pigs, blastocyst production was higher in clones from fetal and 
newborn fibroblast donors and lower in adult fibroblasts and the three groups 
produced corresponding to the live piglet births of 8, 3, and 1, respectively (Wei 
et al., 2013). The organ from which donor fetal fibroblasts are collected also had 
profound influence on blastocyst development in cattle; those derived from hip 
muscle were found to produce 50% more blastocysts than lung fibroblasts 
irrespective of which fetus the two cell types were collected from (Powell et al., 
2004). A study from   hhol er et al. (2001) determined that transgenic clone 
lines derived from the same pig fetus had differences in fusion and subsequent 
development when used in nuclear transfer. In swamp buffalo, fetal fibroblasts 
and granulosa donor cells were able to establish pregnancies, yet only one of the 
clones from fetal fibroblasts had lived past postpartum day 14 (Shi et al., 2007). 
A comparison of cumulus cells, fetal fibroblasts, and adult fibroblast donors in 
horse found that pregnancy rates of adult fibroblast donor SCNT clones was 
more than twice as high than fetal, and no cumulus clones established 
pregnancies (Lagutina et al., 2005). Another observation reported that pig 
blastosyst development was similar in adult donor cells of different origins (liver, 
heart, kidney, muscle, oviduct, ear) except for cumulus cell donors of which less 
than one percent developed to blastocysts (Yin et al., 2002). The same 
researchers used heart and kidney donor- dervied clones for embryo transfer and 
reported 8 healthy piglets from heart cells.  
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 Other evidence indicates that cumulus cells may be a formidible contender 
as sucessful donor cells. Experiments in the ferret illustrated cumulus donor cells 
gave higher birth rates and postnatal viability than fetal fibroblasts, though only 
two ferrets survived to adulthood in the study (Li et al., 2006b). Earlier 
investigations of donor cells in mice found that 1-2% of cumulus donor- derived 
clones lived to adulthood compared to 0.5% of tail fibroblast donors (Wakayama 
et al., 1998a; Wakayama and Yanagimachi, 1999). Although, research from Kato 
et al. (1999) demonstrated a nearby cell type, follicular epithelial cells (used as 
donor cells in comparison to cumulus), produced 5 mice (1 of which died) 
whereas none of the cumulus donor cell clones survived. Use of cumulus cell 
donors has also had success in cattle cloning. Tian et al. (2003) had similar 
pregnancy rates using cumulus and fibroblast donors yet postnatal surival was 
better in cumulus donor cell- derived cows; 4 survived to adulthood vs. 0 of the 
fibroblast donor- derived cattle. In a another cattle study, of the seven female 
calves which survived, 3 were from cumulus donors, 2 from oviduct, 1 from 
fibroblasts, and 1 from newborn fibroblasts (Kato et al., 2000). In addition, Kato et 
al. (1998) had previously found that more pregnancies occurred by using 
cumulus than oviductal cells, though it evidenced higher postnatal death in the 
cumulus donors (3/ 5 vs. 2/ 3 from oviductal donors). The percent of calves which 
were cloned from adult cumulus cells was notablly higher (15.2%) compared to 
adult ear, fetal body cells, or fetal gonadal ridge cells (all ≤ 9.3%) in cattle 
(Forsberg et al., 2002). 
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 In spite of the cumulus cell success, one obvious reason cumulus may be 
less favorable than fibroblasts is that clones produced are female which makes 
expansion of a genetically modified experimental herd more challenging. Another 
disadvantage of cumulus cells is that they do not proliferate well in culture 
making transfection challenging [noted in (Forsberg et al., 2002)]. Nonetheless in 
species which were more challenging to clone, such as the rabbit and cat, 
cumulus cells were the first donor cells to give live births though other cell types 
such as fibroblasts were tried (Chesné et al., 2002; Shin et al., 2002). Shortly 
afterward however, fibroblasts were used in both species sucessfully (Li et al., 
2006a; Yin et al., 2008). Many differentiated cell types from various sources have 
proven clonable in a number of species, including Sertoli cells (Ogura et al., 
2000), macrophages (Wakayama and Yanagimachi, 2001), blood leukocytes 
(Galli et al., 1999; Hochedlinger and Jaenisch, 2002), olfactory neurons (Eggan 
et al., 2004; Li et al., 2004), colostrum-derived epithelial cells (Kishi et al., 2000), 
vaginal smear cells (Kuwayama et al., 2017), and urine-derived cells (Mizutani et 
al., 2016).  
 Age of the cell donor, as well as length of time a donor cell line has been 
cultured were also examined for impacts on cloning efficiency. In one of the 
earliest studies, Campbell et al. (1996) passaged sheep embryonic disk cells for 
6 to 13 passages and found no difference in in vitro development between 
subsequent clones of either passage. Similarly in cattle, it was evidenced that 
while cells from either fetal or adult animals had differences in cell growth and 
cell cycle stages this did not effect the rate of blastocyst formation or cell number 
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in blastocysts (Kasinathan et al., 2001). Moreover, Kubota et al. (2000) produced 
six cloned calves from adult donor cells which had been cultured for a long 
period of time thereby affirming that age of donor nor length of time in culture are 
factors which likely do not profoundly impede cloning ability. In the horse, it was 
reported that two late term abortions both of the same genotype (with one clone 
derived from adult cells and the other from fetal clone cells of the adult) having 
the same umbilical cord defect and was the only abnormality observed in 
otherwise normal fetuses and placentas at necroscopy (Lagutina et al., 2005). 
While it stands to reason that this could have been simply a genetic defect, 
umbilical and placental abnormalities are relatively common in clones. This 
finding might indicate that age of animals from which donor cells were derived 
may not necessarily be the main factor for successful reprogramming. 
 An interesting aspect of cloning is that initially, it was thought that 
differentiated cells would never be able to be cloned. In fact, Gurdon recounted 
that during his ground breaking nuclear transfer work in Xenopus, it was 
unknown whether different kinds of cells of an organism had the same set of 
genes. He noted that due to this, his work was not well received within the 
scientific community for several years (Gurdon, 2017). Briggs and King had 
reported in their Rana pipens nuclear transfer experiments that earlier-staged 
blastula nuclei could be successfully used for nuclear transfer; however, the 
later- staged neurula nuclei were unsuccessful (Briggs and King, 1952). This 
supported the theory of sorts that as cells further differentiate and become 
specialized, they lose their ability to be reprogrammed. It was proposed by 
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Weismann that genes may be lost if they are no longer needed by a given 
differentiated cell type [referenced in (Weismann, 1999)]. The experiments 
conducted by Gurdon demonstrated that differentiated nuclei from intestinal 
epithelium did indeed hold the capacity to be effectively cloned and furthermore 
the offspring of these frogs were alsfo fertile (Gurdon and Uehlinger, 1966).  
 Notably, in most species animals were first cloned from embryonic cells 
for some time prior to cloning being achieved with adult somatic cells. For 
example,before 'Dolly' was born at the Roslin Institute, there were other twin 
sheep named 'Megan' and 'Morag' cloned from embryonic cells born a year prior 
[events described in (Wadman, 2007)]. Preceding 'Second Chance', the first bull 
cloned from adult somatic cells by Hill et al. (2000), Prather et al. (1987) had 
cloned cattle using cleavage-stage bovine embryos. These observations of less-
differentiated cells proving 'clonable' and adult cells proving more challenging to 
clone facilitated the theory that the degree of differentiation is negatively 
correlated to the ability of cells to be cloned. Degree of differentiation, in relation 
to age of the animal or even the duration which cells are kept in culture (passage 
number) and the role it may play in capacity of nuclear remodeling is still 
somewhat puzzling. At this point, in a number of species, various differentiated 
cell types have been effectively cloned and produced animals. This may indicate 
that the degree of donor cell differentiation may not be a highly impactive factor 
in cloning efficiency. Nevertheless, studies continue to arise on occasion 
vindicating this theory regarding donor differentiation, by demonstrating high 
cloning efficiencies using less-differentiated cells.  
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 Developmental comparisons of clones from blastomere donors with other 
donor cell types are evidenced to be quite profound in some species. In primate 
SCNT, Mitalipov et al. (2002) found that blastocyst development of blastomere 
donor NT clones was significantly higher than donors of somatic cells (34 vs. 1 
%) and was much closer to the rate of intracytoplasmic sperm injection controls 
(46%). In mice, transfer of 4-cell embryo donor cells had a high rate of blastocyst 
production (83%) and after transfer to surrogates 8 of 11 mice became pregnant; 
57% of reconstructed embryos transferred were born alive (Kwon and Kono, 
1996). Using either adult or fetal fibroblasts as a donor cell source has proven to 
be less efficient where a reported 4-5% of blastocysts develop to be live pups 
(Saito et al., 2004; Wakayama et al., 2005). Similarly, in goats and sheep, 30% of 
blastocysts derived from blastomere donors develop into viable offspring and 
approximately 5-10% of goat and sheep blastocysts from fetal fibroblast donors 
produce offspring (Schnieke et al., 1997; Wilmut et al., 1999; Keefer et al., 2001; 
Baldassarre et al., 2004). In both of these species, the rate of successful 
offspring from adult fibroblast- derived blastocysts transferred is about 3%. 
[(Wilmut et al., 1999; Keefer et al., 2002) reviewed in (Keefer, 2008)].  
 Perhaps the cow and pig may be the exception to this blastomere donor 
success. Arguably, further research is warranted in the pig. In swine, the cloning 
efficiency is about 1-4%, where the majority of transfers fall between 1-2% 
(Whitworth and Prather, 2010; Kurome et al., 2013). That percentage was not 
improved when blastomeres were used as donors in prior studies; 2 viable pigs 
from 94 reconstructed embryos (2.1%) in research from (Li et al., 2000) and 1 
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piglet from 88 reconstructed embryos (1.1%) in experiments from (Prather et al., 
1989). For the pig however, it would be very useful to repeat these experiments 
as: 1) few were conducted, 2) in vitro culture systems have improved 
substantially in the nearly 20 years that have passed, and 3) blastocyst 
development was low in both studies compared to current developmental rates. 
While there are cases of reported higher SCNT efficiency in pig (Walker et al., 
2002), largely the success rate is typically lower. This has proven to be true 
within large multifactorial data sets demonstrating that 3.95% of transferred 
reconstructed embryos develop to term (Kurome et al., 2013).  
 Inversely in bovine, the percentage of calves born from embryos 
transferred is relatively efficient. Case in point, a reported 10-25% of blastomere 
derived clones transferred produce calves (Stice and Keefer, 1993; Peura and 
Trounson, 1998) and the rate of development from fetal and adult fibroblast 
derived clones is about the same [(Kubota et al., 2000; Gibbons et al., 2002; 
Wells et al., 2003); reviewed in (Keefer, 2008)]. This is probably owed in part to 
cattle typically having singleton pregnancies whereas in pigs, a proportion of the 
uterus must be occupied by viable fetuses to establish a pregnancy (Polge et al., 
1966). Moreover, bovine may have extra time for nuclear reprogramming to 
occur as their embryonic genome activation occurs at the 8- to 16-cell stage (De 
Sousa et al., 1998), whereas in pigs it is the 4-cell stage (Schoenbeck et al., 
1992). Research from Kato et al. (2000) compared adult, newborn, and fetal 
donor cell types from male and female cattle and found that though cells from 
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each stage and six were capable of producing pregnancies, there were higher 
rates of late-term abortion in clones from the adult-dervived cells.  
 Researchers have fused somatic cells to embryonic stem cells (ESCs) of 
the respective species in an effort to reprogram their nuclei (Tada et al., 1997; 
Tada et al., 2001; Do and Schöler, 2004; Cowan et al., 2005) however this 
comes with a set of complications. Somatic cells must be genetically modified to 
incorporate markers for selection of cells that fused properly, and furthermore the 
complete removal of the ESC chromosomes from the fused cells is quite 
challenging [reviewed by (Niemann et al., 2008)]. Due to their pluripotent 
capacity, ESCs as well as induced pluripotent stem cells (iPSCs) were predicted 
to be highly efficient donors for use in cloning. Embryonic stem cells have an 
open chromatin structure (Gaspar-Maia et al., 2011) and increased hyperactive 
global transcription (Efroni et al., 2008). Bona fide iPSCs are capable of 
differentiating into the three different germ layers like ESCs. These cells have 
long-term proliferation in culture, allowing lengthier and potentially more 
sophisticated in vitro gene editing manipulation. When iPSCs were compared 
with their parental cells, it was found that they have improved constitutive 
heterochromatin and, when used as donors, produced live-born cloned mice at 
higher rates (Liu et al., 2012). Traits such as these were thought to make these 
cell types particularly amenable to nuclear reprogramming. 
 When used in nuclear transfer in mice however, ES cells did not replicate 
the high efficiency of cloning observed with blastomeres from a 4-cell embryo; 
22.7 vs. 3.6% pups delivered from reconstructed embryos; however, the percent 
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is similar to that which was achieved by using inner cell mass (ICM) cells, 5.4% 
(Ono and Kono, 2006). Furthermore, the placentas of cloned pups from ES 
donors were enlarged in those experiments. In mice stem cells or induced 
pluripotent stem cells have served to be fruitful donor cells for nuclear transfer. A 
comparison of ES and iPS donor cells used in nuclear transfer demonstrated 
similar percentages of live pups from embryos transferred; 5.7 and 3.2 % 
respectively (Kou et al., 2010). In mice however, it was determined that inbred 
ESC lines are harder to clone than the cross-bred mice; when cross-bred mice 
ESC lines were used as donors for nuclear transfer the percentage of pups born 
from embryos transferred was 17%, whereas the inbred ESC lines produced 8% 
(Eggan et al., 2001). Despite the achievements in mice, rats have proven very 
difficult to clone (Hayes et al., 2001) due to rat oocytes spontaneously activating 
within 60 min of their removal from oviducts (Zernicka-Goetz, 1991). However the 
rat has been cloned from fetal fibroblasts by controlling oocyte activation (Zhou et 
al., 2003b). 
 In spite of the successful induction protocols for ESC and iPSC induction 
in rats (Liao et al., 2009) and mice (Bryja et al., 2006) creating reliable protocols 
has proven to be more challenging in the larger domestic species.  Protocols to 
derive mesenchymal stem cells (MSCs) were developed for pigs and cattle (Kato 
et al., 2004; Colleoni et al., 2005; Faast et al., 2006; da Silva et al., 2016). In 
bovine, (Kato et al., 2004) utilized MSC dervied clones and found 1 of the 13 
embryos transferred survived giving a live born per transferred efficiency of 
7.69%. Similarly, MSCs obtained from aminiotic fluid and adipose tissue both 
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were able to produce a term calf. The live born per transferred efficiency of MSC 
clones from aminonic fluid and adipose tissue were 12.5% and 25% respecitvely; 
1 calf from 8 blastocysts transferred and 1 calf from 4 blastocysts transferred (da 
Silva et al., 2016). 
 Mesenchymal stem cells have also been used as donor cells for cloning in 
pigs. In an experiment from (Faast et al., 2006) blastocyst development of MSC 
donor clones from bone were better than that of MSCs from blood (which were 
similar to fibroblasts), however this group did not transfer the embryos to 
surrogates. Research from (Yang et al., 2016) demonstrated better blastocyst 
development of MSC clones from donors isolated from adipose than of bone 
(which had a rate similar to fibroblast donors). In that study, embryos were 
transferred and the collegues found that the live birth rate was better (1.5%) than 
clones from bone MSC and fibroblast donor cells (0.81 and 0.88%). Another 
study using bone marrow MSCs for nuclear transfer found that 1 of 5 surrogates 
delivered 4 live miniature piglets from 108 reconstructed embryos giving a 
transfer survival efficency of 3.7% for the surrogate which delivered live piglets 
(Lee et al., 2010). As afrorementioned in this review, in the large study by 
Kurome et al. (2013), MSCs and postnatal fibroblast cloning produced fewer pigs 
which were less healthy than those from fetal fibroblast and kidney clones. 
Research from (Hornen et al., 2007) compared in vitro development of clones 
from fetal somatic stem cells and fetal fibroblasts and did not find any 
differences; however, they did demonstrate that these donor cells could make 
piglets, however of the 7 piglets born only 3 were viable. 
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 Others have tried to clone pigs from induced pluripotent stem cells; 
however the results were very disappointing compared to the success this cell 
type brought to mouse cloning. For example one report states that in a multi-
group effort 34,183 reconstructed embryos from 14 different iPSC donor lines 
were transferred into 178 surrogates and while some of these became pregnant 
for awhile, none produced a viable piglet (Fan et al., 2013). A major hurdle for 
cow and pig iPSCs are that both 1) require continued expression of the 
introduced transgenes to maintain some degree of pluripotency, 2) have limited 
passage life, and 3) are not able to form teratomas in immunodeficient mice 
[reviewed in (Ezashi et al., 2016)]. These complications are major drawbacks to 
their utility; however there has been even less success in creating embryonic 
stem cell lines from certain species like the pig. More recently another group 
again evaluated porcine stem cell competence for somatic cell nuclear transfer 
(Secher et al., 2017). The researchers compared 3 iPSC lines with fetal fibroblast 
and embryonic germ cells as donors in cloning and found that while all were able 
to make blastocysts, only the fibroblast and embryonic germ cell lines were able 
to produce pregnancies with 3.2 and 4.0% of transferred embryos producing 
piglets; however, many of the piglets were malformed (Secher et al., 2017).  
 There is ongoing debate as to whether donor cell differentiation is 
important for cloning or not. Some have evidenced and argued that differentiated 
cells may actually be more efficient for cloning than adult stem cells. Experiments 
conducted by (Sung et al., 2006) compared cloning efficiency of mouse 
hematopoietic cells at different differentiation stages: hematopoietic stem cells 
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(HSCs), progenitor cells, or granulocytes, and showed as degree of 
differentiation increased, so did cloning efficiency, where HSCs were not able to 
produce mice and granulocytes were. This was met with scrutiny by other 
researchers whom were less convinced of these findings (Hochedlinger and 
Jaenisch, 2007). They argued among other things, that nuclei of HSCs, in 
contrast to those of granulocytes, are more easily damaged by nuclear transfer, 
flow cytometric sorting, and the freeze-thaw procedures used with all donor cells 
which may give the explanation for lack of HSC- derived mice. 
 In many cases due to isolation procedures, donor cell populations, 
particularly those collected from early fetuses can have high heterogeneity. Due 
to lack of use of genetic markers prior to cloning in many cases, it is impossible 
to unambiguously determine the identities and differentiation states of the donor 
cells that gave rise to the clones in many publications. It has been noted that as 
cloning efficiency is only 1-5% for most mammalian species, it would not be 
impossible for those successful cells cloned to have been adult stem cells. 
However, studies such as the ones performed by Hornen et al. (2007) have 
characterized fetal somatic stem cells from fibroblasts after extraction from 
gestational day 25 fetuses and used both as nuclear transfer donors; however, a 
direct comparison of gestational survival between the cell types was not 
conducted though MSC clones were transferred and did produce piglets. 
 While indeed, it would be useful for donor cells extracted from the fetuses 
to be better characterized, one could argue that depending on the cell culture 
media and flasks, etc provided, only certain cell types like fibroblasts would be 
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able to survive and grow. For example in the study from Hornen et al. (2007), 
while fetal fibroblast cultures were grown in 10% fetal calf serum in standard 
media, growth of fetal somatic stem cells had to be induced with 30% fetal calf 
serum. Furthermore, those cells formed spheroids and were grown in suspension 
cultures. The evidence that iPSCs and ESCs from pigs and cows cannot 
maintain pluripotency without notable effort such as expression of transgene 
factors and culture supplements [reviewed in (Ezashi et al., 2016)] indicates that 
it is somewhat unlikely that undifferentiated stem cells would be 'hiding' in those 
cultures. It is also worthy of note that heterogeneity in stem cell populations is 
also common (Torres-Padilla and Chambers, 2014; Klein et al., 2015) and 
detecting them might be another challenge. 
  Ogura et al. (2013) has suggested that "genomic reprogrammability is 
biologically distinct from the degree of genomic plasticity based on its 
differentiation status". Ogura et al. (2013) also postulated that there is a 
correlation with the gene expression pattern or chromatin structure specific to 
each donor cell type. Indeed this was evidenced to be true (Santos et al., 2003). 
These ideas may also have implications for studies where the same cell type 
collected from different animals can support varying cloning efficiency based on 
which animal it was collected from (Kubota et al., 2000). Perhaps a particular 
animal's genome may be more amenable to cloning than another, which could be 
due to epigenetic effects which are easily influenced by nutrition and diet. 
1.7 Epigenetic correction 
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 Given that nuclear reprogramming entails the need for the reversal of 
acquired somatic cell DNA 'markings' and the establishment of markings 
coherent with proper embryonic gene expression and development, it is not 
surprising that those interested in nuclear remodeling have probed epigenetic 
reprogramming heavily. Additionally the over-sized phenotypes of some clones 
known as 'large offspring syndrome" in addition to placental defects and late 
gestational death, regardless of species, alluded to incorrect expression of genes 
early on. Under normal circumstances after fertilization, parental specific 
demethylation of DNA occurs leading up to global passive DNA demethylation 
[reviewed in (Morgan et al., 2005)]. In the 1-cell to blastocyst stages, 
reorganization and remethylation of histone modifications occurs in waves (Dean 
et al., 2001). During the preimplantation period, there are species-specific 
histone modifications and transcription (Telford et al., 1990; Reik et al., 2001; 
Erhardt et al., 2003; Santos et al., 2003), but in general embryos are in a 
relatively hypomethylated DNA state compared to the hypermethylated DNA 
state of somatic cells. Many studies have made it clear that in clones, complete 
erasure of the somatic epigenome and resetting of imprinted genes does not 
occur (Bourc'his et al., 2001b; Dean et al., 2001; Kang et al., 2002; Santos et al., 
2003; Hörmanseder et al., 2017), and consequently there is aberrant gene 
expression (Inoue et al., 2002; Niemann et al., 2002; Xue et al., 2002; Yang et 
al., 2005; Everts et al., 2008).  
 The discovery that histone deacetylase inhibitors (HDACi) could be used 
in an effort to 'open' chromatin structure via hyperacetylation of histones lead to a 
 30 
 
plethora of studies investigating whether this could aid reprogramming factors' 
access to the donor nuclei. Use of trichostatin A (TSA) in culture media, 
particularly after reconstructed embryos were fused increased development of 
term cloned mice with reports ranging from 3.5 to 10 times higher than that of 
non-treated embryos (Rybouchkin et al., 2006; Maalouf et al., 2009; Van Thuan 
et al., 2009). For cloning of mice, TSA has been largely successful increasing 
blastocyst development rates, cell number within blastocysts, and full-term 
development in several studies. Moreover, TSA was evidenced to reduce 
abnormal DNA hypermethylation (Kishigami et al., 2006), improve 
heterochromatin remodeling (Maalouf et al., 2009), aid formation of DNA 
replication complexes and transcription (Bui et al., 2010), and increase 
expression of development- related genes (Li et al., 2008). Treatment with TSA 
improved blastocyst development regardless of donor cell type used (Kishigami 
et al., 2006) and enabled cloning of mice strains which had never been cloned 
before (Kishigami et al., 2007). Treatment with TSA was truly somewhat of a 
quantum leap for mouse cloning given how little cloning efficiency had improved 
thus far. Recently another HDACi, PXD101 (also known as belinostat) was found 
to have similar impacts on blastocyst development after cloning in mice and the 
establishment of nuclear transfer derived ESCs (Qiu et al., 2017), which TSA had 
not previously achieved (Kishigami et al., 2006). However extended culture (14- 
26 hour duration) with TSA is reported to have deterimental impacts (Tsuji et al., 
2009). 
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 Unfortunately use of TSA was not found to be quite the 'grand slam' for 
cloning of large animals such as pigs and cattle; the results have been mixed. It 
was investigated both as a donor cell treatment and in embryo culture. While 
there were promising reports of improved in vitro development in both species 
(Beebe et al., 2009; Zhao et al., 2009; Hosseini et al., 2016), and in cattle was 
found to be similar to that of IVF development (Iager et al., 2008), there were 
also reports that it did not improve in vitro development (Wu et al., 2008). There 
was a  report of TSA improving in vivo developmental competence in bovine,  but 
the consensus for TSA was that it did not subtantially and reliably improve in vivo 
survival for either species (Zhao et al., 2009; Sangalli et al., 2012; Hosseini et al., 
2016) (Martinez-Diaz et al., 2010). Luckily for these species, another HDACi 
known as Scriptaid (3H-benzoisoquinolin-2-yl)-hexanoic acid hydroxyamide) is 
proving to be effective for cloning of pigs (Zhao et al., 2009; Whitworth et al., 
2011a; Zhang et al., 2017), cattle (Akagi et al., 2011), buffalo (Sun et al., 2015), 
yak (Xiong et al., 2013), and sheep (Wen et al., 2014). Similar to TSA in mice, 
scriptaid is shown to improve histone acetylation and global DNA methylation 
levels to be similar to that of IVF (Sun et al., 2015), upregulate developmental-
related genes and inhibit apoptosis (Zhang et al., 2017), correct some aberrant 
gene expression (Whitworth et al., 2011a), and successfully develop pregnancies 
from inbred pig lines that were previously not able to be cloned (Zhao et al., 
2009). In addition, scriptaid has begun testing in combination with other factors 
such as the proteasomal inhibitor MG132  (Mao et al., 2012) and a DNA 
methyltransferase inhibitor S-adenosylhomocysteine (Zhang et al., 2014). 
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 Several other HDACi were tested in a number of species including 5-aza-
dC (5-aza-deoxy-cytadine)(Enright et al., 2003; Saini et al., 2017), sodium 
butyrate (NaB)(Jafarpour et al., 2011), valproic acid (Kim et al., 2011b; Isaji et al., 
2013; Kang et al., 2013; Miyoshi et al., 2016; Selokar et al., 2017), LBH589 
(panobinostat) (Jin et al., 2013), SAHA (suberoylanilide hyroxamic acid)(Ono et 
al., 2010; Whitworth et al., 2015), APHA (aroyl pyrrolyl hydroxamide)(Van Thuan 
et al., 2009), oxamflatin (Park et al., 2012; Hou et al., 2014; Mao et al., 2015), 
SIRT (sirtinol) (Hirata et al., 2008), PsA (psammaplin A)(Mallol et al., 2014), 
hydralazine (Sangalli et al., 2012), zebularine (Xiong et al., 2013), and 
quisinostat (Jin et al., 2017). The verdict is still out on some of these, whereas for 
others, there was not substantially significant improvement (SIRT and SAHA), for 
others there were mixed results (valproic acid and 5-aza-dC), and the rest  have 
not been tested for in vivo survial or have too few studies to draw conclusions.  
 Another large step in cloning was correction of X chromosome gene 
expression by inhibition or deletion of the gene Xist. Gene expression of cloned 
male and female mouse embryos had revealed ectopic expression of Xist, a 
noncoding RNA that inactivates one of the two X chromosomes in females, was 
downregulating X-linked genes for development in both sexes (Inoue et al., 
2010). The group had deleted Xist which was being expressed from the active X 
chromosome and this resulted in 8-9 fold increase in cloning efficiency in mice. 
Afterword it was determined that RNA interference (injection of siRNA) could be 
used to knockdown Xist in cloned embryos thereby enabling this benefit to be 
instilled in any cloned embryos without need for gene modification (Matoba et al., 
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2011). In those experiments, cloning efficiency with Xist knockdown improved 12 
fold (12 vs. 1% in controls). Cattle and pigs are also evidenced to have X 
chromosome- related faulty epigenetic reprogramming. Xue et al. (2002) 
observed aberrant expression patterns in nine of ten X-linked genes and 
hypomethylation of Xist in organs of deceased clone calves. Similarly in pigs, 
expression of 5 X-linked genes was abnormal in dead cloned piglets, however 
interestingly, expression of these genes was only moderately different from 
controls in living clones (Jiang et al., 2008). The authors suggested that there 
may be a coorelation between clone survival and normality of X-linked gene 
expression. To our knowledge no one has attempted to correct Xist expression in 
cattle, however, in pigs though there were really promising in vitro results with 
Xist knock out, Lia and colleges (2017) have not been able to produce piglets 
after several attempts (personal correspondence).   
 Another discovery which has served mouse cloning well is the 
identification of 'reprogramming resistant regions' (RRRs) in regions expressed in 
2-cell IVF embryos, but not in SCNT embryos (Matoba et al., 2014). They found 
that in somatic cells RRRs are enriched for H3K9me3 and that either use of the 
demethylase Kdm4d (RNA microinjection) or depletion of H3K9 
methyltransferases (donor cell transfection with short interfering RNAs (siRNAs) 
targeting two histone lysine methyltransferases) could greatly improve SCNT 
efficiency from 1% to about 8% of transferred zygotes developing to term 
(Matoba et al., 2014). Currently there are no published reports of similar trials 
testing these experimental findings in other mammals cloned; however, abnormal 
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heterochromatin or H3K9me3 status is found in SCNT embryos of other species 
(Santos et al., 2003; Pichugin et al., 2010; Yang et al., 2013). Therefore clones 
reconstructed from these species could potentially benefit from use of Kdm4d 
microinjections after fusion.  
 More recently, a group characterized epigentic regulation for the 'memory' 
associated with active transcription of endoderm donor cells after use in nuclear 
transfer in Xenopus (Hörmanseder et al., 2017). These researchers found that 
active transcription of endoderm genes after cloning was H3K4 methylation-
dependent, and that when donor cells were treated with Kdm5b, a H3K4-specific 
demethylase, about 60% of embryos reached the tadpole feeding stage, whereas 
only 30% of those treated with inactive version of the enzyme reached this time 
point. In the generation of iPSCs and ESCs in mice, fibroblast-specific genes 
Zfpm2 and Hoxa9 were found to have strong H3K4 methylation in mouse 
embryonic fibroblasts and this was not corrected in subsequently derived iPSCs 
or ESCs demonstrating resistance to reprogramming (Wernig et al., 2007). This 
may indicate that donor cell treatment or embryo microinjection with Kdm5b 
could also benefit mammals as well. In the study from Matoba et al. (2014) 
another candidate RRR gene Zscan4d was also identified. This gene was 
demonstrated to reactivate embryonic developmental genes in iPSCs (Hirata et 
al., 2012) and to function in telomere elongation (Sung et al., 2014), therefore it 
held a lot of promise. However, when Matoba et al. did over express this gene, it 
did not improve blastocyst development and was thereafter not used for embryo 
transfer experiments. Whether this would be beneficial in the cloning of other 
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species remains unknown. In other species, comparison of two-cell IVF and 
SCNT embryos, as was used in investigations from Matoba et al. (2014), would 
likely uncover other RRRs which may be species-specific and aid in efficient 
nuclear reprogramming comparable to what has been achieved in the mouse.  
 Though pig has not had nearly the improvement in cloning success as 
cattle and mice, a methyltransferase has been identified that could prove to be 
useful. Huang et al. (2016) demonstrated that post activation treatment of cloned 
embryos with BIX-01294 [known as specific inhibitor of G9A (histone-lysine 
methyltransferase of H3K9)] significantly enhanced the cloning rate from 1.59% 
in controls to 2.96% with treatment. More recently, the same group showed that 
combination treatment with BIX-01294 and TSA treatment increased expression 
of proteins associated with lineage differentiation in SCNT blastocysts and 
decreased the levels of 5mC and H3K9me2 in trophectoderm lineage similar to 
IVF and IVV counterparts (Cao et al., 2017).   
1.8 Potential future epigenetic modifiers 
 As the importance of nuclear remodeling in reprogramming following 
somatic cell nuclear transfer has been recognized (Mitalipov et al., 2007), use of 
epigenetic chromatin remodelers may be useful as either donor cell treatments or 
for RNA injection after fusion. In evidence of this, prior research indicated 
increased reprogramming efficiency of mouse iPSCs when the histone H3K79 
methyltransferase DOT1L was inhibited using a selective pharmacological 
inhibitor EPZ004777, known as EPZ (Ye et al., 2016). Later, porcine cloning 
researchers inhibited DOT1L via 0.5 nM EPZ treatment post activation which 
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enhanced the blastocyst formation, reduced the level of H3K79me2, increased 
the expression levels of genes involved in pluripotency and early cell 
differentiation (Tao et al., 2017). It remains to be determined whether that will 
impact survival of clones during gestation.  
 There is no shortage of prospective candidates discovered by those 
researching embryonic and induced pluripotency which could be gleaned for use 
in nuclear reprogramming and remodeling in cloning. Moreover (Ohata and Kato, 
2016) have recently shown the ability of OCT4 and SOX2 gene expression 
patterns (in biopsied cells) to be useful in estimation of survival probability for NT 
embryos prior to embryo transfer. Many of the candidate genes identified by 
researchers for preservation or renewal of ES or iPS cells regulate expression of 
these genes. The INO80 complex was identified as self-renewal factor in 
embryonic stem cells (Chia et al., 2010) and is a chromatin remodeling complex. 
Wang et al. (2014) demonstrated that INO80 expression quickly increased during 
the course of reprogramming somatic cells into to iPSCs and when it was 
inhibited by shRNA, this dramatically reduced the number of alkaline 
phosphatase-positive iPSC colonies formed. Furthermore, the researchers 
showed that when INO80 siRNA was injected into one-cell embryos very few 
embryos were able to develop into blastocysts; therefore this might be a good 
candidate for microinjection into reconstructed embryos. The transcription factor 
zinc finger protein 217 (Zfp217) was discovered to play an essential role in ESC 
self-renewal and in the reprogramming of somatic cells (Aguilo et al., 2015). 
Further it was evidenced to regulate transcription of key pluripotency and 
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reprogramming genes, including NANOG, SOX2, KLF4, and C-MYC as well as 
promote their stabilization, therefore it was suggested that it may play an 
important role in embryonic development (Aguilo et al., 2015); however that 
remains to be further elucidated. Other chromatin decondensation and 
remodeling cellular factors identified in derivation of iPSCs which could prove 
useful in SCNT are BRG1, BAF155, and CHD1 [reviewed in (Pasque et al., 
2011)]. Given the evidence that rate of transcription increases as the chromatin 
of nuclei transplanted to Xenopus oocytes becomes decondensed, it is probable 
that the resistance of somatic nuclei to transcriptional reprogramming by oocytes 
can be in part explained by the condensed state of chromatin (Pasque et al., 
2011).  
1.9 Metabolic state 
 Powell and coworkers (2004) examined the impact of cell culture media 
type, serum concentration, and oxygen concentrations on donor cells from 
different bovine tissue sources for cloning; however characterization of cellular 
metabolism was not measured outside of cellular proliferation and GFP 
production. Cloned embryos have been cultured with a number of antioxidants.  
Treatment of adult bovine fibroblast donors with vitamin C improved blastocyst 
rate, reduced the number of apoptotic cells in blastocysts, and increased 
expression of pluripotency genes (Chen et al., 2015). Vitamin C was also 
demonstrated to improve somatic cell reprogramming to iPSCs (Chen et al., 
2013). However, vitamin C addition to culture media has been met with mixed 
results where it improved development of SCNT mouse (Mallol et al., 2015) and 
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pig (Huang et al., 2011) clones, but was harmful to development of bovine clones 
(Li et al., 2014). Other antioxidants such as resveratrol-trolox and melatonin have 
aided the development of pig (Lee et al., 2015) and cow (Su et al., 2015) cloned 
embryos respectively. Few prior studies have sought to program donor cell 
metabolism specifically.  
 Despite the immense number of investigations in search of finding what 
makes a donor cell more clonable, many results are largely inconclusive 
regarding cell type, state of cycle, degree of pluripotency, etc. Epigenetic state 
appears to play an important role and copious investigations into fixing this have 
aided to some degree, however this is a mere increment in the standstill 
efficiency of cloning for some species. While no one factor appears to stand out 
without fail amongst species, it may be reasoned given the evidence we have, 
that using blastomeres as donors for nuclear transfer seems to be one of the few 
factors that demonstrates notable improvement. The metabolism of blastomeres 
has been characterized to have a Warburg effect-like nature whereby there is 
increased glycolytic activity and decreased use of oxidative phosphorylation 
(Krisher and Prather, 2012; Redel et al., 2012; Mordhorst et al., 2016). Glycolysis 
has been evidenced to improve reprogramming to a pluripotent state (Varum et 
al., 2009; Zhu et al., 2010; Folmes et al., 2011; Shyh-Chang and Daley, 2015). In 
light of this, we hypothesized that inducing donor cells to have a Warburg effect-
like metabolism observed in early blastomeres may facilitate better nuclear 
reprogramming and subsequent survival of clones during gestation. The following 
chapters entail our experiments to test that hypothesis using either 
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pharmacologic agents or hypoxia to induce or promote a Warburg effect-like 
metabolism in porcine fetal fibroblasts prior to their use in somatic cell nuclear 
transfer. 
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CHAPTER 2 
PHARMACOLOGIC REPROGRAMMING DESIGNED TO INDUCE A 
WARBURG EFFECT IN PORCINE FETAL FIBROBLASTS ALTERS GENE 
EXPRESSION AND QUANTITIES OF SPENT MEDIA METABOLITES 
WITHOUT INCREASED CELL PROLIFERATION. 
2.1 Abstract 
 The Warburg effect is a metabolic phenomenon characterized by 
increased glycolytic activity, decreased mitochondrial oxidative phosphorylation, 
and the production of lactate. This metabolic phenotype is characterized in 
rapidly proliferative cell types such as cancerous cells and embryonic stem cells. 
We hypothesized that a Warburg-like metabolism could be achieved in other cell 
types by treatment with pharmacological agents which might in turn facilitate 
nuclear reprogramming. The aim of this study was to treat fibroblasts with CPI-
613 and PS48 to induce a Warburg-like metabolic state. We demonstrate that 
treatment with both drugs altered the expression of 69 genes and changed the 
level of 21 metabolites in conditioned culture media but did not induce higher 
proliferation compared to the control treatment. These results support a role for 
the Reverse Warburg effect whereby cancer cells induce cancer associated 
fibroblast cells in the surrounding stroma to exhibit the metabolically 
characterized Warburg effect. Cancer associated fibroblasts then produce and 
secrete metabolites such as pyruvate to supply the cancerous cells thereby 
supporting tumor growth and metastasis. While anticipating an increase in the 
production of lactate and increased cellular proliferation, both hallmarks of the 
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Warburg effect, we instead observed increased secretion of pyruvate without 
changes in proliferation. 
2.2 Introduction 
 A hallmark of the "Warburg effect",  characterized by its namesake, Otto 
Warburg, is the predominate use of glycolysis for energy production as opposed 
to the use of pyruvate metabolism and mitochondrial oxidative phosphorylation 
typically employed in differentiated somatic cells. Warburg speculated that 
cancer was linked to the metabolic switch from respiration of oxygen to the 
fermentation of sugars for energy in normal body cells due to mitochondrial 
impairment (Warburg, 1956; Koppenol et al., 2011). Vander Heiden et al. (2009) 
illustrated the use of this seemingly atypical metabolism is attributed to be 
favorable for the production of biomass and reduction of reactive oxygen species 
(ROS). Indeed, this metabolic phenotype may likely be more resultant of 
mutations in tumor suppressors, oncogenes, and mitochondrial DNA that is 
causative of cancer (reviewed in (Koppenol et al., 2011)). Moreover 
investigations finding that mitochondrial oxidative phosphorylation is active in 
cancer cells have stimulated an emerging hypothesis of the so-called 'reverse 
Warburg effect' (Zheng, 2012). In the reverse Warburg effect epithelial cancer 
cells induce the Warburg effect in nearby stromal fibroblasts thereby coercing 
them to produce pyruvate and lactate to support tumor growth and metastasis. 
We hypothesized that it may be possible to pharmacologically induce a Warburg-
like effect metabolism in fibroblasts by inhibiting mitochondrial oxidative 
phosphorylation and promoting glycolytic activity by using pharmacological 
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agents. Additionally we inquired whether programming of metabolism could lead 
to reprogramming of the nucleus driving changes in gene expression that might 
be similar to Warburg effect-like cell types and lead to increased cellular 
proliferation.  
 There is a correlation between increased glycolytic metabolism and 
pluripotency. Cytosolic acetyl-CoA produced by glycolysis promoted histone 
acetylation during pluripotency in stem cells and the inhibition of glycolysis 
caused deacetylation and differentiation of pluripotent cells (Moussaieff et al., 
2015). Furthermore, prior to cells achieving pluripotency, there is upregulation of 
glycolysis early in induced pluripotent stem cell (IPSC) reprogramming (Folmes 
et al., 2011; Shyh-Chang and Daley, 2015). Increased signaling of the PI3K 
pathway is correlated with an increase in glucose metabolism within cancer cells 
and is consistent with the Warburg effect. The allosteric small molecule PS48 (5-
(4-Chloro-phenyl)-3-phenyl-pent-2-enoic acid) activates phosphoinositide-
dependent protein kinase 1 (PDK1) by binding exclusively to the HM/ PIF binding 
pocket rather than the ATP-binding site (Hindie et al., 2009; Stroba et al., 2009; 
Zorn and Wells, 2010). Our goal was to utilize PS48 to enhance glycolysis and 
decrease mitochondrial oxidation. PS48 has been shown to enhance 
reprogramming efficiency of induced pluripotent stem cells by about 15-fold and 
is evidenced to promote glycolysis and lactate production (Zhu et al., 2010).  
A second candidate to alter metabolism of donor cells to be more similar 
to that of an early embryo is a lipoate analog known as CPI-613 (6, 8-
bis(benzylthio)octanoic acid: hereafter called CPI). CPI is a mitochondrial 
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disrupter via inhibition of the mitochondrial enzymes pyruvate 
dehydrogenase and α-ketoglutarate dehydrogenase (Zachar et al., 2011; Stuart 
et al., 2014). Inhibiting precursors for entry into the TCA cycle should decrease 
use of the TCA cycle activity and promote the glycolytic pathway to meet 
metabolic requirements.  
In this study we investigated effects of PS48 and CPI dosages on cell 
viability, longevity and cell cycle length. Conditioned media metabolites and gene 
expression were analyzed to determine if metabolic pathways consistent with the 
Warburg effect were induced in fibroblasts. 
2.3 Materials and methods 
All materials were purchased from Sigma-Aldrich, St. Louis, MO unless otherwise 
specified. 
Compliance with Ethical Standards 
 This study does not contain any studies with human participants 
performed by any of the authors. All procedures performed in studies involving 
animals were in accordance with the ethical standards of the University of 
Missouri Institutional Animal Care and Use Committee at the University of 
Missouri in Columbia, MO. 
Fetal-derived fibroblast cell culture and Trypan Blue exclusion 
 A gilt was artificially inseminated and humanely euthanized via ear vein 
infusion of Euthasol at 35 days post insemination. The reproductive tract was 
excised from the cervix to ovaries and opened along the entire length of uterine 
horns for fetal collection. Tissue was excised from the posterior region of a single 
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eviscerated fetus and washed in 1 X phosphate-buffered saline (PBS). 
Genotyping was used to confirm this fetus was female. Cells were liberated by 
brief homogenization and tissue pieces were then placed in digestion media 
(Dulbecco-modified Eagle medium containing 1 g/ L and D-glucose and L-
glutamine [DMEM]; Corning, Corning, NY) with 200 units/ mL collagenase and 25 
Kunitz units/mL DNaseI) for three hours. Fibroblast cells were pelleted then 
replated in DMEM (15% fetal bovine serum, FBS; Corning, Manassas, VA) and 
cultured to confluence. Afterwards they were dissociated, pelleted, resuspended, 
and diluted to 1.5 million/ mL in media containing 85% FBS and 15% DMSO, and 
then frozen in liquid nitrogen (0.5 mL aliquots; ~ 80 cryogenic vials). A separate 
vial of fibroblasts was thawed for each replicate of each experiment; the same 
cell line was used throughout all experiments. During the experiments incubators 
were maintained at 38.5°C with a humidified atmosphere of 5% oxygen, 5% 
carbon dioxide, 90% nitrogen. In both experiments, all cells were thawed and 
cultured in DMEM (1 g/ L glucose, glutamine, and pyruvate with phenol red; 
Sigma, St. Louis, MO supplemented with 15% FBS (Corning, Manassas, VA, 
USA)) for seven days in T25 flasks (Corning, Corning, NY) with or without the 
addition of respective treatment concentrations of CPI-613 (CPI, Sigma, St. 
Louis, MO) or PS48 (Stemgent, Cambridge, MA). Media was changed daily on all 
flasks, i.e. those which received PS48 or CPI had new drugs applied daily (24± 2 
hours). In a separate experiment cells were grown in T75 flasks and drugs were 
spiked in during the week of treatment (no media changes) and cell growth was 
 45 
 
measured by Trypan blue staining (1:1 ratio of cell suspension and stain 
volumes) by using an automated cell counter. 
 In a preliminary experiment porcine fetal fibroblasts were treated with 
either CPI (25, 50, or 100 µM), PS48 (1, 5, or 10 µM), or as controls (0 µM) for 7 
days of culture to determine which doses of CPI and PS48 to utilize. In the main 
study, porcine fetal fibroblasts were treated with PS48 (10 µM), CPI (100 µM), a 
mixture of PS48 and CPI (10 µM and 100 µM), or treated as controls (0 µM) for 7 
days of culture. Stock aliquots of CPI were diluted to 100 mM and PS48 stocks 
were 10 mM to eliminate potential confounding of DMSO quantity between the 
two pharmaceutical treatments (CPI and PS48). Cells were initially plated at 1 x 
105 cells/ mL in T25 flasks. After 72 and 120 hours, cells were passaged to new 
T25 flasks. At 120 hours, cells in all treatments were plated (density: 5 x 105 
cells) to achieve ~80% confluence at 168 hours. At initial thawing and 
subsequent passages, cell proliferation and percentage of live cells were 
measured by Trypan blue exclusion staining via automated cell counter (TC20 
automated cell counter, Bio-Rad). At passage, cells were briefly rinsed with PBS 
0.01 M EDTA and dissociated by brief incubation (37°C) from flasks using 1 x 
TrypLE Express (Gibco, Denmark). Cells were pelleted (5 min at 500 x G) and 
suspended in 5 mL DMEM containing 15% FBS; for every treatment 200 µL of 
cell suspension was mixed in a 1:1 ratio with 1X Trypan Blue stain and 10 µL of 
the mixture was quantified in counting chamber slides. As per the vertical axes in 
Figures 2A and 2B, samples measured for viability contained at least 250,000 
cells. After Trypan measures were taken, treatments were diluted as needed to 
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achieve an even cell number across treatments and replated with respective 
treatment media. Life span was measured in PS48 treated cells; fibroblasts 
treated daily with 0, 5, or 10 µM PS48 were continuously passaged after reaching 
~80% confluence and considered dead at the point where after 24 hours of 
passaging the cells did not re-plate and grow. Normality of data was assessed as 
via Univariate procedure in SAS 9.4 (SAS, Cary NC) using the option for 
generation of normality test P-values which included Shapiro- Wilk, Kolmogorov- 
Smirnov, Anderson-Darling, and Cramér- von Mises tests. Log transformations 
were made where appropriate prior to statistical analysis. All Trypan blue 
exclusion proliferation data was analyzed for effects of treatment, day, and the 
interaction of treatment by day using the generalized linear model procedure of 
SAS 9.4. For ease of interpretation, all figures depict SAS generated least 
squared means and standard error values which are not transformed. 
Flow cytometry: cell preparation and staining 
  On day 7 (168 hours) media was removed, flasks were briefly rinsed with 
PBS 0.01 M EDTA, and fibroblast cells were dissociated from flasks by brief 
incubation (37°C) with 1X TrypLE Express (Gibco, Denmark) and pelleted (5 min 
at 500 x G). Fibroblasts used for live cell mitochondrial staining, were 
immediately suspended in 1X DMEM without phenol red (Corning, Corning, NY) 
and appropriate drug concentrations were added for each treatment. For viability 
staining, fibroblasts were suspended in 1X Binding Buffer then stained and 
incubated with Annexin-V-FITC and Propidium Iodide (50 µg/ mL, 37°C, 5 
minutes; BioVision, Milpitas, CA). In viability cytometry acquisitions fibroblast 
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cells received their respective treatments during staining and pharmaceutical 
agents were present in media during data collection. For cell cycle analysis, 
pelleted cells were suspended in ice cold 1X PBS and 2.5 mL of cold (4°C) 100% 
ethanol was slowly dripped into the PBS suspension while under constant slow 
vortex. After fixation, fibroblast cells were rested on ice for 30 minutes. Fibroblast 
cells were subsequently pelleted and incubated in a 500 µL PBS mixture with 50 
µg/ mL of propidium iodide (PI), 0.05% Triton X- 100, and 0.1 mg/ mL RNase A 
for 45 minutes. After staining cells, 3 mL of 1X PBS was added, cells were 
pelleted (500 x G for 5 min), and 3 mL of media was removed and pellet 
resuspended leaving propidium iodide in excess during the cytometry run.  
Flow cytometry: data acquisition and analysis 
 For cytometry data collected, gating protocols were applied for analysis of 
a population free of debris and doublet cells by using plots of side scatter height 
x forward scatter height, forward scatter height x forward scatter area, and 
forward scatter height x forward scatter width. In all flow cytometry experiments, 
three biological replicates were collected for analysis; in each we used three 
technical samples with at least 50,000 cells in the 'single cell' gate using the 
protocol described above for each treatment. Data was assessed for normality by 
using the Univariate procedure in SAS 9.4 (SAS, Cary NC) by using the option 
for generation of normality test P-values which included Shapiro- Wilk, 
Kolmogorov- Smirnov, Anderson-Darling, and Cramér- von Mises tests. Log and 
squre root transformations were made where appropriate prior to statistical 
analysis. Data was analyzed by using the generalized linear model procedure of 
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SAS 9.4 for main effect of treatment for flow cytometry acquisitions. For ease of 
interpretation, all figures depict least squared means and standard error values 
generated by using SAS which are not transformed. 
Annexin-V-FITC and propidium iodide cell viability 
 Fibroblast viability was measured based on positive fluorescence in a FL x 
FL2 (530/40 x 575/25 filters) channel plot by using a Beckman Coulter CyAN 
ADP Analyzer cytometer (Beckman Coulter, Inc, Fullerton, CA). Axis of plots 
were determined by using fibroblasts singly stained with either annexin-V (FITC 
conjugated) or propidium iodide as well as by using unstained control cells. 
Fibroblasts were defined as healthy and viable if they did not stain positively for 
annexin-V or propidium iodide.  
Propidium iodide cell cycle cytometric acquisition 
 Intensity of propidium iodide staining in ethanol fixed fibroblasts was 
measured by using a BD LSR Fortessa X-20 cytometer (Becton Dickinson, 
Franklin Lakes, NJ) equipped with a 552 nm laser and 610/ 20 dichroic filter. 
Stage of the cell cycle was determined by using a Watson pragmatic model and 
curvilinear analysis in FlowJo version 7 software (FlowJ0, LLC, Ashland, OR).  
Conditioned media metabolite gas chromatography and mass 
spectroscopy analysis 
 Conditioned media samples were collected from three replicates of CPI 
(100 µM), PS48 (10 µM), MIX (CPI 100 µM + PS48 10 µM), and CON (0 µM) 
treated flasks on days 3, 5, and 7 of culture and were spun at 600 g for 6 minutes 
to remove any cellular debris then frozen at -20°C. The number of cells growing 
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on flasks from which media was collected are reported in Figures 1A and 1B. 
Samples were thawed, vortexed, and 1 mL was used for metabolite analysis. 
Chloroform (1 mL) and HPLC-grade water containing internal standard 25 µg/ml 
ribitol (1 mL) were added to media samples. The samples were then vortexed 
and centrifuged at 2900 g for 30 min at 4°C to separate the layers. The upper 
aqueous layer (1 mL) was collected and transferred to individual 2.0 mL 
autosampler vials and dried under nitrogen at 45°C. Dried polar compounds were 
methoximated in pyridine with 120 µL of 15.0 µg/ mL methoxyamine-HCl, briefly 
sonicated, and incubated at 50°C until the residue was resuspended. Metabolites 
were then derivatized with 120 µL of MSTFA+1% TMCS for 1 h at 50°C. The 
samples were subsequently transferred to a 300 µL glass insert and analyzed 
using an Agilent 6890 gas chromatographer coupled to a 5973 MSD scanning 
from m/z 50–650. Samples were injected at a 15:1 split ratio, and the inlet and 
transfer line were held at 280°C. Separation was achieved on a 630 m DB-5MS 
column (J&W Scientific, 0.25 mm ID, 0.25 µm film thickness) with a temperature 
gradient of 5°C /min from 80°C to 315°C and held at 315°C for 12 min, and a 
constant helium flow of 1.0 mL/ min.  
 The raw data were processed using AMDIS software (Automated Mass 
spectral Deconvolution and Identification System, http://chemdata.nist.gov/mass-
spectra/amdis/). Derivatized metabolites were identified by matching retention 
time and mass spectra to those in a custom library of authentic compounds. 
Abundances of the metabolites were extracted with MET-IDEA (Broeckling et al., 
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2006; Lei et al., 2012), and then normalized to the abundance of the internal 
standard ribitol for statistical analyses.   
 Conditioned media was analyzed using the program SAS (Cary, NC). The 
model for each of the metabolites included treatment effect (CON, CPI, MIX or 
PS48) and Day effect (3, 5 or 7) as fixed effects, and the replicate as a random 
effect. The interaction between Treatment and Day was included when 
significant. The heterogeneous autoregressive (1) covariance structure was used 
to model the correlations among the repeated measures at different days. To 
meet the normality assumption in the linear regression models, the metabolites 
were either modeled at original scale or transformed to log-scale or square root 
scale. The studentized residual plot and normal quantile plot were used for 
checking model fitting. For the pairwise comparisons, the Tukey- Kramer method 
for multiple test adjustment was used.  
 For day 5 comparisons between culture media with drugs spiked in (Spike; 
no daily media changes) or added daily in a media change (Change) cells 
proliferated differently (Figure 2). To account for this, cell numbers of treatments 
were used to normalize data relative to the Change CON treatment prior to 
further analysis. The model for each response variable consisted of the treatment 
effect (CON, CPI, MIX or PS48), change effect (Spike or Change), and the 
interaction between these two, as fixed effects. The replicate was considered a 
random effect. The data was normalized by using Quantile Normalization. The 
response variables were either modeled at original scale or transformed to log-
scale or square root scale, to fulfill the normality and homogeneity of variances 
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assumptions in the linear regression models. The studentized residual plot and 
normal quantile plot were used for checking model fitting. For the pairwise 
comparisons between the main effects of the Tukey-Kramer method for multiple 
test adjustment was used. In the case of the interaction, the comparison Change 
vs. Spike was considered in each of the treatments. 
Extraction of RNA and sequencing 
 Fibroblasts were collected for RNA after 7 days of respective culture 
treatments for 4 biological replicates. The number of cells in a flask collected for 
sequencing are reflected in Figures 2A and 2B. The cells were dissociated from 
culture flasks by brief incubation (37°C) with 1 x TrypLE Express (Gibco, 
Denmark) by the same method used for cytometry. Cells were pelleted (5 min at 
500 x G) rinsed with 1X PBS, again pelleted and cells were plunged into liquid 
nitrogen and stored at -80 °C. Extraction of RNA was performed as per 
specifications using Qiagen RNeasy mini kits (Qiagen, Germantown, MD). Total 
RNA quality at the University of Missouri DNA core facility by using the Advanced 
Analytical Fragment Analyzer and RNA quality scores were assigned based on 
1) the presence of discrete 18S and 28S rRNA bands, 2) the mass ratio between 
the 28S and 18S rRNA, 3) the absence of fragments in the pre-18S and 28S 
regions, and 4) absence of contaminating high molecular weight fragments. All 
RNA utilized in this study had scores of 10 (the highest score possible). RNAseq 
libraries were prepared at the University of Missouri Core facility by using 
standard Illumina protocol and sequenced on an Illumina HiSeq 2000 platform as 
single-end reads with read depth of 50 million reads/ sample. The raw sequences 
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(FASTQ) were subjected to quality check by FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The program fqtrim 
(https://ccb.jhu.edu/software/fqtrim/) was used to remove adapters, perform 
quality trimming (phred score >30) by sliding window scan (6 nucleotides) and 
select read length 30 nucleotides or longer after trimming. The reads obtained 
from the quality control step were mapped to the Sus Scrofa (v10.2) reference 
genome using Hisat2 aligner which is a fast and sensitive alignment program of 
next-generation sequencing data (Kim et al., 2015). The program FeatureCounts 
(Liao et al., 2014) was used to quantify read counts using the sequences 
alignment files of each sample. The differentially expressed (DE) genes between 
sample groups, representing the culture treatment, were determined by fitting the 
read counts to a generalized linear model implemented in edgeR-robust (Zhou et 
al., 2014). The false discovery rate (FDR) < 0.05 was used as threshold for 
statistical significant differential expression of genes. 
2.4 Results 
Impact of pharmacological treatment on fibroblast viability and 
proliferation 
 Without daily media changes proliferation of cells was decreased in some 
cases to 50% of the cell number achieved with media changes (CPI and MIX; 
Figure 2A) therefore in our further experiments new media and pharmaceutical 
agents were applied daily, as opposed to being spiked into the media. Initial 
experiments were conducted to determine the effect of CPI and PS48 dosage on 
cell viability by using annexin-V-conjugated FITC and propidium iodide staining. 
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Fibroblasts which did not stain positively for either annexin-V-conjugated FITC or 
propidium iodide staining were considered to be healthy non-apoptotic cells. 
Treatment with CPI dosages of 50 and 100 µM did not significantly alter (P = 
0.40) the percentage of cells considered healthy from untreated fibroblasts (all 
dosages ≥ 88.4% appeared healthy; Table 2.1). Treatment with 50 and 100 µM 
CPI did increase (P = 0.03) the percentage of cells which were propidium iodide 
positive compared to untreated cells (9.5 and 7.3 vs. 3.8 ± 1.5 %; Table 2.1). 
However, untreated control cells in initial CPI dosage experiments had higher 
proportions of cells which were annexin-V positive as well as double propidium 
iodide and annexin-V positive compared to 50 and 100 µM CPI (P ≤ 0.05; Table 
2.1). Inversely, treatment with PS48 did not affect cell viability compared to 
controls (P > 0.4; Table 2.2). After determining that the highest concentration of 
CPI and PS48 that would still yield high percentages of viable cells, we then 
tested the combination of the two drugs. 
 Proliferation of cells as well as the percentage of cells alive at the time of 
passage (as measured by Trypan Blue staining) were not augmented with 
treatment (P = 0.4; See Figure 2.1C). All treatments had increased proliferation 
from day 0 to 3 (P < 0.01; Figure 2.1B); however in subsequent passages (days 
3, 5 and 7) numbers did not differ between treatments (P > 0.05). There was no 
interaction of treatment by day of culture amongst treatments (P = 0.8; Figure 
2.1). Lifespan of cells treated daily with PS48 (0 µM = 61.3; 5 µM = 64.7; 10 µM = 
68.0 ± 4.1 days) was measured, as this compound has been demonstrated to 
have pluripotency inducing properties, but was not different (P = 0.5). Stage of 
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cell cycle as measured by propidium iodide staining in ethanol fixed fibroblasts 
was not impacted by the 7 day treatments (P ≥ 0.4; Table 2.3). 
Conditioned cell culture media metabolites 
 Using tandem gas chromatography and mass spectroscopy 55 
metabolites were detected in the conditioned media from culture- treated 
fibroblast cells. The same metabolites were present in analyzed media which had 
never been used in cell culture (unconditioned media). Of the metabolites 
detected, 21 had significantly different quantities (P < 0.05) amongst treatments 
where media was changed daily (Figure 2.2). Of note was increased pyruvate in 
the MIX treatment whereas other treatments had decreased values compared 
with the quantity in day 0 media.  
Comparatively, all metabolites had higher quantities (P < 0.05) when 
comparing day 5 media from cells which did not have media changes (drugs 
spiked in) with day 5 media from cells which had daily media changes (drugs 
added during media change). The quantity of PS48 and CPI were detectible in 
conditioned media by their respective treatments; PS48: MIX and PS48 
treatments were both 14.7 SEM = 2.80 AU; CPI: MIX and CPI treatments had 
6.15 and 4.57; SEM = 1.74 AU. The quantity of PS48 did not differ between day 
5 media samples where media was changed daily or spiked in (P > 0.12). 
Inversely, the quantity of CPI in conditioned media was higher (P = 0.006) when 
it was spiked in daily compared to when the media was changed (22.2 vs.4.57; 
SEM = 2.64 AU) and this also occurred in MIX treated cells (15.96 vs. 6.15; SEM 
= 2.64). Concentrations of lactate, alanine, glutamate, and uric acid were 
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approximately twice as high in media of cells that were not changed daily 
compared to those which were changed daily regardless of treatment (P ≤ 0.003; 
Supplemental figure 2.1). 
Gene expression 
 Sequencing of mRNA revealed 69 differentially expressed genes between 
MIX and CON treatments (Figure 2.3). Of these genes, 15 play roles in lipid 
synthesis and beta- oxidation of fatty acids (Figure 2.3, blue font). Compared to 
CON, MIX cells had downregulation of two fold change or greater in 18 genes 
and upregulation of two fold change or greater in expression of 8 genes. 
Amongst CON and CPI there were 27 differentially expressed genes. All but 6 of 
these genes were found differentially expressed between MIX and CON; those 
genes are ribosomal protein S16, ADP ribosylation factor like GTPase 4C, 
kruppel like factor 9, oxytocin receptor, lysine demethylase and nuclear receptor 
corepressor, and tumor necrosis factor alpha induced protein 6. All these genes 
were downregulated except ribosomal protein S16. There was only one gene 
differentially expressed between PS48 and CON, which was decreased 
expression of Somatostatin. 
2.5 Discussion 
 Our experimental goal was to determine if pharmacological treatment can 
be used to induce fibroblasts to have a metabolism that is characteristic of the 
Warburg effect; wherein there is a greater degree of glycolysis rather than TCA 
cycle activity. In this study we determined concentrations of both CPI and PS48 
that would provide us with a high percentage of viable cells. We show that when 
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PS48 and CPI are used in combination gene expression and metabolite flux is 
augmented. To our knowledge, these drugs have not been used as a treatment 
combination in any type of cell line to promote a Warburg effect-type metabolic 
phenotype.  
 Contrary to our proposed Warburg proliferation hypothesis, there was no 
difference in proliferation between treatments throughout the week. At passages 
3 and 5 all cell treatments were diluted so that fibroblasts across treatments 
would get similar daily drug exposure (see Figure 2.1B for cell growth); this may 
contribute to the reason treatments yielded similar numbers and were not 
different overall. The percentage of viable cells (as measured by Trypan Blue) 
did not differ amongst treatment throughout the week if media was changed daily 
(Figure 2.1C). Additionally passaging on days 3 and 5 likely contribute to the 
similarity in cell cycle states on day 7 amongst treatments (Table 2.1).   
 Previous CPI studies have focused on investigating the efficacy of this 
drug in anti-cancer treatment as a tumor-specific anti-mitochondrial mediator that 
has been tested in a number of cancerous cell lines as well as in vivo (Lee et al., 
2011a; Lee et al., 2011b; Zachar et al., 2011; Perera et al., 2012; Senzer et al., 
2012; Lee et al., 2014; Pardee et al., 2014). A comparison of CPI treatment 
between cancerous and non-cancerous cell lines from lung, breast, and kidney 
demonstrated that CPI reduced cell survival in all of the cancerous lines 
compared to the non-cancerous lines, implying non-cancerous cells are less 
sensitive to CPI (Zachar et al., 2011). The mechanism of cell death in cancerous 
cells by CPI may be in part through redox activity induced within mitochondria of 
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tumor cells (Stuart et al., 2014), and cell death can be induced via apoptotic and 
non-apoptotic pathways (Zachar et al., 2011). In this study CPI decreased the 
number of cells after five days of growth (Figure 1A) and is detected at 2 fold or 
higher concentration in conditioned media from flasks it was 'spiked into' (CPI 
and MIX treated cells) compared to those with daily media changes. While the 
half life in cell culture is not reported to our knowledge, in clinical cancer trials the 
half life is reported to be 1.3 hours in patients (Pardee et al., 2014). We speculate 
that either CPI has a long enough half life duration that changing the media 
removes some of the CPI alleviating toxic reactive oxygen species (ROS) 
inducing effects, or perhaps that when CPI is metabolized those derivatives may 
build up and become toxic. In order to detect CPI and PS48 via tandem liquid 
chromatography- mass spectroscopy (LC/ MS), pure samples were analyzed and 
added to the existing metabolite library at the University of Missouri 
Metabolomics Core facility; the metabolites of CPI and PS48 are not in the library 
for us to identify. 
 The pharmaceutical compound CPI is itself catalytically inert (reviewed in 
(Dörsam and Fahrer, 2016)). Research from Lee et al. (2011b) demonstrated 
that CPI is metabolized in human liver S9 fractions to sulfoxide and glucuronide 
derivatives and that cytochrome P450 (CYP450) isozymes are involved in the 
metabolism and sulfoxide formation. The enzyme CYP450 is involved in the 
metabolism of drugs and toxins and expression of CYP450 isozyme 1A1 is 
induced by substrate presence (Hankinson, 1995). Expression of CYP450 1A1 
was upregulated 1.8 fold in MIX treated fibroblasts compared to CON. 
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 Comparatively, the PS48 concentration was similar in conditioned media 
when spiked in daily or changed daily. The concentration of CPI cells were 
exposed to was ten times higher than PS48 in this study (100 vs.10 µM) yet the 
quantity (relative to the internal standard ribitol) of PS48 detected in the media 
was higher than CPI; implying differences in the rate of metabolism and stability 
of the two drugs. The small molecule PS48 which stimulates glycolysis enhances 
in vitro reprogramming efficiency by about fifteen fold in human somatic cells 
(Zhu et al., 2010). Experimentation using PS48 has been largely focused in the 
area of cellular reprogramming and pluripotency induction. In this experiment 
however, we utilized it in an effort to stimulate the PI3K pathway and promote 
higher glycolitic activity. Lack of altered gene expression in addition to a normal 
length of life for fibroblasts treated with PS48 at the concentration tested do not 
indicate increased pluripotency in this experiment. While expression of 27 genes 
was impacted by CPI, only expression of SST (somatostatin) was augmented by 
treatment of PS48 alone.  
 In MIX treated cells SST expression was also reduced (4 fold from CON). 
The function of SSTs are to inhibit somatotropin or growth hormone. Signaling of 
SST receptors is complex and is evidenced to inhibit PI3K signaling and mediate 
anti-proliferative signals (Briest and Grabowski, 2014). Additionally in the MIX 
treatment there was an increase of TRH (Thyrotropin releasing hormone) and a 
decrease in FST (Follistatin) expression. Growth hormone is stimulated by TRH 
and FST provides a safeguard against uncontrolled cellular proliferation by 
binding activin (Carlson et al., 1974; Sidis et al., 2005). These changes in 
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expression could reflect an increase in translation of these mRNA which could 
explain in part why MIX cells are not proliferative, or inversely that these cells are 
altering transcripts in an effort to proliferate and some other factor is prohibiting 
proliferation. For these experiments we did not perform proteomic analysis 
therefore this information cannot be determined within this study. 
 The nucleus controls and regulates gene expression for products such as 
enzymes involved in metabolic processes. In this study we sought to determine if 
metabolic regulation and feedback could be pharmacologically manipulated in 
such a way as to ‘reprogram’ nuclear gene expression to a more Warburg-like 
state. Some of the differentially expressed genes in MIX treated fibroblasts have 
been identified to play roles in various cancers and proliferation. For example 
mitochondrial ribosomal protein S23 was increased 28 fold and carnitine 
palmitoyltransferase 1A was increased 1.95 fold in MIX treated fibroblasts; these 
were 2 of 8 genes identified as drivers of proliferation in luminal subtype breast 
tumors in human (Gatza et al., 2014). Expression of the gene angiopoietin like 4 
(ANGPTL4) was increased 9 fold in MIX cells. This gene is evidenced to be 
induced by multiple factors including hypoxia, presence of free fatty acids, and 
expression of tumor necrosis factor β (González-Muniesa et al., 2011; Kim et al., 
2011). The ANGPTL4 protein targets peroxisome proliferator- activated receptors 
and is involved in the regulation of cancer metastasis, evasion of anoikis, and 
lipid metabolism (Kersten, 2005; Kim et al., 2011; Semenza, 2012). 
 In the Reverse Warburg effect it is proposed that stroma surrounding 
cancerous cells provide nutrients through autophagy, mitophagy, and aerobic 
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glycolysis. The stromal catabolites such as pyruvate, lactate, glutamine, and free 
fatty acids support the growth of cancer (Yoshida, 2015). Compared to CON, 
CPI, and PS48 treated fibroblasts, MIX produced glutamine whereas others 
consumed it as per comparison to unused media quantity (Figure 2.2).  
 Many of the differentially expressed genes between MIX and CON were 
related to lipid regulation including fatty acid synthesis, uptake, and transport 
(Figure 2.3, blue font). In the MIX treated cells expression of cluster of 
differentiation 36 (CD36) was increased 17.3 fold from control expression. This 
receptor is involved in uptake of long chain fatty acids and long chain fatty acid 
signaling (Ibrahimi and Abumrad, 2002; Pepino et al., 2014). We did not collect 
the non-polar fractions of the conditioned culture media for GC/ MS analysis 
therefore we do not know what differences there are in lipid production between 
treatments. Expression of FYN a CD36-associated tyrosine kinase was 
increased 1.45 fold from CON in MIX treated cells (Bull et al., 1994). In rat 
cardiac membranes CD36 was identified as a binding site for growth hormone-
releasing peptides (Bodart et al., 2002).  
 The changes in gene expression related to lipid synthesis and metabolism 
may be due to decreased de novo lipid synthesis via the action of CPI. 
Mitochondrial citrate production is  needed for de novo lipogenesis; in order for 
acetyl-CoA to be used for the synthesis of fatty acid, cholesterol, and isoprenoids 
acetyl-CoA must be converted to citrate to travel to the cytosol (reviewed in 
(Ward and Thompson, 2012)). The drug CPI is a lipoate derivative which 
activates the E1α subunit of pyruvate dehydrogenase (PDH) preventing the flux 
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of pyruvate into the TCA cycle therefore, the conversion of pyruvate to acetyl-
CoA (Zachar et al., 2011). The compound CPI is inhibitory to α-ketoglutarate 
dehydrogenase, which also facilitates the eventual production of citrate (Zachar 
et al., 2011; Stuart et al., 2014).  
 Pyruvate dehydrogenase kinase (PDK) phosphorylates PDH and thus 
inactivates the PDH enzyme. In the MIX treatment PDK4 expression was 
upregulated 7.4 fold from CON. Hypoxic inducible factor-1 can facilitate the 
expression of PDK1 as a cellular adaptation to hypoxia which aids in the 
prevention of ROS production and apoptosis (Kim et al., 2006). Research from 
Sugden and Holness (2003) evidence that "PDK4 is a 'lipid status' responsive 
PDK isoform" whereby it aids in mitochondrial fatty acid oxidation (Sugden et al., 
2001). Increased pyruvate is demonstrated to inhibit the PDKs; however, 
pyruvate was increased in the MIX treatment compared to day zero controls 
whereas all other groups had negative values indicative of pyruvate consumption 
(Bao et al., 2004; Saunier et al., 2016).   
 Glycine was decreased in the conditioned media of MIX treated fibroblasts 
compared to CON fibroblasts (Figure 2.2). Compared with day zero media 
quantities, MIX had a value of -781.4 and CON had a value of 478.4. We 
speculate based on previously described mitochondrial stress induced by CPI 
(Stuart et al., 2014) that reactive oxygen species may likely be generated and 
some of the glycine might be used for glutathione synthesis. A review from 
Amelio et al. (2014) highlights the roles of serine and glycine metabolism in 
cancer whereby they are necessary to provide precursors for proteins, nucleic 
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acids, and lipids. In this review the coauthors detail the de novo synthesis of 
serine from glycolysis. Two genes within this pathway phosphoglycerate 
dehydrogenase (PHGDH) and phosphoserine phosphatase (PSPH) were 
upregulated from CON expression in the MIX treatment.  
 Serine serves as an allosteric regulator of pyruvate kinase M2 isoform. 
Pyruvate kinase catalyzes the conversion of phosphoenolpyruvate (Pepino et al.) 
to pyruvate. The M2 variant has weaker enzymatic activity and lowers the PEP-
to-pyruvate conversion thus favoring accumulation of glycolytic intermediates for 
use in other pathways inadvertently promoting glycolytic activity (reviewed in 
(Amelio et al., 2014)). This could in part contribute to increased production of 
pyruvate in MIX treated fibroblasts. Additionally, expression of 
phosphoenolpyruvate carboxykinase 2, mitochondrial (PCK2) was upregulated 
with MIX treatment; this enzyme catalyzes the conversion of oxaloacetate to 
phosphoenolpyruvate in the presence of guanosine triphosphate and could also 
be contributing to the production of pyruvate. While more research is warranted 
for verification, our best interpretation of what metabolites and genes are 
influencing WE-related metabolic pathways in MIX treated cells is represented in 
Figure 2.4. In this figure significant genes are in red font and metabolites (purple 
hexagons) which were significantly impacted are outlined in red.  
 Our study is novel in its approach to augment fibroblast cells metabolism 
pharmacologically by promoting glycolysis and inhibiting TCA activity in an 
attempt to achieve a more Warburg effect-like state. The pharmaceutical agents 
CPI and PS48 can be applied at concentrations used on other cell lines in 
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without harmfully impacting viability or proliferation in a porcine fetal cell line. 
While there is evidence of changes in gene expression that are implicated in the 
Warburg-effect and expressed in cancerous cells, instead of the production of 
lactate and alanine, the MIX treated cells increase the concentration of pyruvate 
in media to a level above what that which media originally contained. We 
propose that this phenomenon whereby we attempted to induce a Warburg-effect 
in fibroblasts supports the role of hypoxia- coerced fibroblasts in supporting the 
growth cancer stroma proposed by other researchers known as the Reverse 
Warburg-effect.  
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2.6 Figure legends 
Figure 2.1 Growth and viability of cells cultured for 0, 3, 5, and 7 days with the 
pharmaceutical agents CPI (100 µM), PS48 (10 µM), the mixture of the two 
(MIX), or without drugs (CON; 0 µM). 
A. Cell proliferation numbers from cells grown for 5 days with the pharmaceutical 
agents CPI (100 µM), PS48 (10 µM), the mixture of the two (MIX), or without 
drugs (CON; 0 µM), either spiked in daily without media change (Spike) or when 
drugs were added in fresh culture media daily (Change). 
B. Cell proliferation numbers from cells cultured for 0, 3, 5, and 7 days with the 
pharmaceutical agents CPI (100 µM), PS48 (10 µM), the mixture of the two 
(MIX), or without drugs (CON; 0 µM). 
C. Percentage of viable cells from cells cultured for 0, 3, 5, and 7 days with the 
pharmaceutical agents CPI (100 µM), PS48 (10 µM), the mixture of the two 
(MIX), or without drugs (CON; 0 µM).  
Figure 2.2 Spent media metabolite quantities of fibroblasts treated for 7 days with 
the pharmaceuticals CPI (100 µM), PS48 (10 µM), the mixture of the two (MIX), 
or without drugs (CON; 0 µM). 
Figure 2.3 Differentially expressed genes between MIX and CON treated 
fibroblasts after 7 days with the pharmaceuticals CPI (100 µM), PS48 (10 µM), 
the mixture of the two (MIX), or without drugs (CON; 0 µM). 
Figure 2.4 Influence of CPI and PS48 treatment on gene expression and 
metabolite quantities in Warburg effect- related metabolic pathways in porcine 
fetal fibroblasts. Genes are in italic font and metabolites are in purple hexagons. 
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The genes which were significantly impacted in fibroblasts treated with CPI and 
PS48 are in red font. Metabolites which were significantly impacted are outlined 
in red. This figure was modeled and adapted based on figures created by Vander 
Heiden et al., 2009 and Amelio et al., 2014.  
Supplemental Figure 2.1 Comparison of pyruvate, lactate, glucose, and citrate 
quantities (AU compared to internal standard control ribitol) in fresh (un-used) 
and spent (weekly average of media used for 3, 5, and 7 days of cell culture) 
media.  
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Figure 2.1 Growth and viability of cells cultured for 0, 3, 5, and 7 days with the 
pharmaceutical agents CPI (100 µM), PS48 (10 µM), the mixture of the two (MIX), or 
without drugs (CON; 0 µM). 
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Figure 2.2 Spent media metabolite quantities of fibroblasts treated for 7 days 
with the pharmaceuticals CPI (100 µM), PS48 (10 µM), the mixture of the two 
(MIX), or without drugs (CON; 0 µM). 
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Figure 2.3 Differentially expressed genes between MIX and CON treated 
fibroblasts after 7 days with the pharmaceuticals CPI (100 µM), PS48 (10 µM), 
the mixture of the two (MIX), or without drugs (CON; 0 µM). 
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Figure 2.4 Influence of CPI and PS48 treatment on gene expression and 
metabolite quantities in Warburg effect- related metabolic pathways in porcine 
fetal fibroblasts. Genes are in italic font and metabolites are in purple hexagons. 
The genes which were significantly impacted in fibroblasts treated with CPI and 
PS48 are in red font. Metabolites which were significantly impacted are outlined 
in red. This figure was modeled and adapted based on figures created by Vander 
Heiden et al., 2009 and Amelio et al., 2014.  
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Supplemental Figure 2.1 Comparison of pyruvate, lactate, glucose, and citrate 
quantities (AU compared to internal standard control ribitol) in fresh (un-used) 
and spent (weekly average of media used for 3, 5, and 7 days of cell culture) 
media.  
 
 
 
 
 
 
 
 
 
 
 71 
 
Table 2.1. Viability of fibroblasts treated with CPI-613 for 7 days. 
  Treatment§     
Population  0 µM 50 µM 100 µM  SEM  P-value 
Healthy‡, %  91.2 88.4 91.0  1.6  0.39 
Early apoptoticⱡ, %  0.7A 0.3B 0.4B  0.1  0.05 
Late apoptotic€%  3.8A 9.5B 7.3B  1.5  0.03 
Necrotic≠, %  4.5A 1.8B 1.3B  0.4  <0.01 
§Fibroblasts treated with 0, 50, or 100 µM CPI-613 by daily media changes at 
24± 2 hours. 
‡Percentage of fibroblast population which stained negative for annexin-V-FITC 
and propidium iodide. 
ⱡPercentage of fibroblast population which stained positive for annexin-V-FITC 
and negative for propidium iodide. 
€Percentage of fibroblast population which stained positive for propidium iodide 
and negative for annexin-V-FITC. 
≠Percentage of fibroblast population which stained positive for annexin-V-FITC 
and propidium iodide. 
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Table 2.2. Viability of fibroblasts treated with PS48 dosages for 7 days. 
  Treatment§     
Population  0 µM 5 µM 10 µM  SEM  P-value 
Healthy‡, %  95.3 93.6 93.1  1.3  0.48 
Early apoptotic ⱡ, %  0.8  0.8 0.8  0.1  0.99 
Late apoptotic€, %  1.1 1.3 1.2  0.4  0.88 
Necrotic≠, %  2.9 4.2 4.4  1.0  0.55 
§Fibroblasts treated with 0, 5, or 10 µM PS48 by daily media changes at 24± 2 
hours. 
‡Percentage of fibroblast population which stained negative for annexin-V-FITC 
and propidium iodide. 
ⱡPercentage of fibroblast population which stained positive for annexin-V-FITC 
and negative for propidium iodide. 
€Percentage of fibroblast population which stained positive for propidium iodide 
and negative for annexin-V-FITC. 
≠Percentage of fibroblast population which stained positive for annexin-V-FITC 
and propidium iodide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 73 
 
Table 2.3. Cell cycle phase of fibroblasts after 7 day pharmacological treatment. 
  Treatment§     
Measure  CON CPI MIX PS48  SEM  P-value 
G1 phase, %  65.9 69.2 69.3 67.7  3.0  0.84 
S phase, %  22.5 21.1 20.3 22.1  2.6  0.92 
G2 phase, %  8.4 7.1 7.3 7.0  0.6  0.41 
§Fibroblasts treatments applied during daily media changes at 24± 2 hours; CON (0 
µM), PS48 (10 µM PS48), CPI (100 µM CPI-613), or MIX (10 µM PS48 and 100 µM 
CPI-613).  
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CHAPTER 3 
EVASION OF CHEMICAL ANOXIA BY MITOPHAGY IN CPI-613 AND PS48 
TREATED PORCINE FETAL FIBROBLASTS. 
3.1 Abstract 
 A metabolic phenomenon known as the Warburg effect is characterized by 
increased glycolytic activity, decreased use of mitochondrial oxidative 
phosphorylation, rudimentary mitochondrial morphology, and the production of 
lactate and alanine. This metabolic phenotype has been characterized in certain 
cancerous cells, embryonic stem cells, and other rapidly proliferative cell types. 
We hypothesized that a Warburg-like metabolism could be achieved in other cell 
types such as fibroblasts by treatment with pharmaceuticals which might in turn 
facilitate nuclear reprogramming. Previously we demonstrated that our attempt to 
induce a Warburg-like state pharmaceutically did augment metabolite production 
and gene expression, however contrary to our hypothesis they did not exhibit 
cancer-like increased proliferation and produced pyruvate thereby displaying 
more of a Reverse Warburg-effect observed in cancer stroma. In the current 
study we inquired whether the mitochondria were affected by the pharmaceutical 
treatment and whether they have the characteristically small circular phenotype 
seen in various cell types exhibiting the Warburg-effect. We demonstrate that the 
pharmaceuticals decrease mitochondrial membrane potential in porcine fetal 
fibroblasts however the number and size of mitochondria are similar as is the 
total cell size. Moreover, the fibroblasts that were treated to induce a Warburg-
like phenotype had increased numbers of large autolysosome vesicles. It 
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appears that treated fibroblasts may utilize mitophagy to eliminate mitochondria 
stressed and damaged by pharmaceutical treatment and are producing more 
new mitochondria to compensate. 
3.2 Introduction 
 A hallmark of the Warburg Effect is predominate use of glycolysis as 
opposed to use of the Tricarboxylic acid (TCA) cycle for energy production. The 
latter is most commonly used by differentiated cells (Warburg, 1956). Use of this 
seemingly atypical metabolism is attributed to be more favorable for the 
production of biomass in rapidly proliferative cells (Vander Heiden et al., 2009). 
Somatic cells generally contain mitochondria that are elongated, contain 
numerous cristae, and have a high membrane potential. In contrast many 
Warburg effect-like cell types contain mitochondria that are spherical, contain few 
cristae, and have a low membrane potential. Examples of cells that meet these 
criteria include embryonic stem cells, induced pluripotent stem cells, cleavage 
stage mammalian embryos, and undifferentiated cardiomyocytes (Wakayama 
and Yanagimachi, 2001; Houghton, 2006; Hom et al., 2011; Varum et al., 2011). 
 In a prior study in our laboratory fibroblasts were treated with the 
pharmaceuticals CPI-613 and PS48 in effort to induce a Warburg effect-like 
metabolism. The lipoate analog known as CPI-613 (6, 8-bis(benzylthio)octanoic 
acid: hereafter called CPI) is a mitochondrial disrupter via inhibition of the 
mitochondrial enzymes pyruvate dehydrogenase and α-ketoglutarate 
dehydrogenase (Zachar et al., 2011a; Stuart et al., 2014a). The allosteric small 
molecule PS48 (5-(4-Chloro-phenyl)-3-phenyl-pent-2-enoic acid) was used in 
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effort to promote glycolysis by stimulation of the PI3K pathway as it activates 
phosphoinositide-dependent protein kinase 1 (PDK1) by binding exclusively to 
the HM/ PIF binding pocket rather than the ATP-binding site (Hindie et al., 2009; 
Stroba et al., 2009; Zorn and Wells, 2010). We found that this treatment 
combination did not increase cellular proliferation or decrease cell viability but did 
induce changes in expression of genes with implications in cancer metastasis. 
Furthermore the treated fibroblasts increased the concentration of pyruvate and 
glutamine in spent media thereby exhibiting more of a Reverse Warburg effect of 
cancer stromal cells (Mordhorst et al., 2017b). We inquired how this treatment 
impacted the mitochondria as some research evidences reduced mitochondrial 
mass or an absence of detectible mitochondria in cancer stromal cells (Migneco 
et al., 2010; Sotgia et al., 2012). Additionally, we sought to learn whether the 
mitochondria would exhibit the Warburg Effect-like morphological phenotype 
observed in some cancer cell types. 
 In the current study we demonstrate that treatment of fibroblasts impairs 
mitochondrial membrane potential (Δψm; as measured by JC-10 fluorescence) an 
indicator of cellular capacity to utilize mitochondrial oxidative phosphorylation to 
generate ATP reviewed in (Johnson et al., 1981; Perry et al., 2011). Analysis via 
electron microscopy revealed that treated fibroblasts had a similar number of 
mitochondria, with similar area and perimeter to untreated fibroblasts and 
furthermore no obvious abnormalities were observed in the mitochondrial cristae 
of treated fibroblasts. Moreover, the fibroblasts that were treated to induce a 
Warburg-like phenotype had increased numbers of large autolysosome vesicles 
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some of which contained evident partially degraded mitochondria. One of the 
pharmaceuticals used, CPI-613, is evidenced to have tumor-specific anti-
mitochondrial potency through induction of redox activity (Stuart et al., 2014a). It 
appears that treated fibroblasts may utilize mitophagy to eliminate mitochondria 
stressed and damaged by pharmaceutical treatment and may be producing more 
new mitochondria to compensate. 
3.3 Materials and methods 
All materials and supplies were purchased from Sigma-Aldrich, St. Louis, MO 
unless otherwise specified. 
Compliance with Ethical Standards 
 This article does not contain any studies with human participants 
performed by any of the authors. All procedures performed in studies involving 
animals were in accordance with the ethical standards of the University of 
Missouri Institutional Animal Care and Use Committee at the University of 
Missouri in Columbia, MO. 
Fetal-derived fibroblast cell culture 
 Methods of cell line creation, culture, and pharmacologic treatment have 
been previously published by Mordhorst et al., (2017b). Cell lines are derived 
from the dorsal proportion of day 35 porcine fetuses which were frozen in liquid 
nitrogen (0.5 mL aliquots; ~ 80 cryogenic vials). A separate vial of fibroblasts was 
thawed for each replicate of each experiment; the same cell line was used 
throughout all experiments as well as those in Mordhorst et al., (2017b). During 
experiments incubators were maintained at 38.5°C with a humidified atmosphere 
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of 5% oxygen, 5% carbon dioxide, 90% nitrogen. Cells were thawed and cultured 
in DMEM (1 g/ L glucose, glutamine, and pyruvate with phenol red; Sigma, St. 
Louis, MO supplemented with 15% FBS (Corning, Manassas, VA, USA)) for 
seven days in T25 flasks (Corning, Corning, NY) with or without the addition of 
respective treatment concentrations of CPI-613 (CPI, Sigma, St. Louis, MO) or 
PS48 (Stemgent, Cambridge, MA). Media was changed daily on all flasks, i.e. 
those which received PS48 or CPI had new drugs applied daily (24± 2 hours).  
 In experiment 1 porcine fetal fibroblasts were treated with either CPI (25, 
50, or 100 µM), PS48 (1, 5, or 10 µM), or as controls (0 µM) for 7 days of culture. 
In experiment 1 both CPI and PS48 stock aliquots were diluted to 10 mM. In 
experiment 2, porcine fetal fibroblasts were treated with PS48 (10 µM), CPI (100 
µM), a mixture of PS48 and CPI (10 µM and 100 µM), or treated as controls (0 
µM) for 7 days of culture. In experiment 2, CPI stocks were diluted to 100 mM 
and PS48 stocks were 10 mM to eliminate potential confounding of DMSO 
quantity between the two pharmaceutical treatments (CPI and PS48). Cells were 
initially plated at 1 x 105 cells/ mL in T25 flasks. After 72 and 120 hours, cells 
were passaged to new T25 flasks. At 120 hours, cells in all treatments were 
plated (density: 5 x 105 cells) to achieve ~80% confluence at 168 hours. At 
passage, cells were briefly rinsed with PBS 0.01 M EDTA and dissociated by 
brief incubation (37°C) from flasks using 1 x Tryp- LE Express (Gibco, Denmark). 
At passage cell number across treatments and replated with respective treatment 
media. Data were confirmed to be normally distributed as measured via 
Univariate procedure in SAS 9.3 (SAS, Cary NC) and log transformations were 
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made where appropriate prior to statistical analysis. Trypan blue exclusion 
proliferation data was analyzed for effects of treatment, day, and the interaction 
of treatment by day using the generalized linear model procedure of SAS 9.3. 
Flow cytometry: data acquisition and analysis 
 For all cytometry data collected, gating protocols were applied for analysis 
of a population free of debris and doublet cells by using plots of side scatter 
height x forward scatter height, forward scatter height x forward scatter area, and 
forward scatter height x forward scatter width. In all flow cytometry experiments, 
three replicates were collected for analysis and three technical samples for each 
treatment were run in the flow cytometer for each of the biological replicates. 
Data were confirmed to be normally distributed as measured via Univariate 
procedure in SAS 9.3 (SAS, Cary NC) and therefore no transformations were 
made prior to statistical analysis. Data was analyzed by using the generalized 
linear model procedure of SAS 9.3 for main effect of treatment for flow cytometry 
acquisitions.  
JC-10 mitochondrial membrane potential 
 The biphasic cationic dye JC-10 is able to infiltrate both the cytoplasm and 
mitochondria in a monomeric green emission form (525 nm); however when 
mitochondrial membrane potential is elevated, JC-10 dye forms J-aggregates 
which have an orange emission (590 nm). This property allowed us to determine 
proportions of cells which contained mitochondria in a state of higher or lower 
mitochondrial membrane potential. Initially we tested CPI and PS48 dosages, 
and in a later experiment we measured a combination of the highest drug 
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concentrations. Fibroblasts were dissociated and incubated at 37°C for 30 
minutes with 830 nM JC-10 (optimized by titration). In experiment 1, 
mitochondrial membrane potential was measured for cells stained with JC-10 by 
using a Beckman Coulter MoFlo XDP (Fullerton, CA) flow cytometer equipped 
with a 488 nm laser with 529/ 28 (FL1 ) and 580/ 23 (FL 2) dichroic filters using 
Summit 5.3 software (Beckman Coulter, Inc, Fullerton, CA). In experiment 2 JC-
10 staining was measured by using a Beckman Coulter CyAN ADP Analyzer 
cytometer (Fullerton, CA) also equipped with a 488 nm laser with 530/ 40 (FL 1) 
and 575/ 25 (FL 2) dichroic filters and Summit 4.4 software (Beckman Coulter, 
Inc, Fullerton, CA). Channel compensation was adjusted for every replicate in 
experiments by measuring cells incubated with the mitochondrial membrane 
potential disrupter carbonyl cyanide 3-chlorophenylhydrazone (CCCP; 100 µM) 
for 2 hours prior to analysis as positive controls for monomeric JC-10 staining. 
For both experiments, a florescence intensity (FL 2 x FL 1) plot was divided into 
a four-square grid to determine mean intensities and percentages for cell 
populations. The horizontal axis was set based on an unstained control 
population and the vertical axis based on CCCP treated population (100 µM for 2 
hours at 37°C). Population percentages within quadrants as well as mean FL 
1and FL 2 intensities were data collected for each population for every treatment.  
Mitotracker green cytometry acquisition 
 Fibroblasts were dissociated and incubated at 37°C with 100 µM 
Mitotracker green for 30 minutes. Mean fluorescence intensity in the FL1 (530/ 
40 dichroic filter) channel was measured in Mitotracker green stained fibroblast 
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cells by using a Beckman Coulter CyAN ADP Analyzer cytometer (Beckman 
Coulter, Inc, Fullerton, CA). A plot of arbitrary event 'count' x FL1 intensity was 
used to determine mean intensity for each of the treatment replicates acquired. 
Unstained controls were used to determine positive florescence intensity in the 
FL1 intensity plot.  
High pressure freezing and processing for electron microscopy 
 For ultrastructural analyses, treated (MIX; CPI 100 µM + PS48 10 µM) and 
untreated (CON; 0 µM) fibroblasts were treated daily and grown for 5 days. 
Afterwards fibroblasts were then dissociated and plated in 6 well plates on gold-
coated sapphire discs (3 mm in diameter; Wohlwend GmbH, Switzerland) and 
treated for 2 additional days. On day 7 of treatments the cells were cryo-
immobilized by high-pressure freezing using the Wohlwend HPF Compact 
02 and freeze substituted in acetone containing 0.1% (w/v) uranyl acetate, 0.5% 
(w/v) osmium tetroxide, and 0.5% (w/v) imidazole. Freeze substitution was 
performed in a Leica AFS by raising the temperature from -90°C to 0°C over a 
period of 18h. Samples were infiltrated with Epon and polymerized at 60°C. 
75nm thin sections were prepared, mounted on formvar/carbon 
coated copper grids, and subsequently imaged with the JEOL 1400 transmission 
electron microscope equipped with a CCD camera at an acceleration voltage of 
80 kV. 
3.4 Results 
Impact of pharmacological treatment on fibroblast mitochondrial potential
 Mitochondrial membrane potential (Δψm) was measured by using flow 
 82 
 
cytometric analysis of JC-10 staining in treated fibroblasts as an estimate of 
mitochondrial function for respiratory and tricarboxylic acid cycle capacity. 
Treatment with any concentration of CPI that was used (25, 50, or 100 µM) 
decreased Δψm (P < 0.01) by decreasing mean red intensity (≤ 503 AU vs. 950 
AU) and increasing the proportion of cells in the lowly functional mitochondrial 
population (≥ 87.3 vs. 74.4%; Table 3.1). We found that treatment with 100 µM 
CPI yielded the highest proportion (P < 0.01) of lowly functional mitochondria 
(95.5% vs. ≤ 87.3 % in lower CPI concentrations; Figure 3.1; Table 3.6). 
Similarly, PS48 dosages also increased the proportion of cells with mitochondria 
having a low Δψm (P = 0.04; ≥ 80.2% PS48 treatments vs. 74.4 % in CON; Figure 
3.1; Table 3.2), but did not significantly decrease mean red intensity (≥ 631 in 
PS48 treatments vs. 950 in CON; Table 3.2).  
 Using the highest concentrations of PS48 (10 µM) and CPI (100 µM) we 
then investigated the impact of the drug mixture on Δψm as well as mean 
intensity of Mitotracker green. Treatment with CPI or MIX decreased JC-10 mean 
red intensity (P < 0.01; ≤ 435.7 vs. ≥ 681.8 AU in CON and PS48), and the 
red/green intensity ratio (P < 0.01; ≤ 0.4 vs. ≥ 0.8 in CON and PS48). The CPI or 
MIX treatments increased the percentage of low Δψm fibroblasts as compared to 
CON (P < 0.01; ≥ 97.2 vs. ≤ 53.6% in CON); whereas PS48 performed 
intermediately (P < 0.01; 66.6%; Figure 3.2; Table 3.3). Mitotracker green 
staining intensities were not impacted by treatments (P = 0.5; average 780.0 ± 
72.7 AU; Table 3.4).  
Impact of pharmacological treatment on fibroblast ultrastructure 
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 Electron microscopy was used to count and measure cellular features of 
interest. Area and perimeter of fibroblasts as well as their nuclei were not 
impacted by pharmaceutical treatment (see Table 3.5). The number, perimeter 
size, and area of mitochondria were not different between pharmaceutically 
treated and untreated fibroblasts (Table 3.6). Additionally the proportion of the 
sum mitochondrial area (within a given cell) to the area of the cell (minus the 
area of the nucleus) was not significantly altered by treatment (Table 3.6). The 
number of autolysosomal vesicles was more than twice as high (18.4 vs. 7.8; 
Table 3.5) in the pharmaceutically treated fibroblasts compared to control. Some 
of these vesicles contained apparent degrading mitochondria (Figure 3.3).  
3.5 Discussion 
 Our experimental goal was to determine if pharmacological treatment 
used to induce a Warburg effect-like metabolism in fibroblasts would give rise to 
rudimentary mitochondria characteristic of the Warburg effect. In this study we 
determined concentrations of both CPI and PS48 that would provide us with a 
high percentage of viable cells with low mitochondrial membrane potential 
(Figures 3.1 and 3.2). We previously demonstrated that when PS48 and CPI are 
used in combination, gene expression and metabolite flux is augmented without 
changes in cellular proliferation (Mordhorst et al., 2017b). In the current study we 
found that mitochondrial membrane potential (Δψm) of treated fibroblasts is 
decreased, which is indicative of mitochondrial oxidative phosphorylation 
impairment. A study from Zachar et al. (2011a) demonstrated reduction of 
mitochondrial membrane polarization (as measured by JC-10) in response to CPI 
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in a human lung carcinoma cell line (H460) treated with 240 µM CPI. They could 
decrease the proportion of cells with high mitochondrial polarization to 44% vs. 
94% in controls after 3 hours of treatment with CPI without subsequent recovery 
(measured 3 hours post treatment). This study utilized porcine fetal fibroblast 
cells where CPI treatment for 7 days induced low Δψm in the majority of cells (> 
95% in both experiments). In our cell line at least 53% of control cells already 
had lower Δψm prior to any treatment (Figure 3.2; Table 3.3). All treatments in the 
current experiments did increase the number of lowly functional mitochondria 
(Figure 3.1; Tables 3.1 and 3.2). It should be noted that while the same cell 
isolate was used in all experiments, dosage experiments were performed on a 
different cytometer at a different facility than in the experiment testing the drug 
combination, and this may account for the minor differences seen for Δψm 
measures between experiments 1 and 2 (Figure 3.1 and 3.2; Tables 3.1 and 3.2 
vs. Table 3.3).  
 In our experiments PS48 dosage correlated to an increased percentage of 
porcine fetal fibroblasts with low Δψm compared to control (Figure 3.1; Table 3.2). 
Perhaps this decrease in mitochondrial function is in part due to increased 
glycolytic activity as in the prior study PS48 treated cells produced more pyruvate 
than control; however we did not see differences in the production of either 
lactate or alanine. Zhu et al. (2010) identified PS48 as a small molecule that can 
be used to enhance reprogramming efficiency the mechanism of which is 
attributed to the facilitation of glycolysis. The coauthors demonstrated that 
treatment with PS48 increased expression of 4 glycolytic genes and increased 
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the production of lactate in primary human somatic cells (Zhu et al., 2010). Loss 
of Δψm is frequently associated with looming apoptosis (Ly et al., 2003). 
Although, prior research demonstrates these pharmaceuticals do not impede 
proliferation or the ability to extrude Trypan Blue (a measure of viability) with 
daily media changes (Mordhorst et al., 2017b). A study from Dey and Moraes 
(2000) using osteoscarocoma cells with depleted mitochondrial DNA, revealed 
that low Δψm and lack of oxidative phosphorylation (OXPHOS) decreased 
subsequent susceptibility to apoptosis and caspase 3 activation, thereby having 
an antiapoptotic effect.  
 Inhibition of cellular respiration, or 'reductive stress', can elicit the 
production of reactive oxygen species (ROS) in mitochondria (Gores et al., 1989; 
Dawson et al., 1993). The MIX treatment likely results in chemical anoxia due to 
the compound CPI. Chemical anoxia can be induced by inhibition of ATP 
production which results in impaired mitochondria function (Dawson et al., 1993; 
Sheridan et al., 1993). The pharmaceutical CPI disrupts mitochondrial 
metabolism via inhibition of the mitochondrial enzymes pyruvate 
dehydrogenase and α-ketoglutarate dehydrogenase (Zachar et al., 2011a; Stuart 
et al., 2014a). Accumulation of dysfunctional mitochondria is dangerous for cells. 
Mitochondria play several pivotal roles within cells aside from energy production 
such as regulating intracellular calcium levels, signaling, cell cyclicity, growth, 
differentiation, death, and communication between cells and tissues (for a review 
of functions: (Nunnari and Suomalainen, 2012)) . Furthermore organelles such as 
mitochondria and the endoplasmic reticulum are highly exposed to oxidation as 
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they contain electron carriers. While non-specific autophagy provides a way to 
maintain energy levels, in particular providing recycled amino acids, selective 
forms of autophagy specific for defective mitochondria and peroxisomes aid in 
cell maintenance and viability (Onodera and Ohsumi, 2005; Kim et al., 2007; Oku 
and Sakai, 2010). Defective mitochondria are selectively degraded by autophagic 
encapsulation (aka mitophagy) and hydrolytic degradation via fusion with 
lysosomes (reviewed in (Kim et al., 2007)). The fusion of autophagosomes to 
lysosomes has been referred to as several different terms (see (Klionsky et al., 
2014)) but in this text we will use the term 'autolysosome'. It is remains unknown 
whether this is the only mechanism for the removal of mitochondria within a cell 
(Xue et al., 2001). There is interesting evidence that mitochondria or mtDNA can 
be transferred between cells which can restore aerobic respiration in cells with 
non-functional mitochondria (Spees et al., 2006).  
 Autophagy is induced under starvation, pathogen loads, and via death 
receptor activity; and is highly regulated by ROS which serve as critical signaling 
molecules through redox (reduction-oxidation) modulation (reviewed in (Scherz-
Shouval and Elazar, 2007, 2011)). Mitochondrial ROS are implicated in the 
activation of 5′ adenosine monophosphate-activated protein kinase (AMPK) in 
starvation conditions (Li et al., 2013). Sid et al. (2013) demonstrate that ROS 
activated AMPK signaling pathways promote cell survival under oxidative stress, 
such as in alcohol-induced liver disease. Activation of AMPK by ROS can aid in 
the preservation of cellular vitality by induction of autophagy, mitochondrial 
biogenesis, and expression of genes involved in antioxidant defense (Bergeron 
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et al., 2001; Kukidome et al., 2006; Ray et al., 2012; Sid et al., 2013). Wu et al. 
(2013) have evidenced that nutrient deprivation can induce a WE-like metabolism 
which is mediated through ROS/ AMPK- dependent activation of pyruvate 
dehydrogenase kinase which increased production of lactate and cytoplasmic 
pyruvate concentration. Previously we reported increased production of pyruvate 
and glutamine with our pharmacologic treatment designed to induce a WE-like 
effect (Mordhorst et al., 2017). Investigation from Ko et al. (2011) discovered that 
glutamine increases expression of autophagy markers in fibroblasts co-cultured 
with a breast cancer cell line. The coauthors concluded that autophagic 
fibroblasts may serve as a primary source of glutamine for cancerous cells. 
 Autophagy is inhibited in cells by adequate nutrient sensing via mTOR 
(mammalian target of rapamycin), a phosphatidylinositol kinase-related serine/ 
threonine protein kinase (Raught et al., 2001; Eisenberg-Lerner and Kimchi, 
2009). The PI3K/ AKT pathway is an upstream regulator of mTORC1 (mTOR 
complex 1) (Hay, 2005; Manning and Cantley, 2007). While at first it was thought 
that the role of PI3K pathway was inhibitory to autophagy, evidence now 
illustrates that that the PI3K classes work differently, wherein class I inhibits 
autophagy and class III stimulates autophagy (Petiot et al., 2000; Kondo et al., 
2005; Jaber et al., 2012; Heras-Sandoval et al., 2014). The pharmaceutical PS48 
used in this study is a small molecule activator of phosphoinositide-dependent 
protein kinase 1 (PDK1) which serves as an upstream activator of AKT therefore 
this compound is believed to elicit downstream PI3K signaling (Hindie et al., 
2009; Stroba et al., 2009; Zhu et al., 2010; Zorn and Wells, 2010; Spate et al., 
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2015). It is unclear at this point what PI3K classes and downstream signaling 
PS48 is capable of stimulating and therefore, if this compound plays a role in 
autophagy.  
 In our micrograph sections, we found no differences in the respective size 
(perimeter and area) or number of mitochondria in pharmacologically treated 
fibroblasts compared to untreated controls (Table 3.6). Pharmacologic treatment 
increased the number of large autolysosomes to more than twice that of control 
fibroblasts (Table 3.5). Some autolysosomes contained mitochondria with 
partially intact membranes (Figure 3.3; labeled MIT and AV).). We speculate that 
the mitophagy induced in this study is due to chemical anoxia and serves as an 
adaptive route to self-preservation and survival for cells treated with a 
combination of CPI and PS48. In this study we only quantified autolysosomes 
from the fusion of autophagosomes and lysosomes. These were easily apparent 
large single-membrane dark structures in the cells (Figure 3.3; labeled AV).  
 In this study we initially used mitotracker green as a rough measure in an 
attempt to quantify mitochondria. MitoTracker Green FM accumulation is not 
dependent on membrane potential like other MitoTracker stains available. Since 
the MitoTracker Green purchased binds a translocase protein in the outer 
membrane of mitochondria, and there were no differences in mitotracker green 
intensity in this study, we speculated that there may be roughly equal quantities 
of the translocase, and hence mitochondria which was later confirmed by 
electron microscopy. 
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 We did not quantify non-fused lysosomes, engulfing autophagic vesicles, 
or peroxisomes in electron micrographs due to uncertainty of differentiating 
between structures without further staining techniques. Gene expression of MIX 
treated cells indicated increased β- oxidation (Mordhorst et al., 2017b); therefore 
it would have been useful quantify peroxisomes however the microscopy protocol 
used did not render optimal staining for differentiation of peroxisomes and 
lysosomes. Peroxisome visualization requires staining of catalase with alkaline 3, 
3- diaminobendine (Iwata et al., 2006; Fahimi, 2017).  
 It was not anticipated that mitochondria quantities would be similar 
between MIX and CON treatments given the impact of pharmaceuticals on Δψm 
loss and in doubling the number of autolysomes compared to un-treated 
fibroblasts. One possible explanation is that treated fibroblasts have upregulated 
mitochondrial biogenesis to compensate for mitophagy of pharmaceutically- 
damaged mitochondria, however we did not find statistical significance of 
expression in any of the known genes for mitochondrial biogenesis (Mordhorst et 
al., 2017b). The most upregulated gene (28 fold relative to CON) in MIX treated 
fibroblasts was mitochondrial ribosomal protein S23 (MRPS23) which encodes a 
small subunit of mitochondrial ribosomes. While literature on MRPS23 
specifically is relatively scanty at this time, a genome wide analysis identified 
MRPS23 as a causative gene in mitochondrial respiratory chain complex 
deficiencies (Kohda et al., 2016). Perhaps in this study MRPS23 expression was 
induced after repeated insult to mitochondrial oxidative phosphorylation via daily 
pharmaceutical treatment. Increased expression of MRPS23 was evidenced to 
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play a dire role in proliferation and metastasis of breast and cervical cancers and 
is associated with poor prognosis (Lyng et al., 2006; Gatza et al., 2014; Gao et 
al., 2017).  
 To our knowledge, the two pharmaceuticals have not been used as a 
treatment combination in any type of cell line to promote a Warburg effect-type 
metabolic phenotype by any other laboratories. Contrary to our Warburg effect 
hypothesis this pharmaceutical system seems to parallel more of a 'Reverse 
Warburg effect' (RWE) phenotype as there is more than twice the production of 
pyruvate and autolysomal vesicles compared to control fibroblasts. While we 
would not recommend this induction system to model cancer cell stroma as there 
are notable biological differences, some of the results were similar to findings of 
protocols used to induce the RWE in cancer stroma. A number of studies 
demonstrate that cancer- associated fibroblasts (CAFs) exhibit autophagy/ 
mitophagy, senescence, and predominant use of glycolysis (Chiavarina et al., 
2010; Martinez-Outschoorn et al., 2010; Migneco et al., 2010; Balliet et al., 2011; 
Sotgia et al., 2011; Capparelli et al., 2012a; Capparelli et al., 2012b; Capparelli et 
al., 2012c). By induction of the RWE, these fibroblasts supply cancerous cells 
with mitochondrial fuels such as pyruvate, lactate, glutamine, fatty acids, and 
ketone bodies (Pavlides et al., 2009; Bonuccelli et al., 2010; Ko et al., 2011; 
Martinez-Outschoorn et al., 2011; Sotgia et al., 2012). Many of evidence the role 
of oxidative stress or hypoxia in the induction of the RWE phenotype (Chiavarina 
et al., 2010; Lisanti et al., 2010; Pavlides et al., 2010a; Pavlides et al., 2010b; 
Capparelli et al., 2012c; Guido et al., 2012). Others have revealed that a WE-like 
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metabolism can be induced via nutrient deprivation (or starvation) in a HeLa (Wu 
et al., 2013) and a human fibroblast cell line (Golpour et al., 2014). We speculate 
that our MIX- treated fibroblasts in this study experienced degrees of both 
oxidative stress (via chemical anoxia) and nutrient deprivation likely due to the 
action of the pharmaceutical CPI. In this study we demonstrate that fibroblasts 
treated with CPI and PS48 to induce a Warburg effect-like metabolism do not 
have altered numbers of mitochondria though mitochondrial function is impaired, 
due to increased autophagy/ mitophagy and likely mitochondrial biogenesis.  
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3.6 Figure legends 
 
Figure 3.1. Impact of CPI and PS48 dosages on fibroblast mitochondrial 
membrane potential after treatment for 7 days. 
 
Figure 3.2. Mitochondrial membrane potential of fibroblasts treated for 7 days 
with a mixture of the two pharmaceutical agents (MIX; CPI 100 µM + PS48 10 
µM), or without drugs (CON; 0 µM). 
 
Figure 3.3. Electron micrographs of fibroblasts treated for 7 days with a mixture 
of the two pharmaceutical agents (MIX; CPI 100 µM + PS48 10 µM), or without 
drugs (CON; 0 µM). NUC = Nucleus, ER = Endoplasmic Reticulum, AV = 
Autophagic Vesicle, MIT= Mitochondria. 
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Figure 3.1. Impact of CPI and PS48 dosages on fibroblast mitochondrial 
membrane potential after treatment for 7 days. 
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Figure 3.2. Mitochondrial membrane potential of fibroblasts treated for 7 
days with a mixture of the two pharmaceutical agents (MIX; CPI 100 µM + 
PS48 10 µM), or without drugs (CON; 0 µM). 
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Figure 3.3. Electron micrographs of fibroblasts treated for 7 days with a 
mixture of the two pharmaceutical agents (MIX; CPI 100 µM + PS48 10 µM), 
or without drugs (CON; 0 µM). NUC = Nucleus, ER = Endoplasmic 
Reticulum, AV = Autophagic Vesicle, MIT= Mitochondria. 
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Table 3.1. Mitochondrial membrane potential function of fibroblasts treated 
with CPI-613 for 7 days. 
 Treatment§   
Measure 0 µM 25 µM 50 µM 100 µM SEM P-value 
Red Intensity, AU 950A 503B 368BC 201C 87 < 0.01 
Green Intensity, AU 7808 6699 5865 5090 127    0.15 
High Δψm
‡ populationⱡ˂, % 25.6A 12.8B 9.1B 4.5C 2.3 < 0.01 
Low Δψm population
€˂, % 74.4A 87.3B 90.9B 95.5C 2.3 < 0.01 
§Fibroblasts treated with 0, 50, or 100 µM CPI-613 by daily media changes at 
24± 2 hours. 
‡ Δψm = Mitochondrial membrane potential. 
ⱡPercentage of fibroblast population with high JC-10 red intensity and high 
membrane potential.  
€Percentage of fibroblast population with low JC-10 red intensity and low 
membrane potential 
˂Corresponds to Figure 3.1. 
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Table 3.2. Mitochondrial membrane potential function of fibroblasts treated 
with PS48 for 7 days. 
 Treatment§   
Measure 0 µM 1 µM 5 µM 10 µM SEM P-value 
Red Intensity, AU 950 703 631 729 193 0.28 
Green Intensity, AU 7809 7009 7361 6513 126 0.65 
High Δψm
‡ populationⱡ˂, % 25.6A 19.2B 16.4B 19.7B 3.2 0.04 
Low Δψm population
€˂, % 74.4 A 80.8 B 83.6 B 80.3 B 3.2 0.04 
§Fibroblasts treated with 0, 5, or 10 µM PS48 by daily media changes at 24± 
2 hours. 
‡ Δψm = Mitochondrial membrane potential. 
ⱡPercentage of fibroblast population with high JC-10 red intensity and high 
membrane potential.  
€Percentage of fibroblast population with low JC-10 red intensity and low 
membrane potential. 
˂Corresponds to Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 98 
 
Table 3.3. Mitochondrial membrane potential after 7 day pharmacological 
treatments in fibroblasts. 
 Treatment§   
Measures CON CPI MIX PS48 SEM P-value 
Red intensity, AU 924A 436B 435B 681AB 87 < 0.01 
Green intensity, AU 1144 1093 1132 903 127 0.52 
Red/ green ratio 0.81A 0.40B 0.39B 0.78A 0.06 < 0.01 
High Δψm
‡ populationⱡ˂, % 46.5B 1.8C 2.8C 33.4A 3.3 < 0.01 
Low Δψm population
€˂, % 53.6A 98.2C 97.2C 66.6B 3.3 <0.01 
§Fibroblasts treatments applied during daily media changes at 24± 2 hours; 
CON (0 µM), PS48 (10 µM PS48), CPI (100 µM CPI-613), or MIX (10 µM 
PS48 and 100 µM CPI-613).  
‡ Δψm = Mitochondrial membrane potential. 
ⱡPercentage of fibroblast population with high JC-10 red intensity and high 
membrane potential.  
€Percentage of fibroblast population with low JC-10 red intensity and low 
membrane potential.  
˂Corresponds to Figure 3.2. 
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Table 3.4. Mitochondrial intensity after 7 day pharmacological treatments 
in fibroblasts. 
 Treatment§   
Measure CON CPI MIX PS48 SEM P-value 
Green intensityⱡ, AU 816.7 837.7 766.5 698.8 72.7 0.55 
§Fibroblasts treatments applied during daily media changes at 24± 2 hours; 
CON (0 µM), PS48 (10 µM PS48), CPI (100 µM CPI-613), or MIX (10 µM 
PS48 and 100 µM CPI-613).  
ⱡIntensity of Mitotracker green staining. 
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Table 3.5. Ultrastructural cell features of fibroblasts treated for 7 days 
with MIX (100 µM CPI and 10 µM PS48) or CON (0 µM) during culture. 
 Treatment   
Ultrastructural measures CON MIX SEM P-Value 
Cell perimeter size, µM 103.26 101.33 14.93 0.99 
Cell area§, µM 380.02 362.78 122.91 0.52 
Nucleus perimeter size, µM 28.18 29.43 4.19 0.53 
Nucleus area‡, µM 54.88 56.19 13.87 0.84 
Nucleus proportion of cell ⱡ, % 16.92 17.08 1.63 0.95 
Autolysosome number€, # 7.48 18.75 4.47 0.0038 
§ Area within cell perimeter. 
‡ Area within perimeter of nucleus. 
ⱡ Percent of cell area that was nucleus. 
€ Average number of autolysosomal vesicles within a cell. 
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Table 3.6. Mitochondrial parameters of fibroblasts treated for 7 days 
with MIX (100 µM CPI and 10 µM PS48) or CON (0 µM) during culture. 
 Treatment  
Ultrastructural measures CON MIX SEM P-Value 
Total mitochondrial volume§, µM 5.52 6.13 2.22 0.61 
Mitochondrial proportion of cell‡, % 2.32 2.36 0.83 0.91 
Mitochondrial number ⱡ, # 16.91 14.98 6.14 0.61 
Mitochondrial perimeter size, µM 2.32 2.34 0.07 0.98 
Mitochondrial area€, µM 0.22 0.25 0.01 0.23 
§ Sum area of all mitochondria within a cell. 
‡ Percent of total mitochondrial volume within cell area- nucleus area. 
ⱡ Average number of mitochondria within a cell. 
€ Average area within average mitochondrial perimeter. 
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CHAPTER 4 
PHARMACOLOGIC TREATMENT OF DONOR-CELLS INDUCED TO HAVE A 
WARBURG EFFECT-LIKE METABOLISM DOES NOT ALTER EMBRYONIC 
DEVELOPMENT IN VITRO OR SURVIVAL DURING EARLY GESTATION 
WHEN USED IN SOMATIC CELL NUCLEAR TRANSFER IN PIGS. 
4.1 Abstract 
 Somatic cell nuclear transfer is a valuable technique for the generation of 
genetically engineered animals, however the efficiency of cloning in mammalian 
species is low (1-3%). Differentiated somatic cells commonly used in nuclear 
transfer utilize the tricarboxylic acid cycle and cellular respiration for energy 
production. Comparatively the metabolism of somatic cells contrasts that of the 
cells within the early embryos which predominately use glycolysis. Early embryos 
(prior to implantation) are evidenced to exhibit characteristics of a Warburg Effect 
(WE)-like metabolism. We hypothesized that pharmacologically driven fibroblast 
cells can become more blastomere-like and result in improved in vitro embryonic 
development after SCNT. The goals were to determine if subsequent in vitro 
embryo development is impacted by 1) cloning pharmacologically treated donor-
cells pushed to have a WE-like metabolism, or 2) culturing non-treated donor 
clones with pharmaceuticals used to push a WE-like metabolism. Additionally we 
investigated early gestational survival of the donor-treated clone embryos. Here 
we demonstrate that in vitro development of clones is not hindered by 
pharmacologically treating either the donor-cells or the embryos themselves with 
CPI, PS48, or the combination of these drugs. Furthermore these experiments 
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demonstrate that early embryos (or at least in vitro produced embryos) have a 
low proportion of mitochondria which have high membrane potential and 
treatment with these pharmaceuticals does not further alter the mitochondrial 
function in early embryos. Lastly, we show that survival in early gestation was not 
different between clones from pharmacologically induced WE-like donor cells and 
controls.  
4.2 Introduction 
 Advancing gene editing technologies has allowed the creation of pigs that 
exhibit phenotypes of pathological conditions such as breast cancer, spinal 
muscular atrophy, cystic fibrosis, and other maladies. These models are often 
more reliable and more phenotypically accurate than other animal models 
(reviewed in (Walters et al., 2012; Fan and Lai, 2013; Prather et al., 2013a)). 
Moreover, genetically modified pigs are proving to be advantageous to 
production agriculture and animal welfare as well (Whyte and Prather, 2011b; 
Prather et al., 2013c; Whitworth et al., 2016). In light of these innovations, one 
limitation of the pig is the lack of porcine embryonic stem cell lines or validated 
pluripotency induction protocols which are readily available in other model 
species (Piedrahita et al., 1990; Brevini et al., 2007; Hall, 2008; Koh and 
Piedrahita, 2014). Due to this, the majority of genetic modifications for pig models 
are achieved through Somatic Cell Nuclear Transfer (SCNT), however the 
success rate of this process is currently only 1-3% in swine (Whitworth and 
Prather, 2010). Nuclear transfer embryos which are derived from blastomere 
donor cells are demonstrated to have a high rate of development (Heyman et al., 
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2002; Mitalipov et al., 2002; Wilmut et al., 2002); however, others contend that 
the degree of differentiation of the donor cell may have little impact (Wakayama 
and Yanagimachi, 2001l; Oback and Wells, 2007).  
 Recent evidence suggests that early embryos exhibit a Warburg Effect 
(WE)-like metabolism prior to implantation (Krisher and Prather, 2012; Redel et 
al., 2012). A WE hallmark is the predominate use of glycolysis to acquire energy 
where subsequently lactate is produced as opposed to the tricarboxylic acid 
cycle (TCA) as used by differentiated cells (Warburg, 1956). This is a metabolic 
phenotype exhibited in various types of cancer cells. Increased signaling of the 
PI3K/ AKT pathway is correlated with an increase in glycolytic metabolism 
through regulation of expression and activity of glucose transporters and the 
enzymes phosphofructokinase and hexokinase (reviewed in (Hatzivassiliou et al., 
2005; Robey and Hay, 2009)). The allosteric small molecule PS48 (5-(4-Chloro-
phenyl)-3-phenyl-pent-2-enoic acid) is demonstrated to promote glycolysis and 
lactate production as well as enhance reprogramming efficiency of induced 
pluripotent stem cells by about 15-fold (Zhu et al., 2010). The pharmaceutical 
CPI-613 (6, 8-bis(benzylthio)octanoic acid: hereafter called CPI) inhibits pyruvate 
dehydrogenase which catalyzes the conversion of pyruvate to acetyl-CoA, a 
reaction necessary for entrance to the TCA cycle (Lee et al., 2011b; Zachar et 
al., 2011b). Both compounds should decrease mitochondrial use of the TCA 
cycle and promote the PI3K pathway, promoting resources toward the pentose 
phosphate pathway. In this study, we investigated embryonic development of 
clones as impacted by PS48, CPI, and the combination of drugs (MIX) on 1) 
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embryos created from the treated donor-cells, and 2) during culture of embryos 
created from non-treated donor-cells. Embryos produced from these treatments 
were assessed for percentage of zygotic cleavage and blastocyst formation, total 
cell number within blastocysts, DNA damage or degradation within blastomeres, 
and mitochondrial membrane potential (Δψm) all of which have been previously 
implicated as indicators of developmental quality and competence. 
4.3 Materials and Methods 
 Chemicals and materials were purchased from Sigma-Aldrich, St. Louis, 
MO unless otherwise specified. 
Animal care and compliance with ethical standards 
 All procedures performed in studies involving animals were in accordance 
with the ethical standards of the University of Missouri Institutional Animal Care 
and Use Committee at the University of Missouri in Columbia, MO. This study 
does not contain any experiments with human participants. 
Fetal-derived fibroblast cell culture 
 Porcine fetal fibroblast cell lines used in the study were established from a 
d 35 pregnancy and utilized in previous experiments in our laboratory (Mordhorst 
et al., 2017b). A cryogenic vial of fibroblasts (0.5 mL aliquots; 1.5 million/ mL in 
media containing 85% FBS and 15% DMSO) was defrosted from liquid nitrogen 
storage for each replicate. Cells were thawed and cultured in DMEM (1 g/ L 
glucose, glutamine, and pyruvate with phenol red; Sigma, St. Louis, MO, USA) 
supplemented with 15% FBS (Corning, Manassas, VA, USA) for seven days in 
T25 flasks (Corning, Corning, NY, USA) with addition of respective treatment 
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concentrations: 100 µM CPI-613 (CPI; Sigma, St. Louis, MO, USA), 10 µM PS48 
(PS48; Stemgent, Cambridge, MA, USA), both drug concentrations were mixed 
(MIX), or lacked pharmaceutical addition (CON). Incubators were maintained at 
38.5°C with a humidified atmosphere of 5% oxygen, 5% carbon dioxide, and 90% 
nitrogen during experiments. Cells were cultured as per previously established 
protocol (Mordhorst et al., 2016b) to maintain similar cell densities across 
treatments at passaging in an effort to keep drug exposure amongst treatments 
comparable. Using DMSO for suspension, CPI stocks were diluted to 100 mM 
and PS48 stocks were diluted to 10 mM to eliminate the confounding of DMSO 
concentration with pharmaceutical treatment. Briefly, after thawing, cells were 
plated at 1 x 105 cells/ mL in T25 flasks. After 72 and 120 hours, cells were 
passaged to new T25 flasks and plated (approximately 5 x 105 cells) to achieve 
~80% confluence (desired confluence prior to nuclear transfer). Media was 
changed daily on all flasks, i.e. those which received PS48, CPI, or MIX had new 
drugs applied daily (24± 2 hours). On day 7 (168 hours) flasks were briefly rinsed 
with PBS + 0.01 M EDTA, and fibroblast cells were dissociated from flasks by 
brief incubation (37°C) with 1X TrypLE Express (Gibco, Denmark). Fibroblasts 
were pelleted (5 min at 500 x g) and resuspended with their respective drug 
treatments and approximately 2,000 cells/ treatment were collected to be used 
for selection during SCNT.  
Annexin-V-FITC and propidium iodide cell viability 
 Fibroblast viability was measured based on positive fluorescence in a FL x 
FL2 (530/ 40 x 575/ 25 filters) channel plot by using a Beckman Coulter CyAN 
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ADP Analyzer cytometer (Beckman Coulter, Inc, Fullerton, CA). Axis of plots 
were determined by using fibroblasts singly stained with either annexin-V (FITC 
conjugated) or propidium iodide as well as by using unstained control cells. 
Fibroblasts were defined as healthy and viable if they did not stain positively for 
annexin-V or propidium iodide.  
Somatic cell nuclear transfer and surgical embryo transfer 
 Sow-derived oocytes were purchased from DeSoto Biosciences 
(Seymour, TN) and shipped overnight in maturation medium. After 40-42 h of 
maturation, cumulus cells were removed from the oocytes by vortexing in the 
presence of 0.1% hyaluronidase. Average percentage of oocyte maturation 
across replicates in experiments was 82.1% (standard deviation 3.7%). Oocytes 
used for enucleation were selected based on presence of a polar body and 
uniform cytoplasm. Oocytes were placed in manipulation medium (Lai and 
Prather, 2003) supplemented with 7.0 µg/ mL cytochalasin B during oocyte 
manipulation. In all experiments, SCNT was performed by two technicians and 
each treatment was split evenly amongst the technicians. Order of treatment in 
which SCNT was performed first was selected randomly. A hand-tooled thin 
glass capillary was used to remove the polar body along with a portion of the 
adjacent cytoplasm (presumably containing the metaphase II plate) and a donor 
cell was placed in the perivitelline space. For donor cell treatments, fibroblasts 
which had been treated daily for 7 days with pharmaceuticals were used and had 
the compounds freshly added at the time they were placed in droplets to be used 
for SCNT.  
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 Afterward, reconstructed embryos were fused in a fusion medium (0.3 M 
mannitol, 0.1 mM CaCl2, 0.1 mM MgCl2, 0.5 mM HEPES buffer, pH 7.2) by two 
DC pulses (1-sec interval) at 1.2 kV/ cm for 30 µsec using a BTX Electro Cell 
Manipulator (Harvard Apparatus). After electric pulse fusion, fused embryos were 
fully activated with 200 µM thimerosal for 10 min in the dark and 8 mM 
dithiothreitol for 30 min. Embryos were then incubated in our in house culture 
media MU1 (Redel et al., 2015) with a histone deacetylase inhibitor 0.5 µM 
Scriptaid (Sigma-Aldrich), for 14-16 h in the normal (atmospheric 20%) oxygen 
incubator. The next day, the SCNT embryos were moved into new MU1 culture 
media (without Scriptaid) and placed in a low (5%) oxygen incubator. To 
investigate the impact of the pharmaceuticals on embryos themselves, clone 
embryos were also created from non-drug-treated fibroblast donor cells and 
cultured with CPI-613 (50 or 100 µM), PS48 (5 or 10 µM), or vehicle control 
(DMSO 100 µM) after artificial activation. Additionally, fresh CPI and PS48 for 
respective treatments were applied to MU1 culture media (after incubation with 
scriptaid) and placed in low oxygen incubators. Blastocyst stage SCNT embryos 
were either stained and imaged (day 7 of development) or 40 to 50 were 
surgically transferred into the oviductal ampullary-isthmic junction of a surrogate 
gilt (day four or five of development). Surgical embryo transfer technique was 
conducted as previously established within our laboratory (Lai and Prather, 
2003). To establish which donor-cell treatment the fetuses originated from, we 
bred CAG-promoter driven GFP- Proteasome Fusion Protein (PSMA1) and 
Ubiquitin C (UBC) promoter driven tandem-dimer (td) Tomato fluorescent protein 
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Minnesota miniature boars to domestic (Yorkshire/ Landrace cross) gilts to create 
fluorescent cell lines which were treated with pharmaceuticals (as per donor-cell 
treatments of embryo transfer experiments; see Figure 4.4) and conducted 
embryo transfers using two surrogates each time; one surrogate received an 
even number of GFP expressing treatment '1' fibroblast clones and Tomato 
expressing treatment '2' fibroblast clones and another surrogate received an 
even number of the opposite fluorescent color by pharmaceutical combination of 
embryos. See Figure 4.5 for design of cell line development. 
Embryo staining and imaging 
Blastocyst cell number and chromosomal integrity. 
 On day 7 of embryonic development, blastocysts from all treatments were 
collected, washed in TL HEPES, and zona pellucidae were removed by using a 
physiological saline lowered to a pH of 1.79. Blastocysts were fixed with 4% 
paraformaldehyde (96% TL HEPES) for 20 minutes, then permeablized with 
0.1% Triton (in TL HEPES) for 15 minutes. Embryos were then incubated at 
38.5°C with TUNEL stain (Sigma-Aldrich, St. Louis, MO, USA) for 30 minutes 
then with Hoechst 33342 (2 ng/ mL, Sigma, St. Louis, MO, USA) for an additional 
15 minutes. Embryos which served as positive controls were treated with DNAse 
25 µg/ mL and embryos which served as negative controls were incubated 
without the TUNEL reaction enzyme. After staining, slides were immediately 
prepared using Vectashield mounting medium (Vectashield, Burlingame, CA) and 
embryos were imaged at 20X magnification using a Nikon Eclipse Ti-S (Nikon 
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Instruments Inc., Tokyo, Japan) inverted microscope in FITC and UV filtered 
channels and cell numbers were collected.  
Mitochondrial activity in blastocysts 
 To determine if our treatments impacted mitochondria respiratory capacity 
(and thereby TCA cycle capability) within embryos we measured mitochondrial 
membrane potential (Δψm) using a JC-10 a biphasic cationic dye. The properties 
of JC-10 allow the dye to infiltrate both the cytoplasm and mitochondria in a 
monomeric green emission form (525 nm); yet when mitochondrial membrane 
potential is elevated, the dye forms J-aggregates which have an orange emission 
(590 nm). An increased ratio of red to green fluorescence intensity (Texas red/ 
FITC filters) is indicative of higher mitochondrial membrane potential. Blastocysts 
from each treatment were collected on day 7 of embryonic development and 
washed in TL HEPES. Embryos were then incubated at 38.5°C in TL HEPES 
with 2.5 µM JC-10 (Enzo Life Sciences, Farmingdale, NY) for 30 minutes. 
Positive control embryos were treated with 5 µM valinomycin to depolarize 
mitochondria during incubation with JC-10. Slides were prepared immediately 
using Vectashield mounting medium (Vectashield, Burlingame, CA). Embryos 
were imaged at 40X magnification using a Nikon Eclipse E600 Microscope with 
Y-FL EPI Fluorescence (Nikon Instruments Inc., Tokyo, Japan) in FITC and 
Texas red filter channels by fluorescence microscopy using NIS-Element 
software F 2.30 (Nikon Instruments Inc., Tokyo, Japan). Mean intensity of green 
and orange-red fluorescence was measured using Image J software (available 
from the National Institutes of Health webpage: https://imagej.nih.gov/ij/) by 
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outlining each entire embryo as a region of interest first in the FITC micrograph 
then by applying the same ROI outline to the texas red micrograph. For 
publication images, to visualize both the nuclei and mitochondria, embryos were 
incubated in TL HEPES with 2.5 µM JC-10 for 15 minutes then Hoechst 33342 (2 
ng/ mL) was added and incubation continued another 15 minutes in 38.5°C. 
Afterward embryos were placed in TL HEPES in 35 mm petri dishes which have 
20 mm microwells (MatTek corporation, Ashland, MA, USA) for imaging at 20X 
magnification using an inverted scanning confocal Leica TCS SP8 laser scanning 
microscope with a 405-nm diode laser and tunable supercontinuum white light 
laser to generate maximum projections. The following excitation/ emission band-
pass wavelengths were used: 405/ 430-480 nm (DAPI), 490/ 500-550 nm 
(green), and 540/580-615 nm (red). Supplier recommendations for excitation/ 
emission of JC-10 are: low membrane potential (green; ~510 nm and 520 nm); 
high membrane potential (red; ~510 nm and 570 nm).  
Statistical Analysis 
 In all experiments, three biological replicates were collected for analysis 
and the average number of clone embryos created per treatment (for in vitro 
development) within each replicate was 68.9 ± 5.6. The average number of 
embryos per replicate for each treatment used for JC-10 staining and imaged in 
experiments was 14.9 ± 0.8 and the average number for TUNEL staining was 
14.0 ± 3.4 embryos. Data were normally distributed as confirmed via Univariate 
procedure in SAS 9.4 (SAS, Cary NC) and therefore no transformations were 
made prior to statistical analysis. Analyzed variables were considered statistically 
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different if the P-value was less than 0.05. All variables were compared using the 
generalized linear model procedure of SAS for main effect of treatment. 
Additionally, we analyzed for the effect of 'order' for data from the donor-treated 
fibroblast clones which we define as the order in which the groups of embryos 
were created (cells inserted to enucleated oocytes and fused) during nuclear 
transfer on each day for the variables of rate of embryonic cleavage and 
blastocyst formation.  
4.4 Results 
In vitro development of embryos derived from non-treated donor-cells cultured 
with pharmaceuticals after reconstruction 
 Drug treatments were tested in the culture of SCNT embryos from non-
drug-treated fibroblasts where pharmaceuticals were added during the incubation 
period with scriptaid culture and again (16 hours later) when they were moved to 
new culture media for the remainder of development until the blastocyst stage (d 
7; 168 hours after activation). Blastocyst development was impacted by drug 
culture treatment (P = 0.05): PS48 10 µM and CON (0 µM) had higher 
percentages (43.3 and 41.2%) compared to CPI 100 µM and MIX (33.6 and 32.7 
± 2.9%; Table 4.1). Compared to the other treatments, terminal deoxynucleotidyl 
transferase dUTP nick-end labeling (TUNEL) positive cell number was increased 
in MIX embryos (P = 0.01; MIX = 2.1 vs. ≤ 1.4 ± 0.26 in other treatments; Table 
4.1). Zygotic cleavage percentage and cell number within blastocysts were not 
altered with embryonic drug culture (P ≥ 0.07; Table 4.1). By the time blastocyst 
formation had occurred, mitochondrial membrane potential was not different 
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when either donor-cells received pharmacological treatment (P = 0.12; Table 4.1) 
or with treatment during culture (after cloning; P = 0.23; Table 4.1). 
In vitro development of donor-cell treated derived embryos 
 After 7 days of respective treatments, fibroblasts were analyzed for 
viability by Annexin-V-conjugated FITC and propidium iodide staining. All 
treatments yielded a large proportion of healthy cells for use in SCNT (Figure 
4.1). Initially, we tested for impact of CPI and PS48 dosage on number of 
blastomeres and degree of DNA degradation within clones derived from 
pharmaceutically treated donor-fibroblasts. The percentage of embryos which 
underwent zygotic cleavage, the percent which formed blastocysts, the number 
of blastomeres within blastocysts, and the number of blastomeres with detectable 
DNA damage (as measured by TUNEL) were not augmented with donor-cell 
dosages of CPI (0, 50, 100 µM; P ≥ 0.33; Supplementary Table 4.1), nor by 
dosages of PS48 (0, 5, 10 µM; P ≥ 0.08; Supplementary Table 4.2). As the 
highest concentrations of CPI and PS48 did not negatively impact development, 
they were used in subsequent experiments; moreover the two compounds were 
also used in combination as per the goal to program a WE-like metabolic effect. 
Cleavage and blastocyst percentages, blastocyst cell number, and TUNEL 
positive cell number were not augmented by donor-cell treatments (P > 0.14; 
Table 4.2.). During SCNT, the treatments were randomized so that reconstructed 
embryos from one treatment or another were not always created first or last. We 
kept track of the 'order' of reconstruction and activation during all SCNTs. The 
order in which SCNT embryos were produced in the same day did not affect the 
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rate of zygotic cleavage (P = 0.80); however, it did impact the percentage which 
obtained blastocyst stage development (P = 0.03). Embryos which were in the 
first 3 SCNT groups created had higher blastocyst production rates  ≥ 41.5% 
whereas those which were produced last had a rate of 33.5% blastocyst 
formation (Error = 3.2%; Table 4.3).  
In utero early gestational survival of embryos based on transfer parameters 
 Embryos used for embryo transfer had been reconstructed either 5 or 6 
days prior. Embryos which were transferred on day 6 of development had a 
higher probability of survival to day 35 of gestation than embryos transferred on 
day 5 of development (0.070 ± 0.013 vs. 0.036 ± 0.010; P = 0.017). There was 
also an impact of cell line on embryonic survival (P < 0.0001) where clones 
created from the green fluorescent protein cell line had higher survival 
probabilities than those from the tomato fluorescent line (0.081 vs. 0.025; SEM = 
0.010). There was not an interaction of cell line used for cloning and embryonic 
day of development on survival (P = 0.65). Gilts used as surrogates were either 
in day 3, 4, or 5 of their estrous cycles where day 0 of heat is considered the first 
day gilts were observed as 'in heat' or receptive to breeding. There was an 
interaction of gilt cycle day and day of embryonic development at the time of 
transfer (P < 0.0001) where day 6 developed embryos transferred into day 4 
cyclic surrogates had higher probability of survival (0.119 ± 0.016) than the other 
combinations for transfer ( P≤ 0.054 ± 0.019; Figure 4.2). 
In utero early gestational survival of embryos from CPI and PS48 treated donor 
cells 
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 Five of the twelve surrogates became pregnant in experiments in which 
we transferred embryos created from somatic cell nuclear transfer of cells treated 
for 7 days with either CPI (100 µM) or PS48 (10 µM). For results of day 35 
retrievals, see Table 4.4. One gilt was humanely euthanized shortly after embryo 
transfer for health and welfare concerns unrelated to the experiment and was not 
included in the analysis. There was no main effect of donor-cell treatment on 
survival (P = 0.85; Table 4.5). Moreover there was not an interaction of treatment 
and cell line on survival probability (P = 0.05; Table 4.5). 
In utero early gestational survival of embryos from MIX and CON treated donor 
cells 
 Four of the fourteen surrogates became pregnant in experiments in which 
we transferred embryos created from somatic cell nuclear transfer of cells treated 
for 7 days with either MIX (CPI 100 µM and PS48 10 µM) or CON (0 µM). For 
results of day 35 retrievals see Table 4.6. In this study five gilts were detected to 
be pregnant by ultrasound on day 21, but had lost the pregnancies by day 35 
when fetuses were retrieved. Donor-cell treatment did not impact survival in early 
gestation (P = 0.91; Table 4.7), and there was not a significant interaction of 
treatment and cell line (P = 0.60; Table 4.7). 
4.5 Discussion 
 In the current study we did not detect differences in cleavage, blastocyst 
formation, or DNA degradation amongst our treatments. The SCNT embryos 
produced in our experiments exhibited in vitro development typical of porcine 
clones. For example, 41.4% of SCNT embryos reached the blastocyst stage and 
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had an average cell number of about 33 cells; of these, roughly 1- 2 cells were 
TUNEL positive. These parameters are similar to previous observations of 
porcine SCNT blastocysts (Liang et al., 2015; Samiec et al., 2015). During SCNT 
experiments for donor-cell treatments, we noticed negative association between 
the length of time, or order, in which the embryos were produced, and 
development to the blastocyst stage, as well as with the amount of DNA 
degradation within those blastocysts. This occurred without differences in 
cleavage or total cell number of blastocysts. The impact of order was eliminated 
in the pharmaceutically culture-treated experiments as the fused groups of 
embryos were split evenly amongst treatments prior to addition of 
pharmaceuticals to culture media. We are currently exploring why this occurred; 
however, we recorded the time at which donor-cell treatments were brought to 
the SCNT technicians. The average duration of time between treatments was 
about 20 minutes. We speculate that perhaps the effect of order is due to an 
optimal oocyte maturation time having passed, or related to time-delay of fusion 
and activation, or the time interval between fusion and activation. In any event, 
these results necessitate additional research. 
 The developmental measures in this study are commonly used qualitative 
measures for testing embryonic competence. Recent literature indicates that rate 
of blastocyst formation and total cell number within blastocyst may not be the 
best predictors for in utero survival (Redel et al., 2016). For example, there are 
studies in which blastocyst rate of SCNT embryos was higher than that of IVF 
embryos (Iager et al., 2008; Cui et al., 2011) however the birth rate of IVF 
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produced embryos in many species is currently higher than that of clones. 
Emerging technologies including use of time-lapse recording demonstrate that 
the timing of cleavage and blastocyst formation may be more useful predictors of 
embryonic survival than the actual rate of cleavage and blastocyst formation 
(Cruz et al., 2012; Isom et al., 2012; Kaith et al., 2015; Motato et al., 2016). In the 
present study however, in vitro development was reflective of in utero survival 
where none of the treatments out performed each other.  
 Clone development during in vitro culture to the blastocyst stage and early 
gestation was not largely impacted by pharmaceuticals contrary to our 
hypothesis. From previous metabolomics, RNA sequencing, and flow cytometric 
analysis we know that fibroblasts from the same cell line have augmented 
glycolytic gene expression and metabolite production when treated with these 
pharmaceutical agents, without changes in cell cycle state or proliferation 
(Mordhorst et al., 2017b). In this study (as well as the latter) the same non-
fluorescent cell line was used for all experiments except for the embryo transfers. 
That cell line was created from a fetus within the tomato litter and therefore was a 
full sibling to the fetus from which the tomato cell line (used in embryo transfers) 
came from (see Figure 4.5). Furthermore, the CAG-promoter driven GFP-
Proteasome Fusion Protein (PSMA1) transgenic boar used in experiments from 
Miles et al. (2013) and the transgenic Ubiquitin C (UBC) promoter driven tandem-
dimer (td)Tomato fluorescent boar are both derived from the same original 
Minnesota Mini pig line. Therefore, all cell lines in these experiments are 
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consanguineous. See Figure 4.4 for images of fluorescent cell lines and 
reconstructed embryos. 
 The most profound effect observed in clone gestational survival was 
related to the line of cells used, not by gene expression induced by treatment 
within those cell lines. Interestingly, in this study the UBC driven tdTomato clone 
lines have decreased gestational survival. While there are numerous possible 
reasons why this may be occurring, no specific cause is obvious. This 
observation could be related to the fluorescent protein itself, for example there is 
another red fluorescent protein known as 'KillerRed' from the jellyfish 
Anthomedusa which has a mutated protein anm2CP and is highly phototoxic 
(Pletnev et al., 2009; Vegh et al., 2011). However tdTomato is widely used by many 
other laboratories so the issue at hand is likely related to the insertion site of the 
gene. Further investigations are warranted in determining why cell lines of the same 
cell type with similar genetics can impact the outcome of cloning to such a degree. 
We and other laboratories, have observed that some cell lines are more 'clonable' 
than others (Powell et al., 2004; Shi et al., 2007). 
 We did not observe developmental differences when the embryos from 
non-treated donors were exposed to the pharmaceuticals. Moreover, 
pharmaceutical treatments applied initially during in vitro embryo culture 
treatment did not provide any long-term mitochondrial membrane potential 
impairment. In this study all embryos had a low Δψm (ratio of J-aggregates to 
monomers; see Figure4.3) regardless of treatment. Thereby this is indicative that 
in early embryos, there is not a large amount of mitochondrial respiratory function 
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occurring during this stage of pre-implantation development. This supports the 
observations from Leese et al. (2008) that embryo metabolism is 'quiet' and from 
Krisher and Prather (2012) that early embryonic metabolism is glycolytic and 
exhibits the 'Warburg Effect'. In a study using oocytes from a polycystic ovarian 
syndrome gilt model, lower quality oocytes had lower Δψm (red/ green intensity 
ratios) as measured by JC-1 staining (Jia et al., 2016). The authors' reported 
intensity ratios were higher than those observed in our study. While this may 
simply be due to method of staining and use of JC-1 vs. JC-10, this could be due 
to differences in mitochondrial function between oocytes and blastocysts or 
perhaps indicate that lower Δψm is an adverse impact of SCNT. Jia et al. (2016) 
demonstrated that the lower quality oocytes had abnormally activated one-
carbon metabolism and mtDNA hypermethylation. 
 Phenotypically, mitochondria within oocytes and early pre-implantation 
embryos have few cristae and are spherical; however, mitochondrial morphology 
seems to mature as progressive embryonic development and differentiation 
occurs with mitochondrial elongation and cristae development (Hyttel and 
Niemann, 1990; Houghton, 2006; Van Blerkom, 2009). A similar phenomenon 
occurs in cardiomyocytes and stem cells where differentiation is correlated to 
larger mitochondria with distinct cristae, increased mitochondrial mass or mtDNA 
content, and ATP production (St. John et al., 2005; Lonergan et al., 2007; Chen 
et al., 2010; Rehman, 2010; Hom et al., 2011). Indeed many reviews have 
described the metabolism of early embryos to be largely glycolytic and many 
have discussed the mechanisms and motives for a Warburg-like metabolism 
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(Vander Heiden et al., 2009; Rehman, 2010; Krisher and Prather, 2012; Redel et 
al., 2012; Smith and Sturmey, 2013). Along with observations that suggest 
mitochondrial 'maturation' is associated with differentiation, there is evidence that 
glycolysis may facilitate reprogramming and pluripotency maintenance (Kondoh 
et al., 2005; Zhu et al., 2010; Folmes et al., 2011; Moussaieff et al., 2015). The 
compound PS48 is thought to enhance reprogramming efficiency mediated 
through activation of the PI3K/ AKT pathway (Zhu et al., 2010). In this study 
SCNT embryos that were treated with PS48 in the culture media had a similar 
number of cells and percentage of blastocyst development to that of controls. 
Other research from our laboratory demonstrated that blastocyst rate and total 
cell number was improved when PS48 was added in culture media of IVF 
embryos (Spate et al., 2015); however percentage of blastocyst development 
and total cell number are similar between studies. Of note, however not reaching 
statistical significance, PS48-treated donor embryos had higher survival 
probabilities than CPI-treated donors (Table 4.5).  
 Future investigations as to what constitutes the 'ideal donor-cell' for use in 
SCNT are warranted. There have been numerous attempts to enhance 
synchrony or nuclear reprogramming of donor-cells including but not limited to, 
investigations of serum starvation and cell cycle regulation, type of cell, age of 
animal from which cells were extracted, age of cells themselves (or passage 
number), epigenetic reprogramming, degree of pluripotency, and antioxidant 
treatment of cells (Campbell et al., 1996; Dominko et al., 1999; Kato et al., 2000; 
Tani et al., 2001; Wakayama and Yanagimachi, 2001; Heyman et al., 2002; 
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Mitalipov et al., 2002; Wilmut et al., 2002; Wells et al., 2003; Powell et al., 2004; 
Bonk et al., 2007; Oback and Wells, 2007; Iager et al., 2008; Whitworth et al., 
2011b; Yang et al., 2012; Chen et al., 2015). Alas, none of these treatments have 
served as the breakthrough needed to dramatically improve the standstill 
efficiency of somatic cell nuclear transfer.  
 In the current study, all pregnancies resultant from embryo transfer were 
collected on d 35 of gestation. Therefore, there is the limitation that no term 
piglets have been delivered from these treatments. We chose this day because 
30% of conceptus loss occurs in gestation days 10–30 in pigs (Wessels et al., 
2007). From the CPI and PS48 donor treated clone transfers (5 pregnancies) 
there was the same total number of CPI and PS48 fetuses collected (14) leading 
us to speculate that neither treatment had better enhanced in-utero viability over 
the other. Similarly, in the MIX and CON treated donor clones transferred, there 
were 12 CON fetuses and 13 MIX. In the first embryo transfer experiment we had 
a higher pregnancy rate 41.6% (5/ 12 surrogates) compared to the second 
experiment 28.6% (4/ 14 surrogates) which could be due to numerous factors 
including season. In the first experiment we were able to transfer all blastocysts 
however due to harvest facility complications in the second experiment, some 
morula stage embryos were also transferred which may have contributed to 
pregnancy success. In total we reconstructed 460 clone embryos for transfer in 
the first experiment and 590 for the second. Therefore the rate of success for 
cloning as per embryos transferred to fetus procurement was 6.1% (28 fetuses 
from 460 embryos) and 4.2% (25 fetuses from 590 embryos) in these 
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experiments. This study has demonstrated that fibroblasts pharmacologically 
treated with the compounds CPI-613 and PS48 can be successfully used in 
somatic cell nuclear transfer and subsequently result in early pregnancy; 
however, the altered metabolism of donor-cells did not improve survival in early 
gestation.  
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4.6 Figure legends 
 
Figure 4.1. Cell viability population measures from annexin-V (FITC) and 
propidium iodide intensity of porcine fetal fibroblasts after 7 day pharmacological 
treatment with CPI (100 µM), PS48 (10 µM), the mixture of the two (MIX), or 
without drugs (CON; 0 µM). 
 
Figure 4.2. Survival probability (number of piglets collected at day 35 of gestation 
from total number of reconstructed embryos transferred) of developmental day 5 
or 6 embryos transferred to surrogate gilts on 3, 4, and 5 days after observed 
heat. 
 
Figure 4.3. Representative somatic cell nuclear transfer derived blastocyst 
stained with the biphasic dye JC-10, a measure for mitochondrial membrane 
potential (Δψm). 
 
Figure 4.4. Green and tomato fluorescent cell lines used in somatic cell nuclear 
transfer for embryo transfer experiments and cleaving reconstructed embryos.  
  
Figure 4.5. Design of cell line creation by breeding of CAG- promoter driven 
GFP-Proteasome Fusion Protein (PSMA1) and Ubiquitin C (UBC)- promoter 
driven tandem-dimer (td)Tomato fluorescent protein Minnesota miniature boars 
to domestic gilts.  
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Figure 4.1. Cell viability population measures from annexin-V (FITC) and 
propidium iodide intensity of porcine fetal fibroblasts after 7 day 
pharmacological treatment with CPI (100 µM), PS48 (10 µM), the mixture of the 
two (MIX), or without drugs (CON; 0 µM). 
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Figure 4.2. Survival probability (number of piglets collected at day 35 of gestation 
from total number of reconstructed embryos transferred) of developmental day 5 or 6 
embryos transferred to surrogate gilts on 3, 4, and 5 days after observed heat. 
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Figure 4.3. Representative somatic cell nuclear transfer derived blastocyst stained 
with the biphasic dye JC-10, a measure for mitochondrial membrane potential (Δψm). 
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Figure 4.4. Green and tomato fluorescent cell lines used in somatic cell nuclear 
transfer for embryo transfer experiments and cleaving reconstructed embryos.  
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Figure 4.5. Design of cell line creation by breeding of CAG- promoter driven GFP-
Proteasome Fusion Protein (PSMA1) and Ubiquitin C (UBC)- promoter driven tandem-
dimer (td)Tomato fluorescent protein Minnesota miniature boars to domestic gilts.  
 
 129 
 
Table 4.1. Impacts of PS48 and CPI-613 treatment in culture media on 
subsequent development of clones.  
 Treatment
‡  
 CON CPI PS48 MIX SEM P-
value 
Cleavage rate§, % 91.8 89.2 95.2 87.7 1.9 0.07 
Blastocyst rate*, % 41.1 A 33.6B 43.3A 32.7 B 2.9 0.05 
Blastocyst cell number 32.3 34.8 36.8 35.1 2.2 0.48 
TUNEL positive cell 
number≠ 
1.2A 1.0A 1.4A 2.1B 0.36 0.01 
Red Intensity, AU ⱡ 15.1A 11.4C 12.6 BC 13.9 AB 0.74 0.0038 
Green Intensity, AU ⱡ 79.6A 52.5C 60.7 BC 73.6 AB 5.8 0.0045 
Red/ green ratio ⱡ 0.26 0.29 0.24 0.21 0.02 0.23 
‡Embryos treated with the pharmaceuticals CPI (100 µM), PS48 (10 µM), the 
mixture of the two (MIX), or as a vehicle control (CON; 100 µM DMSO) during 
scriptaid treatment and embryo culture. 
§ Percentage of reconstructed embryos which cleaved after 40 hours. 
*Percentage of reconstructed embryos which developed to the blastocyst stage. 
≠ Number of cells in blastocysts which stained positive for terminal 
deoxynucleotidyl transferase dUTP nick-end labeling.  
ⱡ Intensity of red or green fluorescence or the ratio of red/ green fluorescence of 
blastocyst stage embryos stained with JC-10. 
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Table 4.2. Impacts of donor-cell treatment with PS48 and CPI-613 for 7 days 
prior to nuclear transfer on subsequent development of clones.  
 Treatment
‡  
 CON CPI PS48 MIX SEM P-
value 
Cleavage rate§, % 90.5 91.0 91.8 87.7 2.4 0.67 
Blastocyst rate*, % 41.6 36.1 46.2 45.3 3.1 0.14 
Blastocyst cell numberΔ 34.6 32.0 35.8 35.3 2.1 0.50 
TUNEL positive cell 
number≠ 
1.9 1.2 1.5 1.7 0.3 0.20 
Red Intensity, AUⱡ 10.4
 A 10.0 AB 9.0 BC 9.4C 0.4 0.02 
Green Intensity, AUⱡ 56.0
A 48.7AB 38.5B 46.0AB 4.6 0.05 
Red/ green ratioⱡ 0.23 0.26 0.30 0.26 0.02 0.12 
‡Donor-fibroblasts treated for 7 days with the pharmaceuticals CPI (100 µM), 
PS48 (10 µM), the mixture of the two (MIX), or without drugs (CON; 0 µM). 
§ Percentage of reconstructed embryos which cleaved after 40 hours. 
*Percentage of reconstructed embryos which developed to the blastocyst stage. 
≠ Number of cells in blastocysts which stained positive for terminal 
deoxynucleotidyl transferase dUTP nick-end labeling.  
ⱡ Intensity of red or green fluorescence or the ratio of red/ green fluorescence of 
blastocyst stage embryos stained with JC-10. 
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Table 4.3. Impact of nuclear transfer order on subsequent development of clones.  
 Order of nuclear transfer and 
fusion‡ 
 
 1 2 3 4 SEM P-
value 
Cleavage rate§*, % 88.6 89.7 91.6 91.1 2.4 0.80 
Blastocyst rate*, % 47.6 A 41.6 A 46.4 A 33.5 B 3.2 0.03 
Blastocyst cell number 34.7 36.1 33.4 33.4 2.0 0.73 
TUNEL positive cell 
number≠ 
1.3 A 1.3 A 1.4 A 2.2 B 0.2 0.03 
‡Order in which embryos were reconstructed, fused, and artificially activated. 
§ Percentage of reconstructed embryos which cleaved after 40 hours. 
*Percentage of reconstructed embryos which developed to the blastocyst stage. 
≠ Number of cells in blastocysts which stained positive for terminal 
deoxynucleotidyl transferase dUTP nick-end labeling.  
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Table 4.4. Gestational day 35 fetal retrievals from somatic cell nuclear transfer of 
CPI (100 µM CPI-613) and PS48 (10 µM) treated GFP (green fluorescent 
protein) and TOM (tomato fluorescent protein) fibroblasts. 
Gilt 
recipient 
cycle day 
Blastocysts 
transferred 
Developmental 
day of 
blastocysts  
Total 
litter size 
Number of 
CPI 
fetuses‡ 
Number of 
PS48 
fetuses‡ 
5 50 6 7 2 TOM 5 GFP 
4 40 6 1* 1 GFP None 
4 40 6 5 5 GFP None 
5 50 6 2 1 GFP 1 TOM 
4 46 6 13 5 TOM 8 GFP 
‡Donor-fibroblasts treated for 7 days with the pharmaceuticals CPI (100 µM) or 
PS48 (10 µM) prior to somatic cell nuclear transfer. 
* Uterus contained 3 small regressing fetuses with no observable fluorescence.  
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Table 4.5. Impact of 7 day donor-cell treatment with 100 µm CPI-613 or 10 µm 
PS48 treated GFP (green fluorescent protein) and TOM (tomato fluorescent 
protein) fibroblasts on clone embryo transfer survival to day 35 of gestation. 
Treatment‡ Cell line 
Survival 
probability≠ 
SE P-value 
CPI GFP 0.066 0.023 0.05 
PS48 GFP 0.105 0.021  
CPI TOM 0.057 0.021  
PS48 TOM 0.094 0.023  
‡ Donor-fibroblasts treated for 7 days with the pharmaceuticals CPI (100 µM) or 
PS48 (10 µM) prior to somatic cell nuclear transfer. 
≠ Survival probability: number of piglets collected at day 35 of gestation from total 
number of reconstructed embryos transferred. 
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Table 4. 6. Gestational day 35 fetal retrievals from somatic cell nuclear transfer of 
CON (0 µM) and MIX (100 µM CPI-613 + 10 µM PS48) treated GFP (green 
fluorescent protein) and TOM (tomato fluorescent protein) fibroblasts. 
Gilt 
recipient 
cycle day 
Blastocysts 
and morulas 
transferred 
Developmental 
day of 
blastocysts  
Total 
litter size 
Number of 
CON 
fetuses 
Number of 
MIX 
fetuses 
5 50§ 5 7€ 2 TOM 5 GFP 
4 36‡ 6 2 2 GFP None 
4 40‡ 6 8* 1 TOM 7 GFP 
3 40≠ 5 8⸘  7 GFP 1 TOM 
§Twenty blastocysts and five morula of each treatment were transferred. 
€ Uterus contained two small fetuses both in regression; one TOM and one GFP. 
‡All blastocysts transferred. 
* Uterus contained 2 small fetuses 1 highly regressed and 1 with cranial 
bleeding; one TOM and 1 GFP. 
≠ Seventeen blastocysts and 3 morula of TOM MIX transferred and eighteen 
blastocysts and two morula of GFP CON transferred. 
⸘  Uterus contained three additional highly regressed necrotic fetuses two were 
GFP and one was TOM. 
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Table 4.7. Interaction of 7 day donor-cell treatment with MIX (100 µM CPI-613 
and 10 µM PS48) or CON (0 µM) on GFP (green fluorescent protein) or TOM 
(tomato fluorescent protein) fibroblasts on clone embryo transfer survival to day 
35 of gestation. 
Treatment‡ Cell line 
Survival 
probability≠ 
SE P-value 
CON GFP 0.070 0.019 0.60 
MIX GFP 0.077 0.017  
CON TOM 0.020 0.017  
MIX TOM 0.009 0.019  
‡Donor-fibroblasts treated for 7 days with the pharmaceuticals CPI (100 µM) and 
PS48 (10 µM) or as CON (0 µM) prior to somatic cell nuclear transfer. 
≠ Survival probability: number of piglets collected at day 35 of gestation from total 
number of reconstructed embryos transferred. 
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Supplementary Table 4.1. Impact of CPI-613 treatment of donor-cells on 
subsequent development of clones.  
 Concentration, µM   
 0 50 100 SEM P-value 
Cleavage rate, %§‡  86.5 89.2 92.0 ± 2.4 0.33 
Blastocyst rate, %§‡  42.8 45.5 44.5 ±6.7 0.99 
Blastocyst cell number*  27.7 30.9 28.9 ± 1.8 0.39 
TUNEL positive cell  
number≠ 
3.6 3.2 3.4 ±0.4 0.71 
§ Percentage of reconstructed embryos which cleaved after 40 hours. 
*Percentage of reconstructed embryos which developed to the blastocyst 
stage. 
≠ Number of cells in blastocysts which stained positive for terminal 
deoxynucleotidyl transferase dUTP nick-end labeling.  
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Supplementary Table 4.2. Impact of PS48 treatment of donor-cells on 
subsequent development of clones.  
 Concentration, µM 
 0 5 10 SEM P-value 
Cleavage rate, %§*  93.4 90.7 91.6 ±1.8 0.60 
Blastocyst rate, %§*  47.4 48.1 48.1 ±5.9 0.99 
Blastocyst cell number*  33.1 33.6 33.4 ± 1.4 0.97 
TUNEL positive cell number*  2.0 1.9 1.4 ±0.2 0.08 
§ Percentage of reconstructed embryos which cleaved after 40 hours. 
*Percentage of reconstructed embryos which developed to the blastocyst 
stage. 
≠ Number of cells in blastocysts which stained positive for terminal 
deoxynucleotidyl transferase dUTP nick-end labeling.  
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CHAPTER 5 
FETAL-DERIVED FIBROBLASTS ALTER GENE EXPRESSION AND 
MITOCHONDRIA TO COMPENSATE FOR HYPOXIC STRESS. 
5.1 Abstract 
 The Warburg effect is characterized by decreased mitochondrial oxidative 
phosphorylation and increased glycolytic flux in adequate oxygen. Warburg 
theorized that cancer may be resultant of mitochondrial damage (now evidenced 
to be incorrect). We hypothesized hypoxia might promote a Warburg effect-like 
metabolism in fibroblasts whereby gene expression and media metabolite 
production would reflect increased glycolytic flux. Additionally, we speculated that 
hypoxia would induce a rudimentary small mitochondrial phenotype observed in 
cell types evidenced to demonstrate the Warburg effect. While many have 
examined the role hypoxia plays in pathological conditions, few studies have 
investigated primary fetal-derived cells. We found that cells grown in 1.25% O2 
had normal cell viability and more, but smaller mitochondria with normal 
membrane potential. Several hypoxia- inducible genes were identified including 7 
genes for glycolytic enzymes. In conditioned media from hypoxic cells, the 
quantities of gluconolactone, cytosine, and uric acid were increased. These 
results indicate fibroblasts alter gene expression and mitochondria to 
compensate for hypoxic stress and maintain viability.  
5.2 Introduction 
 Otto Warburg first characterized the Warburg effect in cancer cells as a 
metabolic phenomenon where even in the presence of adequate oxygen, there is 
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high glycolytic activity (aerobic glycolysis) and lactate production (Warburg, 
1956). The Warburg effect has been described in proliferative cell types such as  
cancers, stem cells, yeast, and early embryos (Thomson et al., 2005; Conant and 
Wolfe, 2007; Vander Heiden et al., 2009; Varum et al., 2011; Krisher and 
Prather, 2012; Redel et al., 2012). Warburg had speculated that cancer may be 
resultant of mitochondrial damage in the metabolic switch from mitochondrial 
respiration to increased fermentation of sugars; however, it is now evidenced to 
be a consequence of mutations in tumor suppressors, oncogenes, and 
mitochondrial DNA (Warburg, 1956; Koppenol et al., 2011). All the same, the 
inquisition as to whether hypoxia would inhibit mitochondrial oxidative 
phosphorylation and increase glycolysis thereby inducing a Warburg effect- like 
metabolism in fibroblasts remained unanswered. 
 We hypothesized that hypoxia might elicit the mitochondrial phenotype 
observed in cell types evidenced to demonstrate the 'Warburg effect" 
(Wakayama and Yanagimachi, 2001; Houghton, 2006; Hom et al., 2011; Varum 
et al., 2011). Furthermore we hypothesized subsequent gene expression and 
media metabolite production would reflect increased glycolytic flux after culture in 
restricted oxygen. In this study we investigated effects of hypoxia on fibroblast 
viability and size as well as mitochondrial measures such as quantity, size, and 
membrane potential. Spent media metabolites and gene expression were 
analyzed to determine if metabolic pathways consistent with the Warburg effect 
were induced in fibroblast cells cultured in hypoxic conditions. 
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5.3 Materials and methods 
All materials and supplies were purchased from Sigma-Aldrich, St. Louis, MO 
unless otherwise specified. 
Fetal-derived fibroblast cell culture 
 Methods used to establish the porcine fetal fibroblast cell line used was 
previously published by Mordhorst et al., (2017b). Fibroblasts were excised from 
the dorsal proportion of day 35 porcine fetuses and were frozen in liquid nitrogen 
(0.5 mL aliquots; ~ 80 cryogenic vials). In these experiments a male line resultant 
of a miniature boar to domestic gilt breeding. A separate vial of fibroblasts was 
thawed for each replicate of each experiment. Cells were cultured for 7 days in 
DMEM (1 g/ L glucose; Sigma, St. Louis, MO supplemented with 15% FBS 
(Corning, Manassas, VA, USA)) in T25 flasks (Corning, Corning, NY). Media was 
changed daily and was placed in incubators roughly an hour prior to achieve 
equilibrated gas concentrations and prevent cell shock.  
 During experiments incubators were maintained at 38.5°C with a 
humidified atmosphere of 5% carbon dioxide. Cells were either treated as 
controls (CON) cultured in 5% oxygen for 7 days or cultured in step-wise 
decreasing concentrations of oxygen (hypoxia; HYP) where for 2 days they were 
maintained at 5% oxygen, on the third day cultured at 2.5% oxygen, and from the 
fourth to the seventh days cultured at 1.25% oxygen. Decreased oxygen 
concentrations in incubators were achieved by increased nitrogen concentration. 
A system of four nitrogen gas tanks with regulators set to release sequentially 
was used to maintain constant availability of nitrogen. The concentration of 
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oxygen was regularly monitored by a handheld device with an error of ±0.5% 
oxygen. The oxygen probe was left in the incubator and the line was accessed 
without opening the incubator door.  
 All cells were passaged after 5 days of growth and diluted to achieve even 
numbers across treatments by using an automated cell counter. At this point 
some cells were plated for electron microscopy in 6 well plates. For passaging, 
dissociation reagents were kept cold. At passaging, flasks were briefly rinsed 
with PBS + 0.01 M EDTA, and fibroblast cells were dissociated from flasks by 
brief incubation (37°C) with 1X TrypLE Express (Gibco, Denmark). Cells were re-
plated in media which was equilibrated in the respective treatment incubators for 
approximately one hour. We took great effort to mitigate exposure to oxygen 
whenever possible when we were transporting cells to be analyzed by: 
equilibrating medias, using plug-sealed cap flasks, covering 6 well plates in 
parafilm, and transporting as quickly as possible in styrofoam coolers.   
Flow cytometry: data acquisition and analysis 
 For all cytometry data collected, gating protocols were applied for analysis 
of a population free of debris and doublet cells. In all flow cytometry experiments, 
three replicates were collected for analysis and three technical samples (50,000 
or more single cells) for each treatment were run in the flow cytometer for each of 
the biological replicates. Data were confirmed to be normally distributed as 
measured via Univariate procedure in SAS 9.3 (SAS, Cary NC) which included 
the following normality tests: Shapiro- Wilk, Kolmogorov- Smirnov, Anderson-
Darling, and Cramér- von Mises. Based on these tests square root and log 
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transformations were made as needed to achieve normality prior to statistical 
analysis. Data was analyzed by using the MIXED procedure of SAS 9.3 for main 
effect of treatment for flow cytometry acquisitions. Differences with a P- value of 
< 0.05 were considered significant. Least squared means values are reported 
with standard errors unless otherwise stated.   
JC-10 mitochondrial membrane potential 
 To determine the capacity of treated cells to utilize mitochondrial oxidative 
phosphorylation, we used JC-10 an indicator of mitochondrial membrane 
potential. This allowed us to determine proportions of cells which contained 
mitochondria in a state of higher or lower mitochondrial membrane potential. The 
biphasic cationic dye JC-10 is able to infiltrate both the cytoplasm and 
mitochondria in a monomeric green emission form (525 nm). When mitochondrial 
membrane potential is elevated, JC-10 dye forms J-aggregates which have an 
orange emission (590 nm). All cells were dissociated (as described above) and 
incubated at 37° C for 45 minutes. Immediately after, JC-10 staining was 
measured by using a Beckman Coulter CyAN ADP Analyzer cytometer 
(Fullerton, CA) also equipped with a 488 nm laser with 530/ 40 (FL 1) and 575/ 
25 (FL 2) dichroic filters and Summit 4.4 software (Beckman Coulter, Inc, 
Fullerton, CA). Channel compensation was adjusted for every replicate in 
experiments by incubating cells with the mitochondrial membrane potential 
disrupter carbonyl cyanide 3-chlorophenylhydrazone (CCCP; 100 µM) for 2 hours 
prior to analysis for use as a positive control for monomeric JC-10 staining. A 
florescence intensity (FL 2 x FL 1) plot was divided into a four-square grid to 
 143 
 
determine mean intensities and percentages for cell populations. The horizontal 
axis was set based on an unstained control population and the vertical axis 
based on CCCP treated population (100 µM for 2 hours at 37°C). Population 
percentages within quadrants as well as mean FL 1and FL 2 intensities were 
data collected for each population for every treatment.  
Mitotracker green cytometry acquisition 
 Mean fluorescence intensity in the FL1 (530/ 40 dichroic filter) channel 
was measured in Mitotracker green stained fibroblast cells by using a Beckman 
Coulter CyAN ADP Analyzer cytometer (Beckman Coulter, Inc, Fullerton, CA). A 
plot of arbitrary event 'count' x FL1 intensity was used to determine mean 
intensity for each of the treatment replicates acquired. Unstained controls were 
used to determine positive florescence intensity in the FL1 intensity plot.  
High pressure freezing and processing for electron microscopy 
 For ultrastructural analyses, fibroblasts of both oxygen treatments were 
grown for 5 days. Afterwards fibroblasts were then dissociated and plated in 6 
well plates on gold-coated sapphire discs (3 mm in diameter; Wohlwend GmbH, 
Switzerland) and treated for 2 additional days. On day 7 of treatments the cells 
were cryo-immobilized by high-pressure freezing by using the Wohlwend HPF 
Compact 02 and freeze substituted in acetone containing 0.1% (w/v) uranyl 
acetate, 0.5% (w/v) osmium tetroxide, and 0.5% (w/v) imidazole. Freeze 
substitution was performed in a Leica AFS by raising the temperature from -90°C 
to 0°C over a period of 18 h. Samples were infiltrated with Epon and polymerized 
at 60°C. Seventy-five nm thin sections were prepared, mounted on 
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formvar/carbon coated copper grids, and subsequently imaged with a JEOL 1400 
transmission electron microscope equipped with a CCD camera at an 
acceleration voltage of 80 kV. Cell features and organelles were outlined and 
measured using Image J (Schneider et al., 2012). For each of the three biological 
replicates at least 3 cells were measured as technical replicates; the average 
was 6 fully measured cells for each treatment of each replicate. Data from these 
measures was assessed for normality using the Univariate procedure of SAS to 
generate P-values for Shapiro- Wilk, Kolmogorov- Smirnov, Anderson-Darling, 
and Cramér- von Mises tests. Square root transformations were used as needed 
prior to analysis for main effects of oxygen treatment using a MIXED model in 
SAS. 
Conditioned media metabolite gas chromatography and mass spectroscopy 
analysis 
 Conditioned media samples were collected from three replicates of HYP 
(1.25%) and CON (5%) oxygen cultured flasks on days 3, 5, and 7 of culture and 
were centrifuged at 600 g for 6 minutes to remove any cellular debris then 
storage at -20°C. Samples were processed as previously described by Mordhorst 
et al. (2017b). Conditioned media was thawed, vortexed, and 1 mL was used for 
metabolite analysis. Chloroform (1 mL) and HPLC-grade water containing 
internal standard 25 µg/ mL ribitol (1 mL) were added to media samples. The 
samples were then vortexed and centrifuged at 2900 g for 30 min at 4°C to 
separate the layers. The upper aqueous layer (1 mL) was collected and 
transferred to individual 2.0 mL autosampler vials and dried under nitrogen at 
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45°C. Dried polar compounds were methoximated in pyridine with 120 µL of 15.0 
µg/ mL methoxyamine-HCl, briefly sonicated, and incubated at 50°C until the 
residue was resuspended. Metabolites were then derivatized with 120 µL of 
MSTFA (N-Methyl-N-(trimethylsilyl)trifluoroacetamide) +1% TMCS 
(Trimethylchlorosilane) for 1 h at 50°C. The samples were subsequently 
transferred to a 300 µL glass insert and analyzed using an Agilent 6890 gas 
chromatographer coupled to a 5973 MSD scanning from m/z 50–650. Samples 
were injected at a 15:1 split ratio, and the inlet and transfer line were held at 
280°C. Separation was achieved on a 630 m DB-5MS column (J&W Scientific, 
0.25 mm ID, 0.25 µm film thickness) with a temperature gradient of 5°C /min from 
80°C to 315°C and held at 315°C for 12 min, and a constant helium flow of 1.0 
mL/ min (as previously described Mordhorst et al 2017b). The raw data were 
processed by using AMDIS software (Automated Mass spectral Deconvolution 
and Identification System, http://chemdata.nist.gov/mass-spectra/amdis/). 
Derivatized metabolites were identified by matching retention time and mass 
spectra to those in a custom library of authentic compounds. Abundances of the 
metabolites were extracted with MET-IDEA (Broeckling et al., 2006; Lei et al., 
2012), and then normalized to the abundance of the internal standard ribitol for 
statistical analyses.   
 Conditioned media was analyzed by using the program SAS (Cary, NC). 
The model for each of the metabolites included treatment effect (HYP or CON) 
and day effect (3, 5 or 7) as fixed effects, and the replicate as a random effect. 
The interaction between oxygen treatment and day was included when 
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significant. The heterogeneous autoregressive (1) or heterogeneous compound 
symmetry covariance structures were used to model the correlations among the 
repeated measures at different days. To meet the normality assumption in the 
linear regression models, the metabolites were either modeled at original scale or 
transformed to log-scale or square root scale. The studentized residual plot and 
normal quantile plot were used for checking model fitting. For the pairwise 
comparisons, the Tukey- Kramer method for multiple test adjustment was used. 
Differences with a P- value of < 0.05 were considered significant. Differences 
with P- values ≥ 0.05 and ≤ 0.10 were considered as tendencies. Least squared 
means values are reported with standard errors unless otherwise stated.   
Extraction of RNA and sequencing 
 Fibroblast cells were collected for RNA after 7 days of respective culture 
treatments for 3 biological replicates. The cells were dissociated from culture 
flasks by brief incubation (37°C) with 1 x TrypLE Express (Gibco, Denmark) by 
the same method used for cytometry. Cells were pelleted (5 min at 500 x G) 
rinsed with 1X PBS, again pelleted and cells were plunged into liquid nitrogen 
and stored at -80 °C. Extraction of RNA was performed as per specifications by 
using Qiagen RNeasy mini kits (Qiagen, Germantown, MD). Total RNA quality 
was determined at the University of Missouri DNA core facility by using the 
Advanced Analytical Fragment Analyzer, and RNA quality scores were assigned 
based on 1) the presence of discrete 18S and 28S rRNA bands, 2) the mass 
ratio between the 28S and 18S rRNA, 3) the absence of fragments in the pre-
18S and 28S regions, and 4) absence of contaminating high molecular weight 
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fragments. All RNA utilized in this study had scores of 10 (the highest score 
possible). RNAseq libraries were prepared at the University of Missouri Core 
facility by using standard Illumina protocol and sequenced on an Illumina HiSeq 
2000 platform as single-end reads with read depth of 50 million reads/ sample. 
The raw sequences (FASTQ) were subjected to quality check by FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The program fqtrim 
(https://ccb.jhu.edu/software/fqtrim/) was used to remove adapters, perform 
quality trimming (phred score >30) by a sliding window scan (6 nucleotides) and 
select read length of 30 nucleotides or longer after trimming. The reads obtained 
from the quality control step were mapped to the Sus Scrofa (v10.2) reference 
genome by using Hisat2 aligner which is a fast and sensitive alignment program 
of next-generation sequencing data (Kim et al., 2015). The program 
FeatureCounts (Liao et al., 2014) was used to quantify read counts by using the 
sequences alignment files of each sample. The differentially expressed (DE) 
genes between sample groups, representing the culture treatment, were 
determined by fitting the read counts to a generalized linear model implemented 
in edgeR-robust (Zhou et al., 2014). The false discovery rate (FDR) < 0.05 was 
used as threshold for statistical significant differential expression of genes. 
5.4 Results 
Impact of hypoxia treatment on fibroblast viability and mitochondrial staining 
intensities  
 Positive Annexin- V- FITC and propidium iodide staining was used to 
detect apoptotic and dead cells, respectively. The percentages of viable cells, 
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dead cells, and cells undergoing Annexin-V membrane exposure indicative of 
early apoptosis was not significantly different between HYP and CON cells (P  ≥ 
0.06; Supplemental Table 5.1). The number of cells which were considered to be 
in late apoptosis (stained singly for propidium iodide) was greater (P = 0.02) in 
CON cultured cells than HYP (0.55 vs. 0.29 ± 0.16%) though it was a small 
percentage of fibroblasts. 
 Mitochondrial membrane potential (Δψm) was measured via flow 
cytometric analysis of JC-10 staining as an estimate of mitochondrial capacity for 
oxidative phosphorylation and tricarboxylic acid cycle capacity. Between CON 
and HYP cells, there was not a difference (P = 0.17) in the proportion of cells with 
mitochondria having lowly (LF see Figure 5.1) or highly (HF see Figure 5.1) 
functional membranes (Figure 5.1; Supplemental Table 5.2). Though overall red 
and green intensities of JC-10 staining were not different (P > 0.06) between 
HYP and CON (red: 680.2 vs. 674.5 ± 180.3 AU; green: 1004.0 vs. 1111.4 ± 
517.1 AU) the red/ green intensity ratio was increased (P = 0.02) in HYP cells 
compared to CON (0.56 vs. 0.50± 0.03 AU). Intensity of MitoTracker 
fluorescence intensity was greater (P < 0.0001) in HYP compared to CON 
(1097.3 vs. 668.8 ± 22.9 AU; Supplemental Table 5.3).  
Impact of hypoxia treatment on fibroblast ultrastructure 
 Electron microscopy was used to count and measure cells and 
mitochondria. Area and perimeter of fibroblasts as well as their nuclei were not 
impacted by oxygen restriction during culture (P ≥ 0.20; Table 5.1). Percentage 
of the cell that was occupied by the nucleus and the percentage of non-nuclear 
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area of the cell that was mitochondria were also not altered when cells were 
cultured in hypoxia (P ≥ 0.20; Table 5.1 and Table 5.2). The number, perimeter 
size, and area of mitochondria were significantly impacted by HYP culture 
treatment (P ≤ 0.0009; Table 5.2). The number of mitochondria was increased 
with HYP treatment compared to CON (14.01 vs. 10.69 ± 0.34 mitochondria; 
Table 5.2). However, CON cells had larger mitochondrial area and perimeters 
than HYP (area = 0.22 vs. 0.16 ± 0.01 µM; perimeter = 2.16 vs. 2.39 ± 0.35 µM; 
Table 5.2).  
Conditioned cell culture media metabolites 
 Fifty metabolites were detected in conditioned culture media via tandem 
mass spectroscopy- gas chromatography. There was a tendency (P = 0.06) for 
the quantity of gluconolactone to be decreased in the media from HYP cell 
culture compared to control (121.6 vs. 200.6 ± 73.2 AU). Both of these values are 
increased from the quantity of gluconolactone in unconditioned media (40.2; 
standard deviation = 20.1 AU). The interaction of day (media collected on days 3, 
5, and 7) and oxygen culture treatment (HYP vs. CON) was significant (P < 0.05) 
for uric acid and cytosine. The level of cytosine remained similar throughout the 
week in media from HYP cultured cells (day 3 = 2.3 ± 0.5; day 7 = 2.6 ± 1.5 AU) 
but had increased in CON (day 3 = 2.1 ± 0.5; day 7 = 7.2 ± 1.5 AU). The quantity 
of cytosine in media from HYP fibroblasts throughout the week was similar to the 
quantity in unconditioned media (1.9; standard deviation = 1.8 AU). Uric acid 
quantity in unconditioned media was 41.5 AU (standard deviation = 4.1 AU). On 
day 3 both treatments had similar concentrations (HYP = 44.2; CON = 46.8 ± 2.1 
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AU). By day 7, CON had greater uptake compared to HYP, and thereby a lower 
concentration in conditioned media (8.3 vs. 34.8 ± 3.6 AU). Of the other 
metabolites detected, the quantities within HYP vs. CON conditioned media were 
not different (P > 0.10). 
Gene expression 
 Sequencing of mRNA revealed 51 differentially expressed genes between 
HYP and CON treatments (Figure 5.4). Of these genes, 7 play a role in 
glycolysis/ gluconeogenesis and were increased in HYP cells relative to CON 
(Figure 5.2, blue font). Compared to CON, HYP cells had downregulation of two 
fold change or greater in 4 genes and upregulation of two fold change or greater 
in expression of 16 genes. Of the 51 genes, 5 genes were down-regulated and 
differentially expressed in HYP vs. CON. In order of fold change in expression, 
those genes are somatostatin; aldo-keto reductase family 1, member C1; splA/ 
ryanodine receptor domain and SOCS box containing 2; prostaglandin E receptor 
3; and enoyl-CoA delta isomerase 2. Several genes were identified that were 
previously induced by hypoxia in other cell types (Figure 5.2, red font); these are 
elaborated on in the discussion. 
5.5 Discussion 
 This study sought to investigate if hypoxia could elicit a Warburg effect- 
like phenotype in fetal-derived fibroblast cells. Electron microscopy was 
employed to establish whether hypoxia impacted the quantity or relative size of 
mitochondria in cultured monolayers. The relative total mitochondrial area 
(proportion relative to non-nuclear cell area) amongst HYP and CON fibroblasts 
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was not different; however HYP fibroblasts on average had more mitochondria (a 
36.7% increase) that were smaller in area (37.5%) and perimeter (19.6%; Table 
5.2). We had hypothesized that mitochondria from fibroblasts cultured in hypoxic 
conditions might become spherical in shape and have less or no respiratory 
function similar to  what is known as the "mitochondrial petite mutation" (Claude 
and Fullam, 1945; Ferguson and von Borstel, 1992; Bianchi et al., 1996). 
However, the morphology of mitochondrial cristae appeared relatively normal in 
HYP fibroblasts (Figure 5.4; HYP; MIT). The surface area and perimeters of our 
fibroblasts (Table 5.1) are similar to the findings of others using human fibroblast 
cell lines (Brugmans et al., 1983; Barbucci et al., 2005). There were not statistical 
differences in cell size or viability between CON and HYP cultured cells. 
Comparably, in human cardiac fibroblasts, 2% oxygen did not alter cell viability; 
however, it did impair protein synthesis (Agocha et al., 1997).  
 A review of cancer by Wouters and Koritzinsky (2008) highlights two 
hypoxia signaling pathways: regulation of the mammalian target of rapamycin 
(mTOR) and the unfolded protein response (UPR). In this study we measured 
changes in mRNA expression by RNA sequencing of HYP and CON cultured 
cells after 1 week of culture. Increased expression of DNA damage- inducible 
transcript 4 protein (DDIT4; also known as REDD1) and endoplasmic reticulum 
oxidoreductase 1 alpha (ERO1A) in HYP fibroblasts evidence that these 
pathways may have been stimulated. Both genes were previously evidenced to 
be expressed under hypoxic stress (Shoshani et al., 2002; Gess et al., 2003; Jin 
et al., 2007). The mTOR pathway is inhibited by DDIT4, thereby regulating cell 
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growth and survival; which may in part explain why HYP cells had no differences 
in size or viability from CON. In addition to expression of ERO1A, a gene 
essential for the maintenance of endoplasmic reticulum redox homeostasis and 
protein folding activity during stress, we observed a 'stressed' appearance in 
endoplasmic reticulum from HYP fibroblasts (Figure 5.4; HYP; ER). Hypoxic 
tension has been linked to ER stress and autophagy (Bi et al., 2005; Ye and 
Koumenis, 2009; Pereira et al., 2014). In HYP cells, expression of autophagy 
related 9B (ATG9B), was increased compared to CON; this protein organizes 
early autophagosome structure by facilitating cytoplasm- to- vacuole transport 
and vesicle formation. Furthermore autophagic vesicles were observed in both 
CON and HYP cells; however, not directly quantified due to the challenges of 
correctly deciphering autophagic vesicles from other vesicle types present 
without proper immunomarkers when visible organelles are not contained (Figure 
5.4; AV). 
 Under hypoxic stress, cells can induce autophagy and mitophagy to 
promote survival which is achieved through activation of hypoxia-inducible factor 
(HIF-1) (Mazure and Pouysségur, 2010; Hu et al., 2012). An important well-
studied modulator of oxygen homeostasis and survival, HIF activates the 
transcription of genes for metabolic adaptation to hypoxia including glycolytic 
enzymes, glucose transporters, and angiogenic genes (Jiang et al., 1997; 
Bergeron et al., 1999; Semenza, 2000). We did not detect a statistical difference 
in HIF expression however, we did see increased expression of several 
established HIF- activated downstream genes (Figure 5.2, red font) including 
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vascular endothelial growth factor A (VEGFA), interleukin 13 receptor subunit 
alpha 1 (IL13RA1), family with sequence similarity 162 member A (FAM162A), 
insulin like growth factor binding protein 2 (IGFBP2), inhibitor of DNA binding 2, 
HLH protein (ID2), stanniocalcin (STC1), stanniocalcin (STC2), adrenomedullin 
(ADM), and aldolase (ALDOC) as well as 7 glycolytic enzymes (Figure 5.2, blue 
font; Figure 5.3, blue font) in HYP cultured cells (Jiang et al., 1997; Bergeron et 
al., 1999; Feldser et al., 1999; Leonard et al., 2003; Löfstedt et al., 2004; Jean et 
al., 2006; Copple et al., 2011). A limitation we have is that the glycolytic genes 
expressed are all reversible enzymes which are used in both glycolysis and 
gluconeogenesis. However, increased expression of hexokinase 1 and 2 in HYP 
fibroblasts might indicate glycolytic activity to be the predominating pathway. In 
addition, expression of Mannose phosphate isomerase (Attig et al.) was 
increased in HYP cells (Figure 5.2 and 5.3, blue font); this enzyme catalyzes the 
conversion of mannose- 6- phosphate to fructose- 6- phsophate a metabolite in 
the glycolytic pathway. Reasonably, gluconeogenesis would be useful to 'recycle' 
pyruvate in a hypoxic state. Since we did not see differences in the metabolite 
production of alanine, pyruvate, or lactate between HYP and CON cells this may 
therefore indicate activation of gluconeogenesis. In a previous study using 
related fibroblasts, pharmacologic treatment designed to induce a Warburg 
effect- like metabolism was able to increase the production of pyruvate 
(Mordhorst et al., 2017b). In HYP fibroblasts, expression of lactose 
dehydrogenase A (LDHA) was increased compared to control (Figure 5.2; blue 
font). 
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 Papandreou et al. (2006) evidenced hypoxic adaptation whereby in 
addition to increased expression of glycolytic enzymes, mitochondrial oxygen 
consumption was decreased through downstream HIF activation of pyruvate 
dehydrogenase kinase 1 (PDK1). This kinase functions to inactivate pyruvate 
dehydrogenase the enzyme which facilitates entry of pyruvate into the TCA cycle 
thereby decreasing mitochondrial oxidative phosphorylation. Expression of PDK1 
was increased in HYP cells compared to CON; however, mitochondrial 
membrane potential of HYP fibroblasts was not hindered with treatment as 
measured by JC-10 fluorescence (Figure 5.1). This could be due to two reasons. 
One, a limitation of this study is that HYP cells were inevitably exposed to higher 
concentrations of oxygen while being briefly transported to the electron 
microscopy and flow cytometry facilities however we tried to mitigate the 
exposure as much as possible by transporting and processing cells with brevity. 
Secondly, hypoxic cells may have had higher stores of calcium in their 
mitochondria, which has been observed to increase mitochondrial membrane 
potential (Wojtczak et al., 1999). This may be a possibility as HYP cells had 
increased expression for both stannocalcins (1 and 2) which is a gene involved in 
cellular calcium regulation.  
 Conditioned media collected throughout the week was processed for 
metabolites by using tandem gas chromatography- mass spectroscopy (GC/ 
MS). While both HYP and CON cells produced gluconolactone, an intermediate 
between glycolysis and the pentose phosphate shunt, CON media had higher 
quantities than HYP. The amount of cytosine in HYP cells was similar to the 
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initial quantities found in unconditioned media however in CON cells cytosine had 
increased. These results may indicate that while both HYP and CON cells were 
producing these metabolites, HYP cells may have had increased need and 
usage of metabolites perhaps for the synthesis of nucleotides via the pentose 
phosphate pathway. In day 7 conditioned media, the concentration of uric acid 
was higher in HYP cells than CON; however, they were both lower than the 
quantity present in unconditioned media. Uric acid is a recognized antioxidant 
(Ames et al., 1981). In vivo, uric acid was shown to protect rat neurons and 
restore mitochondrial function after insult (Yu et al., 1998). Uric acid 
concentration may have been lower in CON cells because they had oxygen 
available to oxidize it, whereas in HYP cell inability to oxidize uric acid may have 
caused a buildup. One limitation to measuring metabolites in media is that the 
intracellular concentration and production is unknown. 
 Future research is needed to further investigate intracellular 
concentrations of metabolites to determine what pathways and mechanisms are 
prevailing in hypoxic stressed cells. This research is well warranted. There is 
growing evidence for the metabolic role of cancer associated fibroblasts in the 
metastasis and growth of cancer, whereby stroma is coerced to exhibit a 
Warburg effect- like metabolism deemed the 'reverse Warburg effect'. Moreover 
an interesting mystery remains in the origin of carcinomas; why and how do the 
fibroblasts not become cancerous? What mechanisms exist through which 
epithelial cells accumulate somatic mutations and develop into carcinomas but 
not fibroblasts? How might this be related to metabolism and cell signaling 
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pathways? Currently the majority of hypoxia research is conducted in cancerous 
cell lines and tissues exhibiting other pathological conditions (such as the liver). 
However we did detect many of the same hypoxia-related genes detected in  a 
study from Benita et al. (2009) using 7 different cancer lines.  
 The results from this study indicate fibroblasts alter gene expression and 
mitochondrial quantities to compensate for hypoxic stress and maintain viability. 
While cells in this study were healthy fibroblasts, hypoxia induced expression of 
the genes previously described in other types of cells and tissues, downstream of 
HIF-1, or otherwise. The increased transcript abundance of glycolytic genes in 
addition to expression of PDK-1 implies that glycolysis was favored over 
mitochondrial oxidative phosphorylation, and therefore a Warburg effect- like 
metabolism was induced by hypoxia. Otto Warburg was incorrect in his theory of 
the origin of cancer being in part due to 'damaged respiration', and indeed many 
evidence that cancer does respire (reviewed in (Zheng, 2012)). However, 
perhaps he was 'on to something' regarding the induction of the Warburg effect: 
"Since the respiration of all cancer cells is damaged, our first question is, How 
can the respiration of body cells be injured?...One method for the destruction of 
the respiration of body cells is the removal of oxygen." (Warburg,1956). New 
questions posed in these experiments such as intracellular calcium and 
metabolite levels in hypoxic cells warrant additional research. Determining the 
true metabolic flux occurring between glycolysis, gluconeogenesis, and the 
pentose phosphate pathways in oxygen deprived fibroblasts may be useful in 
understanding the role of these cells as part of cancer stroma. Moreover whether 
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the indications of increased autophagy observed in this study are relevant to 
general hypoxia, and the mechanism for this induction as it is implicated to play 
an important role in cancer growth (Kondo et al., 2005; Chiavarina et al., 2010; 
Capparelli et al., 2012a; Capparelli et al., 2012b; Capparelli et al., 2012c; Hu et 
al., 2012). Further investigations into cell types which also encounter hypoxic 
microenvironments that do not typically become cancerous, such as fibroblasts 
may elucidate new preventions and treatments for either the tumor or the cancer 
associated stroma.  
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5.6 Figure legends 
Figure 5.1. Mitochondrial membrane potential of fibroblasts after 7 days in 5% 
oxygen (CON) or a stepwise hypoxic culture (2 days in 5%, 1 day in 2.5% and 4 
days in 1.2% oxygen; HYP); HF = highly functional mitochondria quadrant; LF = 
lowly functional mitochondria quadrant.  
 
Figure 5.2. Differentially expressed genes between fibroblasts cultured for 1 
week in hypoxia (HYP; 2 days in 5%, 1 day in 2.5% and 4 days in 1.2% oxygen) 
or as controls (CON; 5% oxygen for 7 days). 
 
Figure 5.3. Glycolytic/ gluconeogenic pathway with genes increased with hypoxic 
culture (2 days in 5%, 1 day in 2.5% and 4 days in 1.2% oxygen) in blue lettering.  
 
Figure 5.4. Electron micrographs of fibroblasts cultured for 7 days in hypoxia 
(HYP; 2 days in 5%, 1 day in 2.5% and 4 days in 1.2% oxygen) or as controls 
(CON; 5% oxygen for 7 days). NUC = Nucleus, ER = Endoplasmic Reticulum, AV 
= Autophagic Vesicle, MIT= Mitochondria. 
 
 
 
 
 
. 
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Figure 5.1. Mitochondrial membrane potential of fibroblasts after 7 days in 
5% oxygen (CON) or a stepwise hypoxic culture (2 days in 5%, 1 day in 
2.5% and 4 days in 1.2% oxygen; HYP); HF = highly functional 
mitochondria quadrant; LF = lowly functional mitochondria quadrant.  
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Figure 5.2. Differentially expressed genes between fibroblasts cultured for 1 week 
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Figure 5.4. Electron micrographs of fibroblasts cultured for 7 days in hypoxia 
(HYP; 2 days in 5%, 1 day in 2.5% and 4 days in 1.2% oxygen) or as controls 
(CON; 5% oxygen for 7 days). NUC = Nucleus, ER = Endoplasmic Reticulum, 
AV = Autophagic Vesicle, MIT= Mitochondria. 
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Table 5.1. Ultrastructural cell features of fibroblasts cultured for 7 days under HYP 
(restricted oxygen gradient culture; 5% - 1.25%) or CON (5 %) oxygen 
concentrations. 
 Treatment   
Ultrastructural measures CON HYP SE P-Value 
Cell perimeter size, µM 102.3 110.56 24.66 0.64 
Cell area§, µM 375.6 475.51 163.87 0.34 
Nucleus perimeter size, µM 28.0 25.53 6.48 0.20 
Nucleus area‡, µM 54.2 53.60 19.51 0.93 
Nucleus proportion of cell ⱡ, % 16.9 15.38 2.33 0.54 
§ Area within cell perimeter in section. 
‡ Area within perimeter of nucleus in section. 
ⱡ Percent of cell area that was nucleus in section. 
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Table 5.2. Mitochondrial parameters of fibroblasts cultured for 7 days under HYP 
(restricted oxygen gradient culture; 5% - 1.25%) or CON (5 %) oxygen 
concentrations. 
     Treatment   
Ultrastructural measures CON HYP SE P-Value 
Total mitochondrial volume§, µM 5.2 4.7 1.71 0.44 
Mitochondrial proportion of cell‡, % 3.20 10.31 6.20 0.84 
Mitochondrial number ⱡ, # 10.69 14.02 0.34 0.0009 
Average mitochondrial perimeter size, µM 2.26 1.89 0.17 <0.0001 
Average mitochondrial area€, µM 0.22 0.16 0.01 <0.0001 
§ Sum area of all mitochondria within a cell section. 
‡ Percent of total mitochondrial volume within cell area- nucleus area in cell section. 
ⱡ Average number of mitochondria within a cell section. 
€ Average area within average mitochondrial perimeter in section. 
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Supplemental Table 5.1. Viability of fibroblasts after 7 day culture under HYP 
(restricted oxygen gradient culture; 5% - 1.25%) or CON (5 %) oxygen 
concentrations. 
 Oxygen treatment   
 Control Hypoxia SE P-Value 
Healthy‡ 95.18 96.25 1.24 0.34 
Early apoptoticⱡ  1.11 1.70 0.24 0.06 
Late apoptoticⱡ 0.55 0.29 0.16 0.02 
Necrotic≠ 3.20 1.76 1.30 0.23 
‡Percentage of fibroblast population which stained negative for annexin-V-FITC 
and propidium iodide. 
ⱡPercentage of fibroblast population which stained positive for annexin-V-FITC 
and negative for propidium iodide. 
€Percentage of fibroblast population which stained positive for propidium iodide 
and negative for annexin-V-FITC. 
≠Percentage of fibroblast population which stained positive for annexin-V-FITC 
and propidium iodide. 
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Supplemental Table 5.2. Mitochondrial membrane potential of fibroblasts after 
7 day culture under HYP (restricted oxygen gradient culture; 5% - 1.25%) or 
CON (5 %) oxygen concentrations. 
 Oxygen treatments   
 Control Hypoxia SE P-Value 
Red Intensity, AU 674.48 680.23 180.34 0.97 
Green Intensity, AU 1111.38 1003.97 517.1 0.06 
Red/ green ratio 0.50 0.56 0.03 0.02 
High Δψm
‡ population, %ⱡ 17.16 23.71 8.10 0.17 
Low Δψm population, %
€ 82.84 76.29 8.10 0.17 
‡ Δψm = Mitochondrial membrane potential. 
ⱡPercentage of fibroblast population with high JC-10 red intensity and high 
membrane potential.  
€Percentage of fibroblast population with low JC-10 red intensity and low 
membrane potential 
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Supplemental Table 5.3. Mitotracker green intensity of fibroblasts cultured for 7 
days with hypoxic or normal oxygen treatment HYP (restricted oxygen gradient 
culture; 5% - 1.25%) or CON (5 %) oxygen concentrations 
 Oxygen treatment   
 Control Hypoxia SE P-Value 
Intensity, AUⱡ 668.8 1097.3 22.9 < 0.0001 
 ⱡIntensity of Mitotracker green staining. 
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CHAPTER 6 
TO BREATHE OR NOT TO BREATHE: IMPROVEMENT OF IN VITRO 
PORCINE CLONE DEVELOPMENT AFTER SOMATIC DONOR CELLS ARE 
CULTURED UNDER HYPOXIA. 
6.1 Abstract 
 Gene- edited pigs serve as excellent models in biomedicine and 
agriculture. To date, the most reliable way to generate genetically engineered 
pigs is via somatic cell nuclear transfer (SCNT), however the efficiency of cloning 
in pigs is low (1-3%). Somatic cells such as fibroblasts frequently used in nuclear 
transfer utilize the tricarboxylic acid cycle and mitochondrial oxidative 
phosphorylation for efficient energy production. The metabolism of somatic cells 
contrasts that of the cells within the early embryos which predominately use 
glycolysis. Prior to implantation, blastomeres are evidenced to exhibit 
characteristics of a Warburg Effect (WE)-like metabolism. We hypothesized that 
fibroblast cells could become blastomere-like if mitochondrial oxidative 
phosphorylation was inhibited by hypoxia and that this would result in improved 
in vitro embryonic development after SCNT. The goal was to determine if 
subsequent in vitro embryo development is impacted by cloning cells cultured in 
hypoxia pushed to have a WE-like metabolism. Here we demonstrate that in vitro 
developmental measures of clone embryos are improved when donor cells are 
cultured in hypoxia prior to nuclear transfer.  
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6.2 Introduction 
 For two decades, since the creation of the cloned first lamb using a 
somatic cell donor, the scientific community has strived to improve the standstill 
efficiency of somatic cell nuclear transfer (SCNT) in mammals. While other 
emerging techniques are improving, to date, this invaluable technique is still the 
most efficient way to create reliably edited genetically engineered animals. Gene- 
edited and/ or transgenic (GET) pigs serve as excellent models to study disease 
progression and develop treatments for human genetic disorders. The pig in 
particular conveys great similarity to humans in their anatomy, physiology, and 
genomics therefore allowing them to exhibit symptoms of human pathologies 
more accurately and reliably than other animal models (reviewed in (Walters et 
al., 2012; Fan and Lai, 2013; Prather et al., 2013a)). To date, GET pig models 
have been created for human conditions such as breast cancer, spinal muscular 
atrophy, cystic fibrosis, and others (Krisher et al., 2006; Lowe et al., 2007; 
Rogatcheva et al., 2007; Prather et al., 2008; Stoltz et al., 2010; Luo et al., 2011; 
Newell-Fugate et al., 2011; Whyte and Prather, 2011a; Luo et al., 2012b; 
Meurens et al., 2012; Ross et al., 2012; Fan and Lai, 2013; Flisikowska et al., 
2013; Donninger et al., 2015). For several reasons, GET pigs are the most likely 
donor option for future xenotransplantation of organs; therefore great efforts have 
been underway to make this possibility a reality (Lai et al., 2002a; Lavitrano et 
al., 2002; Ekser et al., 2009; Klymiuk et al., 2010; Lutz et al., 2013; Bottino et al., 
2014; Mohiuddin et al., 2014; Yang et al., 2015).  
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 Moreover GET pigs are also proving beneficial to production agriculture in 
terms of investigating ways to improve 1) animal health and welfare by studying 
and eradicating disease; 2) the nutritional value of meat products; and 3) the 
impact of livestock production on the environment (Forsberg et al., 2003; Lai et 
al., 2006; Prather, 2006; Forsberg et al., 2013; Whitworth et al., 2016).  
 Due to the usefulness of GET pigs in both biomedicine and agriculture 
there is growing need for the creation of new or improved upon models which at 
this time, is still predominately achieved via SCNT. Currently the efficiency of 
SCNT in pigs is approximately 1-3% (Whitworth and Prather, 2010). This 
percentage varies slightly depending on if investigators calculate success rate 
based on total embryos reconstructed, total embryos transferred, or pregnancy 
rate of surrogates to which embryos were transferred. Nevertheless, this rate is 
low and there is substantial need for improvement. When blastomeres are used 
as donor- cells for SCNT the rate of success is significantly improved (Mitalipov 
et al., 2002). Therefore we speculated that if somatic cells could be induced to be 
more blastomere-like, the cloning efficiency may be greatly improved. As there is 
growing evidence that cellular reprogramming is facilitated in part by upregulation 
of glycolysis maintenance (Kondoh et al., 2005; Zhu et al., 2010; Folmes et al., 
2011; Moussaieff et al., 2015). In light of this, we reasoned promoting a highly 
glycolytic metabolism would facilitate nuclear reprogramming. Somatic cells 
predominately use mitochondrial oxidative phosphorylation and the citric acid 
cycle for the production of energy whereas the metabolism of pre-implantation 
embryos is evidenced to be more glycolytic and Warburg-like in nature (Krisher 
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and Prather, 2012). We hypothesized that if donor- fibroblasts were cultured 
under hypoxic conditions, it would elicit higher glycolytic activity thereby 
promoting a more Warburg-like metabolism exhibited in the blastomeres of early 
embryos. We speculated this would aid in facilitation of nuclear reprogramming 
and improve cloning efficiency. In this study, we demonstrate that restricting 
oxygen from donor- fibroblasts during cell culture does improve measures of in 
vitro developmental quality in reconstructed pig embryos.  
6.3 Materials and Methods 
 Chemicals and materials were purchased from Sigma-Aldrich, St. Louis, 
MO unless otherwise specified. 
Animal care and compliance with ethical standards 
 All procedures performed in studies involving animals were in accordance 
with the ethical standards of the University of Missouri Institutional Animal Care 
and Use Committee at the University of Missouri in Columbia, MO. This study 
does not contain any experiments with human participants. 
Fetal-derived fibroblast cell culture 
 Porcine fetal fibroblast cell lines used in the study were established from a 
d 35 pregnancy and utilized in previous experiments in our laboratory (Mordhorst 
et al., 2017b, Mordhorst et al., 2017c, Mordhorst et al., 2017d). A cryogenic vial 
of fibroblasts (0.5 mL aliquots; 1.5 million/ mL in media containing 85% FBS and 
15% DMSO) was defrosted from liquid nitrogen storage for every replicate in the 
experiment. Cells were thawed and cultured in DMEM (1 g/ L glucose, glutamine, 
and pyruvate with phenol red; Sigma, St. Louis, MO, USA) supplemented with 
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15% FBS (Corning, Manassas, VA, USA) for seven days in T25 flasks (Corning, 
Corning, NY, USA). Cells were either treated as controls (CON) cultured in 5% 
oxygen for the duration of 7 days or cultured in step-wise decreasing 
concentrations of oxygen (LOW) where for 2 days they were maintained at 5% 
oxygen, on the third day cultured at 2.5% oxygen, and from the fourth to the 
seventh days cultured at 1.2% oxygen. 
 Oxygen concentration of incubators was regularly monitored by a 
handheld gas monitor (model: InControl 1050; Labotect Labor-Technik-Göttingen 
GmbH ; Göttingen, Germany) which was professionally tested by Utility Lab 
Services (part of Thermo-Fisher Scientific; Waltham, MA, USA) and proved to 
have an error of ±0.5% oxygen. Therefore the low oxygen treatment may have 
been as high as 1.25% or as low as 1.15% oxygen in this study. Incubators were 
maintained at 38.5°C with a humidified atmosphere of 5.5% carbon dioxide 
during experiments. Increased nitrogen gas concentrations were used to achieve 
lower oxygen concentrations in incubators. A system of four nitrogen tanks 
connected by one gas line was assembled to ensure adequate nitrogen gas was 
available to incubators. The regulators of nitrogen tanks were set to sequentially 
empty the tanks one by one as culture experiments required a large quantity of 
nitrogen gas, and at least one of the tanks had to be exchanged for a full tank 
daily. Cells from all treatments were passaged on day 5 of growth and plated at 
the same density after being counted in an automated cell counter. For 
passaging, dissociation reagents were kept cold in an effort to decrease 
metabolism of cells and prevent as much metabolism of oxygen as possible. 
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Media that cells were plated in on day 5 had been equilibrated to oxygen 
concentrations by incubating media in the incubators in petri dishes for an hour 
or more. At passaging, flasks were briefly rinsed with PBS + 0.01 M EDTA, and 
fibroblast cells were dissociated from flasks by brief incubation (37°C) with 1X 
TrypLE Express (Gibco, Denmark). Fibroblasts were pelleted (5 min at 500 x g), 
on day 5 cells were diluted and replated; on day 7 approximately 2,000 cells/ 
treatment were collected to be used for selection during SCNT.  
Somatic cell nuclear transfer and embryo culture 
 Methods for SCNT were previously reported by Mordhorst et al., (2017c). 
For in vitro experiments sow-derived oocytes were purchased from DeSoto 
Biosciences (Seymour, TN) and shipped overnight in maturation medium. After 
40-42 h of maturation, cumulus cells were removed from the oocytes by 
vortexing in the presence of 0.1% hyaluronidase. Average percentage of oocyte 
maturation across replicates in experiments was 72.9% (standard deviation 
3.1%). Oocytes used for enucleation were selected based on presence of a polar 
body and uniform cytoplasm. Oocytes were placed in manipulation medium (Lai 
and Prather, 2003) supplemented with 7.0 µg/ mL cytochalasin B during oocyte 
manipulation. In all experiments, SCNT was performed by two technicians and 
each treatment was split evenly amongst the technicians. Order of treatment in 
which SCNT was performed first was selected randomly. A hand-tooled thin 
glass capillary was used to remove the polar body along with a portion of the 
adjacent cytoplasm (presumably containing the metaphase II plate) and a donor 
cell was placed in the perivitelline space. For donor cell treatments, fibroblasts 
 174 
 
which had been treated daily for 7 days with pharmaceuticals were used and had 
the compounds freshly added at the time they were placed in droplets to be used 
for SCNT.  
 Afterward, reconstructed embryos were fused in a fusion medium (0.3 M 
mannitol, 0.1 mM CaCl2, 0.1 mM MgCl2, 0.5 mM HEPES buffer, pH 7.2) by two 
DC pulses (1-sec interval) at 1.2 kV/ cm for 30 µsec using a BTX Electro Cell 
Manipulator (Harvard Apparatus). After electric pulse fusion, fused embryos were 
fully activated with 200 µM thimerosal for 10 min in the dark and 8 mM 
dithiothreitol for 30 min. Embryos were then incubated in MU1 (Redel et al., 
2015) with a histone deacetylase inhibitor 0.5 µM Scriptaid (Sigma-Aldrich), for 
14-16 h in the normal (atmospheric 20%) oxygen incubator. The next day, the 
SCNT embryos were moved into new MU1 culture media (without scriptaid) and 
placed in a low (5%) oxygen incubator. During culture, embryos were inspected 
for cleavage and blastocyst formation. Blastocyst stage SCNT embryos were 
fixed with 4% paraformalin (in HEPES buffer) and stained with Hoechst on day 7 
of development.  
 Two experiments with three biological replicates each were conducted to 
investigate whether clones from oxygen restricted donor cells had improved 
development. In both experiments gestational day 35 fetal fibroblasts were used, 
however different cell lines were used in experiment 1 and 2. Additionally in 
experiment 2, gene-edited fibroblasts with a mono-allelic 111 base pair deletion 
in the gene fumarylacetoacetate hydrolase (FAH) and un-edited fibroblasts (both 
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from the same original cell line) were cultured under both oxygen treatments and 
used as donor- fibroblasts for SCNT. 
6.4 Results 
 In these experiments proliferation of fibroblasts after 5 days of culture was 
not significantly impacted (P = 0.12) by restricted oxygen culture compared to 
control (1.72 x 106 vs. 1.50 x 106 ± 0.12 x 106). In experiment 1 fusion of 
reconstructed embryos was not significantly different (P = 0.41) between HYP 
and CON donor- fibroblasts; however in experiment 2, HYP donors had improved 
(P < 0.01) rate of successful fusion (Figure 6.1A). In experiment 2, the un-edited 
cells had a better rate of fusion compared to cells with a mono-allelic deletion (P 
< 0.01; 85.1 vs. 78.9 ± 2.6%). Overall the non-edited and edited donor- 
fibroblasts clones did not have different (P = 0.36) proportions of embryos which 
cleaved. However, the non- edited line had more embryos cleave earlier (P < 
0.01; 49.7 vs. 42.2 ± 9.7%) and the edited fibroblasts had more embryos which 
cleaved later (P < 0.01; 51.3 vs. 42.6 ± 9.1%). No other measures were impacted 
between edited and non-edited fibroblast clones (P ≥ 0.07).  
 While the total proportion of reconstructed embryos which cleaved was not 
different between oxygen culture treatments (P ≥ 0.08) HYP reconstructed clones 
had a higher (P < 0.04) proportion cleave earlier (within the first 24 hours) 
compared to control in both experiments (Figure 6.1B). There were no 
differences in late cleavage of embryos in experiment 1 (P = 0.49), but in 
experiment 2 a higher proportion of CON clones cleaved later than HYP (P < 
0.01; Figure 6.1B). Blastocyst production was improved when embryos were 
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created from HYP donors (P < 0.001; Figure 6.1C). In experiment 1, 34.5% of 
HYP reconstructed embryos formed blastocysts vs. 21.8% in CON (SE = 2.3%). 
In experiment 2, 55.5% of HYP embryos had achieved blastocyst stage of 
development whereas 42.5% of CON embryos had (SE = 3.2%). Therefore the 
rate of blastocyst formation was improved 12.7 and 13.0% by HYP donors in 
experiments 1 and 2 respectively.  
 Earlier cleaving embryos were more likely to form blastocysts than 
embryos which had cleaved late (after the first 24 hours; P < 0.01; Figure 6.1C). 
Of the embryos which had cleaved early, the total percentage of blastocysts that 
developed from HYP donors was higher than CON (P ≤ 0.001; Figure 6.1C). 
Amongst the late cleaving embryos there were no treatment differences (P ≥ 
0.25) in either experiment (Figure 6.1C). In experiment 1, more HYP- derived 
early- cleaving embryos had reached the blastocyst stage by day 5 of 
development (P < 0.01) whereas the number of early- cleaving embryos which 
formed blastocysts on days 6 and 7 were not significantly different between 
treatments (P ≥ 0.08) see Figure 6.1C. More HYP clones which had cleaved 
early had formed blastocysts by day 6 (P = 0.02; Figure 6.1C; Figure 6.2A) 
compared to CON but on days 5 and 7 of development the numbers of newly 
formed blastocysts were not different (P ≥ 0.07; Figure 6.1C) in the second 
experiment. Blastocysts from HYP donors contained more cells than CON (P ≤ 
0.002; Figure 6.2). In experiment 1, HYP clones contained 52.7 vs. 35.1 cells in 
CON (SE = 2.9 cells) and in the second experiment HYP clones contained 37.9 
vs. 32.2 cells in CON (SE = 2.5 cells; See Figure 6.2C). 
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6.5 Discussion 
 The advent of Dolly, the first lamb created from somatic cell nuclear 
transfer (SCNT) of an adult mammary cell prompted many to explore the 
phenomenon of cloning (Campbell et al., 1996). Somatic cell nuclear transfer has 
enabled the creation of many valuable gene- edited animals useful in 
biomedicine, agriculture, and biotechnology (for example BioSteel spider silk in 
goat milk). However a large impediment to researchers is that only a small 
percentage of reconstructed embryos survive gestation and some of these 
animals are born with developmental abnormalities; therefore the inefficient 
process can be quite expensive. In light of this however, cloning is still the most 
reliable way to produce a gene- edited animal at this point in time. Zygote 
injections using CRISPR have the complication of unpredictable editing where 
individuals produced can be highly mosaic (Yen et al., 2014). This poses a large 
challenge where mosaic animals created by zygote injection may not have the 
desired disease phenotype or genotype as a biomedical model. Sperm-mediated 
gene transfer has not been largely adopted in the field due to very low success 
rate of transgenesis among many other reasons for the creation of gene edited 
pigs reviewed in (García-Vázquez et al., 2011).  
 In an effort to improve cloning, several studies have attempted to elucidate 
what constitutes the 'ideal donor- cell'. These studies include investigations of 
serum starvation and cell cycle regulation, type of cell, age of animal from which 
cells were extracted, age of cells themselves (or passage number), epigenetic 
reprogramming, degree of pluripotency, and antioxidant treatment of cells 
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(Campbell et al., 1996; Dominko et al., 1999; Kato et al., 2000; Tani et al., 2001; 
Wakayama and Yanagimachi, 2001; Heyman et al., 2002; Mitalipov et al., 2002; 
Wilmut et al., 2002; Wells et al., 2003; Powell et al., 2004; Bonk et al., 2007; 
Oback and Wells, 2007; Iager et al., 2008; Whitworth et al., 2011b; Yang et al., 
2012; Chen et al., 2015).  
 Proper nuclear remodeling and epigenetic reprogramming of donor-cells is 
revered to be the key to improving SCNT and is thoroughly under examination 
(reviewed in (Armstrong et al., 2006; Niemann et al., 2008; Whitworth and 
Prather, 2010)). Improper nuclear reprogramming has also been attributed to the 
developmental defects which are sometimes observed in clones; the genome of 
somatic cells must be reset to express genes consistent with appropriate 
progression of embryonic development (reviewed in (Armstrong et al., 2006)). In 
accordance to this, when blastomeres are used as donor- cells for SCNT the rate 
of success was improved (Mitalipov et al., 2002). Therefore we speculated that if 
somatic cells could be induced to be more blastomere-like the cloning efficiency 
may be greatly improved. Early implantation embryos are evidenced to be highly 
glycolytic. There is growing indication that glycolysis may facilitate 
reprogramming and pluripotency maintenance (Kondoh et al., 2005; Zhu et al., 
2010; Folmes et al., 2011; Moussaieff et al., 2015). We hypothesized that if 
donor- fibroblasts were cultured under hypoxic conditions, it would elicit higher 
glycolytic activity thereby promoting a more Warburg-like metabolism exhibited in 
the blastomeres of early embryos. It was desirable that this 'reprogramming' 
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induction be through a simple mechanism that could be applied to any cell line 
we receive such as altering the metabolism during culture via hypoxia. 
 Previously our laboratory reported that oxygen restriction in porcine fetal 
fibroblasts induced expression of 7 genes involved in glycolysis in addition to 
expression of pyruvate dehydrogenase kinase 1 (Mordhorst et al., 2017d). This 
kinase is evidenced to be a key player in thwarting the entrance of pyruvate into 
the TCA cycle thereby effectively decreasing mitochondrial oxidative 
phosphorylation (Papandreou et al., 2006). These changes in gene expression 
indicate that metabolism of fibroblasts cultured in hypoxia exhibit a Warburg 
effect- like phenotype. However in this study we demonstrate that proliferation of 
cells cultured in hypoxia (HYP) was not substantially increased compared to 
controls (CON), as might be predicted in Warburg effect metabolism. There is 
literature evidencing enhanced proliferation in restricted oxygen culture of 1-3% 
(Falanga and Kirsner, 1993; Saito et al., 1995; Betts et al., 2008). 
 In this study, we demonstrate that measures of in vitro development are 
improved when fibroblasts cultured in hypoxia are used as donor- cells for SCNT. 
Clones from HYP fibroblasts consistently cleaved earlier and had higher total 
blastocyst production (Figure 6.1B and C) regardless of fibroblast line used for 
cloning. Early cleavage is a predictor of developmental competence and embryo 
quality (Cruz et al., 2012; Isom et al., 2012; Kaith et al., 2015). Use of time lapse 
imaging in human embryology has demonstrated that the timing of cleavage 
divisions are linked to early formation (day 5) of more competent embryos with 
higher viability scores (Cruz et al., 2012). Additionally early cleaving embryos 
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have better rates of pregnancy (Lundin et al., 2001). In our experiments, earlier 
cleaving embryos were more likely to form blastocysts than embryos which had 
cleaved after 24 hours post activation regardless of donor-cell treatment (Figure 
6.1C). Of the early cleaving embryos, the percentage that developed into 
blastocysts was higher in HYP clones compared to CON (Figure 6.1C). Early 
timing of blastocyst formation is also an indicator of embryo quality and success 
of implantation (Motato et al., 2016). More HYP clones had formed blastocysts 
on earlier days than their CON counterparts in both experiments, however in 
experiment 1 this was apparent by day 5 whereas in experiment 2 this difference 
was seen on day 6 (Figure 6.1D). Although the rate of blastocyst formation 
between experiments was not the same, HYP clones had stable higher total 
percentages of reconstructed embryos which formed blastocysts; 12.7 and 
13.0% more than CON in experiments 1 and 2 respectively (Figure 6.1C). 
Blastocysts derived from HYP donor- fibroblasts had more total blastomeres than 
CON donors, though in experiment 1 this difference was more profoundly 
observed where HYP donors had about 18 more cells than CON blastocysts vs. 
experiment 2 where HYP donors had 6 more cells on average (Figure 6. 2C). 
 Interestingly there were differences between fibroblasts derived from the 
same fetal cell line based on whether they were edited with an ~ 100 base pair 
deletion or un-edited. Un-edited fibroblast donors had better rates of fusion after 
activation and cleaved earlier than the edited line. Another study from Kuhholzer 
et al. (2001) clonal transgenic lines derived from the same pig fetus had different 
efficiencies of fusion, but also development to the morula and blastocyst stages. 
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One possibility is complications for the embryo due to the gene edited, however 
in our experience these particular FAH mono-allelic knock out pigs have normal 
gestational survival which would indicate the gene edited may not be a 
hindrance. Another possibility is that there may be off- target editing in the 
genome which is evidenced to occur using the CRISPR-CAS9 editing system 
(Cradick et al., 2013; Fu et al., 2013; Cho et al., 2014). 
 One limitation to this study is that at the present time, we do not know if 
HYP clones have improved gestational survival or pregnancy rates. Research 
from others demonstrates that good in vitro development does not always 
correlate to successful pregnancies (Redel et al., 2016). While HYP embryos 
cleave earlier and have higher rates of blastocyst formation, other factors such 
as rate of fusion after activation, the differences of timing of blastocyst formation, 
and the total percentage of blastocysts which form are different between 
experiments. These differences as well as many others have the potential to vary 
even week to week in any embryo making it challenging to generalize findings.  
 Currently, experiments are underway to determine if HYP donor- cells do 
improve early gestational survival of reconstructed embryos. Additional studies 
may be needed to determine if these clones have normal gestational 
development and are born viable. More research is warranted in investigating 
whether these results are replicable in other cell lines and laboratories. 
Furthermore additional research is needed to perfect and optimize low oxygen 
culture, including whether stepwise decreases in oxygen concentration are 
necessary, as well as to look at other effects such as whether hypoxia impacts 
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epigenetics or pluripotency. From these experiments we conclude that the clones 
from donor cells cultured in hypoxia may be more developmentally competent 
embryos and this could possibly be due to better nuclear reprogramming during 
somatic cell nuclear transfer.  
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6.6 Figure legends 
Figure 6.1. In vitro development measures of somatic cell nuclear transfer 
(SCNT) embryos from donor cells cultured in hypoxia (hypoxic; 2 days at 5% 
oxygen, 1 day at 2.5% oxygen, 4 days at 1.2% oxygen) or as controls (control; 
5% oxygen 7 days) in experiments 1 and 2. 
A) Fusion percentage (percentage of embryos successfully fused from total 
reconstructed embryos) of SCNT embryos derived from hypoxic or control donor 
cells in experiments 1 and 2. 
B) Cleavage percentage (percentage of embryos successfully cleaved from total 
reconstructed embryos) of SCNT embryos derived from hypoxic or control donor 
cells in experiments 1 and 2. 
C) Day 7 blastocyst percentages (percentage of embryos successfully forming 
blastocyst stage embryos from total reconstructed embryos) of total, early 
cleaving (24 hours), and late cleaving (> 24 hours) SCNT embryos derived from 
hypoxic or control donor cells in experiments 1 and 2. 
D) Blastocyst percentages (percentage of embryos successfully forming 
blastocyst stage embryos from total reconstructed embryos) on days 5, 6, and 7 
of early cleaving (24 hours) SCNT embryos derived from hypoxic or control donor 
cells in experiments 1 and 2. 
 E) Blastocyst percentages (percentage of embryos successfully forming 
blastocyst stage embryos from total reconstructed embryos) on days 5, 6, and 7 
of late cleaving (24 hours) SCNT embryos derived from hypoxic or control donor 
cells in experiments 1 and 2. 
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Figure 6.2. Representative images and graph of total blastocyst cell number for 
developmental day 7 somatic cell nuclear transfer (SCNT) embryos from donor 
cells cultured in hypoxia (hypoxic; 2 days at 5% oxygen, 1 day at 2.5% oxygen, 4 
days at 1.2% oxygen) or as controls (control; 5% oxygen 7 days) in experiments 
1 and 2. 
A) 4X magnification of early cleaving SCNT embryos in culture derived from 
hypoxic and control cultured donor cells from 2 different cell lines.  
B) 20X magnification of SCNT embryos stained with Hoechst 33342 derived from 
hypoxic and control cultured donor cells from 2 different cell lines. 
C) Graph representing average total cell numbers of SCNT blastocysts derived 
from cells cultured in hypoxia or as controls. Numbers are least squared means. 
Error bars represent standard error. 
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Figure 6.1. In vitro development measures of somatic cell nuclear 
transfer (SCNT) embryos from donor cells cultured in hypoxia (hypoxic; 2 
days at 5% oxygen, 1 day at 2.5% oxygen, 4 days at 1.2% oxygen) or as 
controls (control; 5% oxygen 7 days) in experiments 1 and 2. 
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Figure 6.2. Representative images and graph of total blastocyst cell number for 
developmental day 7 somatic cell nuclear transfer (SCNT) embryos from donor 
cells cultured in hypoxia (hypoxic; 2 days at 5% oxygen, 1 day at 2.5% oxygen, 
4 days at 1.2% oxygen) or as controls (control; 5% oxygen 7 days) in 
experiments 1 and 2. 
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